- Staat
- SC
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 30.07.2023
- Impfdatum
- 20.06.2022
- Beginn
- 03.07.2022
- Tage bis Beginn
- 13,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Amyotrophic lateral sclerosis
Bedridden
Death
Fall
Gait disturbance
Laboratory test
Musculoskeletal disorder
Peroneal nerve palsy
Walking aid user
Symptomtext
Started have problems walking and had issues with left leg than would fall and couldn?t get up on own than dr said drop foot than left arm and hand turned unusable than a walker than on dec 22nd 2022 was told she had ALS and than in February bed ridden than in hospice and my wife passed on June 19th almost one year to the day of the vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- She had every test and dr could not figure it out and said they never herd the vaccine could cause this but we kept asking
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Na
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 95,0
- Geschlecht
- M
- Eingang
- 24.03.2023
- Impfdatum
- 11.08.2022
- Beginn
- 07.01.2023
- Tage bis Beginn
- 149,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
COVID-19 pneumonia
Death
SARS-CoV-2 test positive
Symptomtext
hospitalized for COVID 19 pneumonia and then died
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 7,0
- Labordaten
- Tested positive for COVID 1-7-2023
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- atrial fibrillation, black lung disease, and congestive heart failure
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 23.03.2023
- Impfdatum
- 25.06.2022
- Beginn
- 15.12.2022
- Tage bis Beginn
- 173,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Cough
Dyspnoea
Headache
Hypoxia
Mental status changes
Pain
SARS-CoV-2 test positive
Unresponsive to stimuli
Symptomtext
Patient brought to the ED by EMS on 12/15/22 for altered mental status, headache, worsening cough, shortness of breath, and generalized pain over the past few days. Prior to presentation, the patient's daughter found the patient unresponsive to questions, so she called EMS. In the ED, patient was found to be hypoxic in the 80s requiring 2L O2 by NC. COVID PCR test preformed in the ED also resulted positive. Patient was admitted 12/15/22 - 12/17/22 with discharge diagnoses including acute hypoxic respiratory failure due to COVID-19 pneumonia. During admission, she required up to 3L of supplemental oxygen, but was able to be weaned down to room air by discharge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 09.01.2023
- Impfdatum
- 09.08.2022
- Beginn
- 05.11.2022
- Tage bis Beginn
- 88,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
Anticoagulant therapy
Blood gases
Blood potassium decreased
C-reactive protein increased
COVID-19
Chest X-ray abnormal
Computerised tomogram thorax abnormal
Fibrin D dimer
Oxygen saturation decreased
Pleural effusion
Pneumonia
Productive cough
SARS-CoV-2 test positive
Troponin normal
White blood cell count increased
Symptomtext
11/5/2022-Presents to ED via EMS "I have pneumonia". ABG-7.452/44/55/30.3/ 88% 6L. Acute hypoxic rsp failure s/t covid. Covid + test. HX copd chronic 02 dep. Trop neg. D Dimer-248. WBC-12 CRP 22.5 Start decadron, inhalers. K-3.0 potassium 10 Meq x 5 doses given. Heparin. CXR-small b/l plueral effusion. VSS, 02 93%. Remdesivir started. 11/7/2022- 3L NC 02 sat low 90's. 11/11/2022- Doxy,Flagyl and mucinex ordered. Chest Ct possible spiration L upper lobe. Pt refused ABG's Productive cough On 15L nRB up from 3L , desat to 73% now 94%. 11/12/2022-WBC-17.4 Continue Doxy and Fagyl additional 5 days 11/15/2022-Titrate o2 to 2l NC. 11/16/2022-On dexamethasone, finished remdisivir. Chronic SOb d/t copd. Improved. WBC 15.0. Follow up with PCP d/c to SNF,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 11,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD,hyperthyroidism, schixophrenia, bladder ca,
- Andere Medikamente
- -
- Allergien
- PCN and potassium.
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 07.11.2022
- Impfdatum
- 22.06.2022
- Beginn
- 31.10.2022
- Tage bis Beginn
- 131,0
- Dosis
- 4
- Route/Site
- UN / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Appendicectomy
Aspiration
Atrial fibrillation
Bacterial infection
Blood culture positive
Bradycardia
COVID-19
Cardiac arrest
Central venous catheterisation
Chest X-ray abnormal
Constipation
Death
Electrocardiogram
Endotracheal intubation
Fall
Hypotension
Hypoxia
Intensive care
Symptomtext
Adverse event note: Per web report received by local County Public Health Department and per local Immunization Registry. COVID Vaccination information: Moderna 2/4/2021 043L20A Moderna 3/4/2021 032M20A Pfizer 9/29/2021 30155BA Moderna 6/22/2022 014B22A Patient presented to Hospital ED with a chief complaint of 2 falls. This patient was recently admitted for an appendectomy on 10/28/2022. He states that he had been home for a little more than a day and he had 2 falls 1 of those out of bed and another 1 onto the ground. He had difficulty getting up both times. Patient denied complaints of shortness of breath, cough. Patient stated he had a normal appetite but stated that he is constipated. Denies chest pain, headaches, dizziness, lightheadedness, or dysuria. In the ER, the patient was found to be COVID-positive and requiring a supplemental oxygen. Per additional web report notes. ?This patient underwent an appendectomy on 10/28/2022, was discharged after an unremarkable hospital course, and presented to ED after having fallen twice at home within a 24-hour time span, found to be COVID-positive, and a presentation concerning for sepsis. The patient had noted that he had not had a bowel movement following surgery, however chart review demonstrates that the patient had been refused suppositories. The patient was empirically covered with zosyn and blood cultures where obtained which grew with g ram positive rods with subsequent repeat blood cultures without growth. The patient had a new oxygen requirement on admission prompting COVID treatment with dexamethason e and Remdesivir. His oxygen was subsequently weaned to one liter on the morning of 11/1/2022. That evening, a rapid response was called overhead after the patient had vomited and became profoundly hypoxic requiring an oxygen mask at 15 L. Shortly after transfer to the IC U, the patient had another emesis and aspiration event with subsequent respiratory/cardia c arrest with subsequent ROSC at first pulse check. The patient became hypotensive requiring vasopressors. Amiodarone was initiated due to new onset A-fib with RVR. Multiple blood gasses were drawn chest xrays obtained showing worsening respiratory failure and respiratory acidosis secondary to his aspiration. The patient suffered a second cardiac arrest with ROSC achieved after several rounds of CPR and epinephrine pushes. The patient's family made him a DNR following ROSC. The patient again became bradycardic at which point the family requested that we not treat and let him pass peacefully with his daughter present. The patient was pronounced dead at 01:08 on 11/02/2022. No further information
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 3,0
- Labordaten
- Labs, ECG, Chest Xray, {dates unknown} Procedures: Intubation, Right IJ CVC
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- renal insufficiency, kidney stones, hypertension, BPH, and on Parkinson's disease
- Andere Medikamente
- unknown
- Allergien
- unknown. not noted in record
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 10.10.2022
- Impfdatum
- 13.06.2022
- Beginn
- 26.09.2022
- Tage bis Beginn
- 105,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Alanine aminotransferase increased
Anticoagulant therapy
Aspartate aminotransferase increased
Blood creatinine increased
Blood lactic acid increased
Blood potassium increased
COVID-19
Computerised tomogram head normal
Echocardiogram normal
Ejection fraction normal
Electrocardiogram ST-T change
Epistaxis
Hyperkalaemia
Hypertension
Hypertransaminasaemia
Hypotension
Intensive care
Symptomtext
Discharge Provider: DO Primary Care Provider : MD Admission Date: 9/26/2022 Discharge Date: 10/07/2022 Admitting Diagnoses: Active Problems: Goals of care, counseling/discussion Multiple comorbid conditions PRESENTING PROBLEM: Septic shock HOSPITAL COURSE: 87 y.o. man who has a past medical history significant for hypothyroidism, prostate cancer, hypertension, depression, and GERD who was brought to the emergency department with altered mental status and was found to be hypotensive. Patient was also noticed to have some degree of ST changes involving the inferior leads. Initial workup was significant for elevated lactic acid at 4.6, hyperkalemia with K of 6.2, AKI with creatinine of 2.73, mild transaminitis with AST of 144, ALT of 95, initial elevated troponin but with flat delta, and positive COVID swab. He received IV fluids along with antibiotics. Cardiology evaluated the patient and given his AKI, decision was made not to proceed with a left heart catheterization. TTE was performed and showed LVEF of 60-65% with normal RV function and size. No pericardial effusion. Given his persistent hypotension, patient was started on norepinephrine infusion. MICU team was consulted for hypertension and decision was made to transfer the patient to MICU service for evaluation and management of shock. CT head was unremarkable. Patient's shock it did improve and he was weaned off pressor therapy. Patient renal failure also did improve. Patient was continued to seen by Cardiology recommendation was to continue with medical therapy. Patient was started on aspirin and Eliquis however unfortunately patient developed a persistent nosebleed which required ENT evaluation and rhino rocket placement. Recommendation from ENT is to use hold the Eliquis and aspirin for a total of 5 days. On discharge patient will be continued on aspirin daily. Will continue to hold Eliquis due to his risk of bleeding and limited benefit on hospice services. Patient was discharged under hospice care on 10/07/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Septic shock
- Hospital-Tage
- 11,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Goals of care, counseling/discussion Multiple comorbid conditions
- Andere Medikamente
- aspirin 81 MG chewable tablet azaTHIOprine (IMURAN) 50 MG tablet baclofen (LIORESAL) 20 MG tablet busPIRone (BUSPAR) 5 MG tablet calcium carbonate antacid (TUMS ULTRA 1000) 1000 MG chewable tablet cholecalciferol (VITAMIN D3) 50 MCG (2000 U
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 07.10.2022
- Impfdatum
- 26.10.2021
- Beginn
- 30.07.2022
- Tage bis Beginn
- 277,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
COVID-19
Death
Fall
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 03/09/2021, 03/30/2021, and 10/26/2021. The individual also received a dose of the Moderna product on 06/24/2022. They tested positive for COVID-19 on 07/30/2022 at the nursing home at which they were a resident. They were described as having developed "weakness" as a result of the COVID-19 infection. They fell on 07/31/2022 and died in the ambulance on the way to the hospital. This individual was not admitted to hospital for this illness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Positive COVID-19 antigen test despite being vaccinated.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Congestive Heart Failure, Type II Diabetes, COPD, Hypertension, Obesity, Heart Murmur, Stage 4 Chronic Kidney Disease
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 31.08.2022
- Impfdatum
- 08.04.2021
- Beginn
- 12.07.2022
- Tage bis Beginn
- 460,0
- Dosis
- 4
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: unbekannt
Erholt: nein
Cerebrovascular accident
Dysarthria
Movement disorder
Symptomtext
Two severe strokes on July 12, 2022. Was hospitalized at Medical Center. Cannot move left leg and left hand with slurred speech. Went to acute care and is not in sub-acute rehabilitation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 51,0
- Labordaten
- July 12, 2022 through present
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Singular, Trazadone
- Allergien
- Penicillin, shell fish, pollen
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 31.08.2022
- Impfdatum
- 05.07.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 22,0
- Dosis
- 4
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Ankle fracture
Base excess decreased
Blood bicarbonate decreased
Blood gases
Blood glucose normal
Blood lactic acid
Blood pH decreased
Blood potassium normal
Blood sodium normal
COVID-19
Calcium ionised normal
Cardiac arrest
Cardiac monitoring
Cardio-respiratory arrest
Cardiomegaly
Cardioversion
Cerebrovascular accident
Chest X-ray abnormal
Symptomtext
DO Last attending ? Treatment team Cardiopulmonary arrest Clinical impression Cardiac Arrest Chief complaint ED Provider Notes DO (Physician) ? Emergency Medicine (F) - 60 y.o. Note Creation:8/1/2022 Encounter Date:7/27/2022 History Chief Complaint Patient presents with ? Cardiac Arrest The patient is a 60 y.o. female with hx of cervical CA, chronic anemia, COPD, GERD, and MRSA colonization who presents to the ED for evaluation of cardiac arrest that began around 8am. Pt was eating breakfast at 0745. She is currently staying at facility s/p surgery for right ankle open trimalleolar fracture on 7/11. She tested positive for covid-19 at that time. Staff states that they came back at 0809 and began chest compressions. She was asystole with EMS and they got ROSC for a few seconds, but she returned to asystole. EMS also reports that they had a palpable pulse en route but lost it before arriving to this department. Pt was shocked x1. She was intubated 6'0 22 at the lip per EMS. Her glucose was 145 in this department. Time of Death called 0913. The history is provided by the EMS personnel, medical records and the nursing home. The history is limited by the condition of the patient. Past Medical History: Diagnosis Date ? Cancer cervical ? Chronic anemia 07/11/2022 ? Chronic constipation ? Chronic diarrhea ? Colitis 12/05/2020 ? Colon polyp ? COPD (chronic obstructive pulmonary disease) ? GERD (gastroesophageal reflux disease) 01/13/2011 ? MRSA nasal colonization 07/01/2022 Past Surgical History: Procedure Laterality Date ? ENDOSCOPY, COLON, DIAGNOSTIC ? HX CLOSED REDUCTION N/A 7/11/2022 ANKLE, EXTERNAL FIXATOR performed by MD at MC MAIN OR ? HX COLONOSCOPY N/A 12/9/2020 COLONOSCOPY /C POLYPECTOMY VIA SNARE(HOT) performed by MD ? HX CONE BIOPSY/CONIZATION (LASER ABLATION), CERVIX ? HX EGJ N/A 12/7/2020 EGD /C BIOPSY performed by MD ? HX EGJ N/A 7/14/2022 EGD /C ARGON PLASMA COAGULATION performed by MD ? HX KNEE ARTHROSCOPY ? HX TONSILLECTOMY ? LUMBAR PUNCTURE - FLUID TO LAB N/A 12/18/2020 LUMBAR PUNCTURE - DIAGNOSTIC performed by MD ? PR UPPER GI ENDOSCOPY,EXAM Family History Problem Relation Age of Onset ? Heart Disease Mother ? Cancer Mother lung (smoker) ? Colon Cancer Father ? Cancer Father colon, stomach ? Stomach Cancer Father Social History Tobacco Use ? Smoking status: Current Every Day Smoker Packs/day: 1.00 Years: 30.00 Pack years: 30.00 Types: Cigarettes ? Smokeless tobacco: Never Used Vaping Use ? Vaping Use: Never used Substance Use Topics ? Alcohol use: No ? Drug use: No Patient is a tobacco user, and I have offered a counseling referral. No LMP recorded. Patient is postmenopausal. Allergies Allergen Reactions ? Doxycycline Nausea Only ? Penicillins Rash Has tolerated rocephin in the past and during admission in 7/2022 Current Outpatient Medications on File Prior to Encounter Medication Sig ? sucralfate (CARAFATE) 1 gram tablet Take 1 Tablet by mouth Before meals and at bedtime. ? tiotropium (SPIRIVA) 18 mcg inhalation cap Take 1 Capsule by inhalation Once Daily. ? [EXPIRED] senna (SENOKOT) 8.6 mg tablet Take 1 Tablet by mouth Once Daily for 3 days. ? pantoprazole (PROTONIX) 40 mg DR tablet Take 1 Tablet by mouth Twice a day. ? gabapentin (NEURONTIN) 100 mg capsule Take 1 Capsule by mouth Once Daily. ? HYDROcodone-acetaminophen (NORCO) 5-325 mg per tablet Take 1 Tablet by mouth Every 6 hours. ? lactulose (CHRONULAC) 20 gram/30 mL solution Take 30 mL by mouth Three times a day. ? metoprolol (LOPRESSOR) 25 mg tablet Take 1 Tablet by mouth Twice a day for 30 days. ? ipratropium-albuteroL (DUO-NEB) 0.5 mg-3 mg(2.5 mg base)/3 mL nebulizer solution Take 3 mL by nebulization Every 4 hours. Indications: bronchi muscle spasm resulting from COPD ? budesonide-glycopyr-formoterol (BREZTRI AEROSPHERE) 160-9-4.8 mcg/actuation HFAA Take 160 mcg by inhalation Twice a day. ? roflumilast (DALIRESP) 250 mcg tablet Take 1 Tablet by mouth Once Daily. ? umeclidinium-vilanteroL (ANORO ELLIPTA) 62.5-25 mcg/actuation DsDv Take 1 Puff by inhalation Daily. ? albuterol (VENTOLIN HFA) 90 mcg/Actuation inhaler Take 1 Puff by inhalation Every 4 hours as needed (shortness of breath, wheezing). ? sodium chloride 1 gram tablet Take 1 Tablet by mouth Three times a day with meals for 30 days. ? leg brace (ANKLE BRACE) Misc 1 Device Daily as needed. ? RT OXYGEN PER DELIVERY DEVICE 2 L/min by Nasal Cannula route RT Continuous. Indications: COPD ? cetirizine (ZYRTEC) 10 mg tablet Take 10 mg by mouth Daily. ? esomeprazole (NEXIUM) 40 mg capsule Take 1 Cap by mouth Daily. ? metoclopramide HCl (REGLAN) 10 mg tablet Take 1 Tab by mouth Twice a day. Review of Systems Review of Systems Unable to perform ROS: Acuity of condition Constitutional: Negative for fever. Eyes: Negative for redness. Cardiovascular: Negative for leg swelling. Skin: Negative for pallor and rash. Neurological: Negative for facial asymmetry. Hematological: Negative for adenopathy. Does not bruise/bleed easily. Physical Exam ED Triage Vitals BP BP Manual or Automatic? Patient Position BP Location Heart Rate (Monitor) -- -- -- -- -- Pulse Pulse Source Resp Temp Temp src -- -- -- -- -- SpO2 SPO2 Location O2 Delivery O2 Device O2 Flow Rate (l/min) -- -- -- -- -- FIO2 (%) Pain Intensity 1 Exacerbated By Relieved By Quality -- -- -- -- -- Duration -- Physical Exam Vitals and nursing note reviewed. Constitutional: General: She is in acute distress. Appearance: She is well-developed. She is ill-appearing and toxic-appearing. Comments: ACLS protocol in place, compressions going on arrival. Pupils fixed round 5+ non reactive. Pale appearance. Cool to touch. HENT: Head: Normocephalic and atraumatic. Eyes: Comments: Pupils fixed. Neck: Vascular: No JVD. Trachea: No tracheal deviation. Pulmonary: Effort: No respiratory distress. Breath sounds: No stridor. No wheezing, rhonchi or rales. Abdominal: General: Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. There is no guarding or rebound. Comments: Soft non distended. No ecchymosis. Musculoskeletal: General: No tenderness. Skin: General: Skin is warm. Capillary Refill: Capillary refill takes less than 2 seconds. Coloration: Skin is pale. Neurological: Mental Status: She is unresponsive. Coordination: Coordination normal. Comments: gcs 3T MDM Treatment: Procedures Medications EPINEPHrine injection (1 mg Intravenous Given 7/27/22 0910) magnesium sulfate injection ( Intravenous Canceled Entry 7/27/22 0911) sodium bicarbonate injection (50 mEq Intravenous Given 7/27/22 0907) atropine injection (1 mg Intravenous Given 7/27/22 0912) Results for orders placed or performed during the hospital encounter of 07/27/22 SARS-CoV-2, QL, PCR (Rapid) Specimen: Throat Result Value Ref Range SARS-CoV-2 RNA Detected (A) Rapid Tox Screen, Urine Result Value Ref Range CANNABINOID NEGATIVE Cutoff: 50 ng/mL PHENCYCLIDINE NEGATIVE Cutoff: 25 ng/mL COCAINE NEGATIVE Cutoff: 300 ng/mL OPIATES POSITIVE (A) Cutoff: 300 ng/mL FENTANYL NEGATIVE Cutoff: 200 ng/mL BUPRENORPHINE NEGATIVE Cutoff: 5 ng/mL AMPHETAMINES NEGATIVE Cutoff: 1000 ng/mL BENZODIAZEPINE NEGATIVE Cutoff: 200 ng/mL METHADONE NEGATIVE Cutoff: 300 ng/mL BARBITURATES NEGATIVE Cutoff: 200 ng/mL OXYCODONE NEGATIVE Cutoff: 300 ng/mL PROPOXYPHENE NEGATIVE Cutoff: 300 ng/mL D-Dimer, QT Result Value Ref Range D-DIMER 2,483 (HH) 151 - 318 ng/mL Troponin I Result Value Ref Range TROPONIN I 0.14 (A) 0.00 - 0.02 ng/mL Fingerstick Glucose Result Value Ref Range GLUCOSE FINGERSTICK 145 (H) 70 - 110 mg/dL RT Blood Gas, Venous Result Value Ref Range PH,VENOUS 7.01 (LL) 7.32 - 7.42 PCO2,VENOUS 77 (HH) 41 - 51 mm[Hg] PO2, VENOUS 18 (LL) 28 - 48 mm[Hg] HCO3 13 mmol/L BASE EXCESS -13 mmol/L O2 SATURATION 11 % DRAW SITE Other O2 DEVICE 1 Ambu FIO2 100.0 % RT Potassium Result Value Ref Range RESP K 5.0 3.5 - 5.0 meq/L RT Sodium Result Value Ref Range RESP NA 137.00 130.00 - 150.00 meq/L RT Ionized Calcium Result Value Ref Range RESP IONIZED CALCIUM 1.23 1.10 - 1.35 meq/L RT Lactic Acid Result Value Ref Range RESP LACTIC ACID 14.9 (HH) 0.5 - 2.2 mmol/L Results XR Portable Chest (Final result) Result time 07/27/22 10:03:41 Final result Narrative: Medical Center Radiology PROCEDURE DATE: 07/27/2022 ORDERING PHYS: EXAM: Portable chest x-ray CLINICAL INDICATION:Cardiac arrest TECHNIQUE:Portable AP view of the chest COMPARISON: 07/18/2022 FINDINGS:The endotracheal tube terminates 5 cm above the carina. There is enlargement cardiomediastinal silhouette. There are patchy bilateral airspace opacities, similar to comparison exam. No pneumothorax or definite pleural effusion. IMPRESSION: No pneumothorax. Similar appearance of patchy bilateral airspace disease. Endotracheal tube appropriately positioned. THIS IS AN ELECTRONICALLY VERIFIED REPORT 7/27/2022 10:00 AM: MD MD DD: 07/27/2022 TD: 07/27/2022 Radiology Page 1 of 1 COPY Plan: RECHECK: Time of Death 0913 MDM Number of Diagnoses or Management Options Cardiopulmonary arrest Diagnosis management comments: Family made aware. And coroner notified. Amount and/or Complexity of Data Reviewed Clinical lab tests: ordered and reviewed Tests in the radiology: ordered and reviewed Tests in the medicine section: ordered and reviewed Discussion of test results with the performing providers: yes Decide to obtain previous medical records or to obtain history from someone other than the patient: yes Obtain history from someone other than the patient: yes Review and summarize past medical records: yes Discuss the patient with other providers: yes Independent visualization of images, tracings, or specimens: yes Risk of Complications, Morbidity, and/or Mortality Presenting problems: moderate Diagnostic procedures: moderate Management options: moderate Patient Progress Patient progress: stable DIFFERENTIAL DIAGNOSIS Differential Diagnosis: The following diagnoses were considered in the evaluation of this patient: cardiac arrest, sepsis, MI, PE, CVA, metabolic derangement, electrolyte disturbance and other acute pathologies. . Progress Note: deceased. family made aware. Coroner made aware. ED Prescriptions None Final diagnoses: Cardiopulmonary arrest ED Disposition ED Disposition Deceased Condition Stable Comment --
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 18.08.2022
- Impfdatum
- 25.07.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Unresponsive to stimuli
Symptomtext
On July 27th patient's son went to her home and found patient unresponsive face down on the floor. 911 was called. Per EMS report on their arrival to home, obvious signs of death were noted and patient was pronounced dead at 1214pm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Increase swelling in legs/feet
- Vorgeschichte
- Atrial Fibrillation COPD Hypothyroidism Peripheral Neuropathy CHF Mixed Hyperlipidemia Rheumatoid Arthritis Osteoporosis Steatosis of liver Vitamin D deficiency
- Andere Medikamente
- Aspirin 81mg Atorvastatin 80mg Combivent Respimat 20mcg/100mcg actuation solution for inhalation Vitamin B12 1000mcg Diltiazem CD 120mg Erythromycin 5mg/gram (0.5%) eye ointment Fenofibrate Nanocrystallized 145mg Flecainide 50mg Furesmide 2
- Allergien
- Levaquin - Hives Codeine - nausea
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 29.07.2022
- Impfdatum
- 22.06.2022
- Beginn
- 23.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Atrioventricular block complete
Cardiac arrest
Cardiac pacemaker insertion
Cardioversion
Death
Dyspnoea
Fatigue
General physical health deterioration
Intensive care
Malaise
Non-small cell lung cancer
Pulseless electrical activity
Resuscitation
Unresponsive to stimuli
Symptomtext
Patient presented to the ED via ambulance unresponsive and in cardiac arrest. Patient's son states that the patient said she felt fatigue, SOB and unwell that morning and later he heard a thump and found her unresponsive on the floor. The ambulance crew defibrillated the patient x 1 and the patient was then found to be in PEA. She had CPR in the home, received 2 doses of epinephrine and had ROSC. The EMS team placed an I-gel airway and the patient was brought to the ED. Patient was admitted to the critical care unit and underwent targeted temperature management, she was found to have an NSTEMI and to be in complete heart block. A temporary pacemaker was placed. Patient's condition continued to worsen and 12 days after admission the patient was admitted to inpatient hospice and died on 7/7/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 18,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Cough since COVID in January
- Vorgeschichte
- Hyperlipidemia, Hypertension
- Andere Medikamente
- Atorvastatin, Ergocalciferol, Lisinopril
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 22.07.2022
- Impfdatum
- 18.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Headache
Medical induction of coma
Respiratory tract congestion
Seizure
Symptomtext
Patient representative reported that the following day the patient encountered severe congestion and headache, patient reported to the hospital and had a seizure. Patient was placed into a medical coma and airlifted to larger medical center.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medical induction of coma
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Epilepsy
- Vorgeschichte
- Epilepsy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 95,0
- Geschlecht
- M
- Eingang
- 07.07.2022
- Impfdatum
- 17.06.2022
- Beginn
- 26.06.2022
- Tage bis Beginn
- 9,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Acute respiratory failure
Angiogram pulmonary abnormal
Anticoagulant therapy
Asthenia
COVID-19
Cardiomegaly
Chest X-ray abnormal
Confusional state
Cough
Decreased appetite
Delirium
Diarrhoea
Dyspnoea
Echocardiogram
Ejection fraction
Encephalopathy
Fatigue
Symptomtext
Discharge Provider: MD Primary Care Provider: MD Admission Date: 6/26/2022 Discharge Date: Jul 1, 2022 PRESENTING PROBLEM: Difficulty breathing [R06.89] Acute respiratory failure with hypoxia (HCC) [J96.01] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) [A41.9] COVID-19 virus infection [U07.1] HOSPITAL COURSE: Patient is a 95M with Alzheimer's dementia, hearing loss, vertigo, previous stroke, sleep apnea, BPH, severe aortic stenosis status post TAVR, chronic systolic and diastolic heart failure and hypothyroidism who presented with a chief complaint of 1-2 days of fatigue/weakness and decreased appetite. He was in his usual state of health until the day prior to presentation. He was out with family and when he returned, he had no appetite and did not eat dinner and this continued again in the morning. He also had an episode of diarrhea. Upon arrival, he had a fever of 39? C and mild leukocytosis of 11.19. He had a mild nonproductive cough and his chest x-ray showed mild cardiomegaly and pulmonary vascular congestion, but no obvious infiltrate or pleural effusion. Procalcitonin was negative (0.13). His SARS-CoV-2 PCR was negative. However, respiratory viral panel was sent and SARS-CoV-2 resulted positive there. He was admitted for sepsis and acute respiratory failure due to COVID 19. He is fully vaccinated against COVID 19. CXR no infiltrate. CT angiogram thorax showing subsegmental right middle lobe pulmonary embolism no evidence of right heart strain. Echo with EF of 59% no WMA. He received remdesivir x5 days given acute hypoxemia. Levaquin started in ED but was not continued. He was weaned down to room air by discharge. For his acute PE, he was transitioned from lovenox to eliquis with plan for 3 months of treatment. Home ASA 81 mg held while on eliquis to decrease bleeding risk. He appeared to have a mild acute kidney injury compared to his previous baseline labs (0.89-- >1.06). UA negative for UTI. Renal function improved to baseline by discharge. He did develop mild delirium/acute encephalopathy in the setting of known dementia. He has hearing loss which makes it harder to communicate. He is known to lip read which makes it harder for him to understand his care team with mask on. No treatment needed for his acute confusion. Frequent redirection, avoiding sedative/narcotics and encourage proper sleep wake cycle was re inforced. PT/OT recommend SAR and he was discharged to facility in stable condition on 7/1/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Atherosclerosis of coronary artery Problems with hearing Joint pain Dizziness BPH without urinary obstruction ED (erectile dysfunction) DJD (degenerative joint disease), cervical Hyperlipidemia LDL goal <70 Right bundle branch block Severe aortic stenosis Benign prostatic hyperplasia with urinary obstruction Hyperglycemia OSA (obstructive sleep apnea) Recurrent vertigo Myocardial infarction (HCC) Memory problem H/O: stroke Alzheimer's dementia (HCC) Hypothyroidism Special screening for malignant neoplasm of prostate Essential hypertension Numbness of both lower extremities Syncope, unspecified syncope type PVC (premature ventricular contraction) Late onset Alzheimer's disease without behavioral disturbance (HCC) At risk for falls Chronic obstructive pulmonary disease (HCC) Abnormal gait Chronic obstructive pulmonary disease, unspecified COPD type (HCC) Chest pain Tremor Coronary artery disease involving native heart, angina presence unspecified, unspecified vessel or lesion type NSTEMI (non-ST elevated myocardial infarction) (HCC) CVA (cerebral vascular accident) (HCC) Chronic combined systolic and diastolic CHF, NYHA class 3 (HCC) Urinary retention Localized edema S/P TAVR (transcatheter aortic valve replacement) Weakness Chronic right shoulder pain Mixed simple and mucopurulent chronic bronchitis (HCC) History of recent pneumonia Pneumonia due to COVID-19 virus COVID-19 virus infection
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler apixaban (ELIQUIS) 5 MG tablet atorvastatin (LIPITOR) 10 MG tablet Brimonidine Tartrate (LUMIFY OPTH) Carboxyme
- Allergien
- Bee VenomAnaphylaxis Advair DiskusOther Ceftin [Cefuroxime]Other CeftriaxoneOther Crestor [Hmg-coa-r Inhibitors]Myalgia Florinef [Fludrocortisone]Swelling Hytrin [Terazosin]Dizziness IbuprofenSwelling Lovastatin [Altoprev]Myalgia StatinsMyalgia TuberculinSwelling Zocor [Simvastatin]Myalgia Doxycycline [Tetracyclines]Unknown AzithromycinOther
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 07.07.2022
- Impfdatum
- 28.06.2022
- Beginn
- 29.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrovascular accident
Death
Full blood count abnormal
Haemoglobin decreased
Leukocytosis
SARS-CoV-2 test negative
Symptomtext
6/30/22 @ 1243 patient had stroke 7/6/22 @ 0938 patient expired
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 1,0
- Labordaten
- 6/30/22 COVID-19 test: negative 6/30/22 CBC: Leukocytosis, HGB 7.4
- Aktuelle Erkrankungen
- Leukocytosis, Muscle weakness, nonspecific abnormal find of lung field, anemia
- Vorgeschichte
- unspecified convulsions, allergic rhinitis, hypocalcemia, heart failure, Vitamin D deficiency, pacemaker, aphasia, muscle wasting and Atrophy, GERD, Diverticulitis, constipation, Chronic A-Fib, HTN, nonrheumatic mitral valve insufficiency, atherosclerotic heart disease, asthma, hearing loss, attention and concentration deficit, anxiety, hydrocephalus, personal history of COVID-19
- Andere Medikamente
- Claritin, Ergocalciferol, Folic Acid, Iron, Lipitor, Multi-vitamin, Plavix, Protonix, Tylenol, and Ativan
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 24.06.2022
- Impfdatum
- 15.06.2022
- Beginn
- 23.06.2022
- Tage bis Beginn
- 8,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Computerised tomogram thorax normal
Death
Laboratory test normal
Symptomtext
Patient was found dead at home
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Previous labs from visit on 6/15/22 were all stable for patient Chest CT scan that was done on 6/21/22 for screening lung nodule was stable
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- ACTIVE PROBLEMS Hypertension Primary malignant neoplasm of rectum Peripapillary choroidal neovascular membrane Pseudophakia Bilateral age-related nonexudative macular degeneration Vertical strabismus Presbyopia Anxiety Neuropathy Nicotine dependence Cancer of colon Colon Polyp Impaired fasting glucose External hemorrhoids without mention of complication Multiple pulmonary nodules
- Andere Medikamente
- Active Outpatient Medications Status ========================================================================= 1) ATROPINE 0.025/DIPHENOXYLATE 2.5MG TAB TAKE 2 TABLETS ACTIVE BY MOUTH FOUR TIMES A DAY 2)
- Allergien
- Nickel
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 29.07.2022
- Impfdatum
- 08.07.2022
- Beginn
- 08.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood test normal
Cardiac monitoring normal
Computerised tomogram head normal
Computerised tomogram spine
Contusion
Electrocardiogram normal
Eye injury
Fall
Feeling of body temperature change
Haemorrhage
Loss of consciousness
Nausea
Retinal disorder
Rib fracture
Vision blurred
Symptomtext
I received the injection mid-day. During the night I had nausea and hot and cold episodes. I got up around 5:30 a.m. extremely nauseated, went to the bathroom, and waited until the nausea passed. Walked into the kitchen, became extremely nauseated again, and then blacked-out. When I came to I was on the floor and bleeding. I believe when I fell I hit the kitchen island, counter top and then the floor. Contusions to the head (4), trauma to the left eye, and 2 rib fractures (#4 and5). Because of my history of Meniere's I want to clarify that I was NOT experiencing vertigo.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- The ER department completed an EKG, heart monitoring, head CT, upper spine CT, and bloodwork. All reports were excellent except for the rib fractures. I saw an Ophthalmologist and Retina Specialist for the eye injury. They identified fluid buildup around the retina causing blurred vision. Second checkup showed no more swelling around the retina.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Meniere's Disease Arthritis
- Andere Medikamente
- Prescription: Triamt/HCTZ 37.5-25 - 1/2 tab daily for Menieres Meloxicam 7.5mg - daily Fluticasone nasal spray 50 mcg ? PRN OTC: Vitamin D3 ? 5,000IU ? 1 daily Super B complex with Flic Acid Plus Vitamin C ? 1 daily Antacid calcium t
- Allergien
- Keflex
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 25.07.2022
- Impfdatum
- 22.07.2022
- Beginn
- 22.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood culture
Blood test
Dizziness
Echocardiogram
Electrocardiogram
Fall
Feeling abnormal
Loss of consciousness
SARS-CoV-2 test
Sleep disorder
Syncope
Symptomtext
PATIENT DID NOT FEEL GOOD AND WAS DIZZY 30 MINUTES AFTER VACCINATION. PATIENT STARTED TO FEEL WORSE AND NEED HELP TO GET TO BED THAT EVENING. PATIENT WOKE UP IN MIDDLE OF NIGHT AND FELL AT 2AM. AT 5AM PATIENT COLLAPSED AND WAS UNCONSCIOUS FOR 1 MINUTE. WIFE CALLED 911 FOR PATIENT TO GO TO ER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- 1,0
- Labordaten
- ER DID BLOOD WORK, EKG, ECHOCARDIOGRAM, BLOOD CULTURES, RECEIVED IV FLUID, DID COVID TEST AND RECEIVED BREATHING TREATMENTS FOR COPD. PATIENT WAS ADMITTED FOR OBSERVATION FOR 24 HOURS. AFTER 24 HOURS PATIENT WAS RELEASED FROM HOSPITAL AND IS HOME NOW. PATIENT IS GOING TO RECEIVE IN HOME CARE AND THERAPY.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- AFIB, COPD,
- Andere Medikamente
- LOSARTAN/HCTZ, AMLODIPINE, ROSUVASTATIN, ELIQUIS, TRELEGY
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 20.07.2022
- Impfdatum
- 27.06.2022
- Beginn
- 03.07.2022
- Tage bis Beginn
- 6,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Chest X-ray normal
Computerised tomogram head normal
Cough
Dizziness
Electrocardiogram normal
Fatigue
Feeding disorder
Fluid intake reduced
Malaise
Nausea
Respiratory tract congestion
SARS-CoV-2 test positive
Sleep disorder
Syncope
Symptomtext
On July 3 2022 in the evening I started to feel sick. I woke up middle of the night I woke up dizzy and fainted. I did an at home COVID-19 on July 4 2022. From then I got sicker. I couldn't eat or drink with nausea. Then I thought I was getting better. I spoke with my doctor and they told me to go to the emergency room. I went to the emergency room on July 11 2022. I was hooked up with fluids. I have never been that sick. I had a CT of my face, chest x-ray, and EKG at the emergency room. I was given Zofran. I was sent back home from the emergency room the same day with Zofran. I still a cough and congestion today. The fatigue lasted about one week.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- COVID-19, positive; CT, normal; X-ray of chest, normal; EKG, normal
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Rheumatoid Arthritis
- Andere Medikamente
- Remicade; Losartan; Ativan; Prilosec; Amlodipine; Crestor; Wellbutrin; Prolactin; Buspar; Baclofen; Calcium; Vitamin C; Flax seed oil; Glucosamine; Turmeric; Vitamin D3; Multivitamin
- Allergien
- Lisinopril
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 17.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anaphylactic reaction
Dyspnoea
Symptomtext
Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 05.07.2022
- Beginn
- 06.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Contusion
Diarrhoea
Fall
Headache
Injection site erythema
Injection site swelling
Lip injury
Pyrexia
SARS-CoV-2 test negative
Syncope
Vomiting
Symptomtext
Extreme headache for 3 days, vomiting, diarrhea, fainting Wednesday 7/06/2022, left arm swelling, fever in arm and redness for 7 days. Bruising on right arm, chin & small lip cut from fall when fainted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- I took a COVID home self test on Thursday, 7/07/2022, which was negative.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Rx none, Vitamins: D3, Cranberry,. etc.
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 04.07.2022
- Impfdatum
- 30.06.2022
- Beginn
- 30.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Flushing
Hyperhidrosis
Nausea
Syncope
Unresponsive to stimuli
Symptomtext
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Mild, Additional Details: patinet received the first dose of moderna. shortly after administration of the vaccine he fainted. woke up was dizzy and sweating. called 911 and int he meantime asked him to postion himself on his back and feet elevated and gave him water! 911 arrived and took hid blood pressure and sugar and heart rate. he mentioned he is feeling much better and does not need additional medical service. He stated this has happened once more at the dentist's office. He left and said he was feeling ok.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 29.06.2022
- Impfdatum
- 27.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Facial paralysis
Headache
Hypoaesthesia
Neck pain
Symptomtext
The day after the first dose was taken; the right side of my face is getting numb, I cannot move the right side of my face, I have a headache and right side of neck hurts
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 28.06.2022
- Impfdatum
- 28.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Hypotonia
Syncope
Unresponsive to stimuli
Symptomtext
after moderna 2nd booster vaccination , the patient felt lightheaded and requested some water. We gave her bottle of water and she was sitting in chair and then she dropped her water bottle and her head fell back and Rph asked if she was ok. She did not respond right away and was just staring and not able to respond so the staff called emergency. When the EMT arrived the patient was beginning to be aware of her surroundings and what was going on and was embarrassed she "fainted". The EMT checked her vitals etc, and she was able to leave on her own.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- EMT checked vitals but not sure exactly what kind, blood pressure and were talking to her about blood sugars as well
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma
- Andere Medikamente
- unknown
- Allergien
- no allergies listed for medications,food components, vaccine components, or latex
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 27.06.2022
- Impfdatum
- 19.06.2022
- Beginn
- 20.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Arthralgia
Asthenia
Chills
Confusional state
Diarrhoea
Dizziness
Fall
Fatigue
Hypotension
Injection site bruising
Injection site pain
Injection site swelling
Lethargy
Nausea
Pain
Pyrexia
Syncope
Unresponsive to stimuli
Symptomtext
Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Confusion-Severe, Systemic: Diarrhea-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Fever-Severe, Systemic: Hypotension-Severe, Systemic: Joint Pain-Severe, Systemic: Nausea-Severe, Systemic: Vomiting-Severe, Systemic: Weakness-Severe, Additional Details: PT REPORTING SHE CANNOT MOVE HER LEG/WALK ALONG WITH ALL ABOVE SYMPTOMS, SHE REPORTED FALLING DOWN AND WAS BROUGHT TO ER. ACCORDING TO PT, ER MD TOLD HER THAT HER SYMPTOMS COULD BE DUE TO COVID VACCINE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 24.06.2022
- Impfdatum
- 24.06.2022
- Beginn
- 24.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hyperhidrosis
Loss of consciousness
Syncope
Symptomtext
Profuse sweating, loss of consciousness, syncope
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Diabetes
- Andere Medikamente
- unknown
- Allergien
- penicillins
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 07.11.2023
- Impfdatum
- 28.06.2022
- Beginn
- 05.11.2023
- Tage bis Beginn
- 495,0
- Dosis
- 4
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Alanine aminotransferase normal
Anion gap
Aspartate aminotransferase normal
Atelectasis
Auscultation
Bacterial test positive
Base excess increased
Basophil count increased
Basophil percentage
Bilirubin urine
Blood albumin normal
Blood alkaline phosphatase normal
Blood bicarbonate increased
Blood bilirubin normal
Blood calcium normal
Blood chloride decreased
Blood creatinine normal
Blood culture
Symptomtext
Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on November 05, 2023 12:04 Verified By: MD on November 05, 2023 12:40 Encounter Info: Hospital, Inpatient, 11/05/23 - * Final Report * History of Present Illness/Subjective 87-year-old female with past medical history of COPD on 2 L of oxygen at baseline through nasal cannula, CHF, afib, diabetes, hypothyroidism, hypertension hyperlipidemia presenting with shortness of breath x few days Patient was noted to be apparently well until few days ago when she said shortness of breath began. She had just recovered from COVID diagnosed more than 10 days ago. She never needed hospitalization or increasing oxygen requirements during her COVID treatments but remembered she was on antibiotics that she could not remember the name. Shortness of breath progressively got worse until few hours prior to presentation when her oxygen was noted to be low. She normally uses 2 L of oxygen at home through nasal cannula, while she was checked in the home it was noted that her oxygen saturation dropped to the 70s leading to increased oxygen requirements. This was associated with altered mental status leading to presentation to the hospital. No chest pain, abdominal pain, nausea vomiting diarrhea constipation, urinary symptoms, lower extremity or swelling. No recent travel or sick contacts. No recent trauma. She reports fever of 101 this morning On bedside evaluation, patient is awake and alert AOx3, endorses improvement in shortness of breath. She notes recurrent episodes of vomiting but no diarrhea. In the ER Vitals Blood pressure 135/62, heart rate 95, respiratory rate 21, SPO2 96% on 2 L of OxiMax Labs WBC 21,000, hemoglobin 12.1, platelets 248, Sodium 141, potassium 4.0, chloride 96, bicarb 36, BUN/creatinine 31/1.04, LFTs unremarkable troponin 29 Lactate 2.6 down trended to 2.1 Blood gas pH 7.43, PCO2 61, bicarb 40 Urinalysis pH 6.5, protein 30, ketones trace, leukocyte esterase trace, WBC 0-5, RBC 3-5 COVID-negative Flu AB undetected Imaging CXR 1. Small left pleural effusion and probable left basilar atelectasis, infiltrate and/or parenchymal scarring. Review of Systems All 13 point review of systems were reviewed with the patient and are negative except as specified in the HPI Physical Exam/Objective Vitals & Measurements most recent past 24 hours WT: 119.90 kg (WFC) BMI: 49 Hemodynamics Neurologic Patient Weight Current Daily Weight: 119.9 kg 11/05/23 BMI: 49 11/05/23 Morbid Obesity (BMI > = 40) Patient Height Current Height: 156.5 cm 11/05/23 General: Alert and oriented, No acute distress. Eye: Normal conjunctiva. Cardiovascular: Regular rate, Normal rhythm, No murmur. Respiratory: Lungs are clear to auscultation, Respirations are non-labored. Gastrointestinal: Soft, Non-tender, Non-distended, Normal bowel sounds, No organomegaly. Neurologic: Alert, Oriented, non focal Psychiatric: Cooperative, Appropriate mood & affect. Musculoskeletal: No swelling, Assessment/Plan 87-year-old female with past medical history of COPD on 2 L of oxygen at baseline through nasal cannula, CHF, afib, diabetes, hypothyroidism, hypertension hyperlipidemia presenting with shortness of breath x few days 1. Severe sepsis R65.20 Evidenced by leukocytosis, lactic acidosis, tachypnea and fever Source of severe sepsis is likely due to pneumonia. Recent history of COVID that did not require hospitalization adequate capillary refill/perfusing pressure on repeat examination, imaging positive for infiltrate, Patient is already improving and therefore at low risk for hemodynamic and respiratory instability. Blood cultures pending, urinalysis appears weakly negative at this time, procalcitonin pending, lactate repeat WNL. Continue empiric coverage with ceftriaxone and doxycycline. De-escalate therapy as appropriate. SARS CoV 2 negative. Continue IVF at 100cc/hr and encourage p.o. hydration 2. Pneumonia J18.9 Seen on x-ray. RT eval to follow. Not requiring 2.5 L of oxygen through facemask. Baseline is 2 L through nasal cannula. Reports to be feeling much better. RT eval to follow Continue oxygen supplementation to greater than 92% Takes prednisone 10 mg chronically for unknown reason. Resume 3. Hypoxia R09.02 Already improving. Continue to monitor. Telemetry 4. Chronic hypercapnic respiratory failure J96.12 Blood gas shows well compensated respiratory acidosis RT eval to follow Continue oxygen supplementation and wean as able 5. Chronic hypoxemic respiratory failure J96.11 6. Diabetes mellitus type 2, noninsulin dependent E11.9 CDU protocol in place. Carb controlled diet 7. Chronically on opiate therapy Z79.891 Resumed 8. Essential hypertension I10 Hold antihypertensives due to ongoing sepsis 9. Hyperlipidemia E78.5 Resume. Follow-up on lipid profile. 10. Hypothyroidism E03.9 Follow-up TSH. Resume current home dose of levothyroxine 11. Obstructive sleep apnea G47.33 RT eval to follow 12. On apixaban therapy Z79.01 Resume home meds 13. Severe obesity E66.01 Counseled on lifestyle modification to encourage weight loss, patient is however not ambulatory PT eval to follow Code Status None Recorded Chronic Problem List Abnormal CT of the abdomen Chronic hypoxemic respiratory failure Chronically on opiate therapy Diabetes mellitus type 2, noninsulin dependent Diuretic-induced hypokalemia Essential hypertension History of lumbar laminectomy History of total knee replacement Hyperlipidemia Hypothyroidism Nausea & vomiting Noncompliance with CPAP treatment Obstructive sleep apnea On apixaban therapy Severe obesity Stage 1 mild COPD by GOLD classification Procedure/Surgical History ?EGD - Esophagogastroduodenoscopy (11/24/2021) ?Cholecystectomy (12/05/2020) ?Biopsy of breast (01/01/2000) ?Post-surgery back pain (01/01/1999) ?Abdominal hysterectomy (01/01/1987) ?Birth of child ?Knee Replacement Surgical History Internal 11/24/2021 EGD Diagnostic MD 12/05/2020 Cholecystectomy Laparoscopic MD Medications Home Medications (35) Active acetaminophen 650 mg, PRN, Orally, Q4H Adalat CC 60 mg oral tablet, extended release 60 mg = 1 Tablet, Orally, Daily albuterol (Eqv-ProAir HFA) 90 mCg/inh inhalation aerosol 2 Puff, PRN, Inhalation, Q4H, as needed albuterol-ipratropium See Instructions, Q 6 HRS ascorbic acid 1000 mg oral tablet 1,000 mg = 1 Tablet, Orally, BID Aspercreme with Lidocaine 4% topical cream See Instructions, BID right shoulder Biofreeze 4% topical gel See Instructions, PRN, q 6 hours Breo Ellipta 200 mCg-25 mCg inhalation powder 1 Puff, Inhalation, Daily calcium carbonate 500 mg oral tablet, chewable 500 mg = 1 Tablet, PRN, Q2 cholecalciferol (vitamin D3) 50 mCg (2,000 intl units) oral capsule 50 mCg = 1 Capsule, Orally, Daily Claritin 10 mg oral tablet 10 mg = 1 Tablet, Orally, Daily cyanocobalamin 250 mCg oral tablet 2,000 mCg = 8 Tablet, Orally, Daily diclofenac 1% topical gel See Instructions, TWICE DAILY ferrous sulfate 325 mg (65 mg elemental iron) oral delayed release tablet 325 mg = 1 Tablet, Orally, BID guaiFENesin 600 mg oral tablet, extended release 600 mg = 1 Tablet, Orally, BID hydroCODONE-acetaminophen 10 mg-325 mg oral tablet 1 Tablet, PRN, Orally, Q6H Incruse Ellipta 62.5 mCg inhalation powder , 62.5 MG DAILY Lasix 20 mg oral tablet 20 mg = 1 Tablet, Orally, Daily levothyroxine 100 mCg (0.1 mg) oral tablet 100 mCg = 1 Tablet, Orally, Daily lysine 500 mg oral tablet 500 mg = 1 Tablet, Orally, BID magnesium oxide 500 mg oral tablet 500 mg = 1 Tablet, Orally, BID metFORMIN 750 mg oral tablet, extended release 750 mg = 1 Tablet, Orally, Daily metOLAzone 2.5 mg oral tablet 2.5 mg = 1 Tablet, Orally, Daily metoPROLOL succinate 100 mg oral tablet, extended release 100 mg = 1 Tablet, Orally, Daily Mirapex 1 mg oral tablet 1 mg = 1 Tablet, Orally, BID montelukast 10 mg oral tablet 10 mg = 1 Tablet, Orally, QPM Mucinex DM 30 mg-600 mg oral tablet, extended release 1 Tablet, PRN, Orally, Q12H Paxil HCl Tab 20 mg 20 mg = 1 Tablet, Orally, Daily Potassium Chloride (Eqv-K-Tab) 20 mEq oral tablet, extended release 60 mEq = 3 Tablet, Orally, BID predniSONE 10 mg oral tablet 10 mg = 1 Tablet, Orally, Daily PreserVision AREDS 2 oral capsule 1 Capsule, Orally, BID PreserVision AREDS 2 oral capsule 1 Capsule, Orally, Daily Refresh ophthalmic solution 1 Drop, PRN, Eyes, Both, Q6H zinc sulfate 50 mg, Orally, Daily Zofran 4 mg oral tablet 4 mg = 1 Tablet, PRN, Orally, Q6H Active Scheduled Inpatient Medications None Reported One-Time Medications Given 11/04/23 00:00:00 TO 11/05/23 12:04:47 None Reported PRN Medications (0600 - 0559) from 11/04 - 11/05 None Reported Allergies NKA Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Substance Abuse Denies Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. Family History Diabetes mellitus: Grandfather (P) and Grandmother (P). Kidney disease: Father. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 21 k/cumm High (11/05/23 01:38:00) RBC: 4.32 million/cumm (11/05/23 01:38:00) Hgb: 12.1 GM/dL (11/05/23 01:38:00) Hct: 38.3 % (11/05/23 01:38:00) MCV: 89 fL (11/05/23 01:38:00) MCH: 28 pg (11/05/23 01:38:00) MCHC: 31.5 GM/dL Low (11/05/23 01:38:00) RDW: 17.6 % High (11/05/23 01:38:00) Platelet: 248 k/cumm (11/05/23 01:38:00) MPV: 7.7 fL (11/05/23 01:38:00) Neutrophils %: 84 % (11/05/23 01:38:00) Lymphocytes %: 12 % (11/05/23 01:38:00) Monocytes %: 2 % (11/05/23 01:38:00) Eosinophils %: 0 % (11/05/23 01:38:00) Basophils %: 1 % (11/05/23 01:38:00) Absolute Neutrophil: 17.7 k/cumm High (11/05/23 01:38:00) Absolute Lymphocyte: 2.5 k/cumm (11/05/23 01:38:00) Absolute Monocyte: 0.4 k/cumm (11/05/23 01:38:00) Absolute Eosinophil: 0.1 k/cumm (11/05/23 01:38:00) Absolute Basophil: 0.2 k/cumm (11/05/23 01:38:00) Chemistry: Sodium SerPl QN: 141 mmol/L (11/05/23 01:38:00) Potassium SerPl QN: 4 mmol/L (11/05/23 01:38:00) Chloride SerPl QN: 96 mmol/L Low (11/05/23 01:38:00) Carbon Dioxide SerPl QN: 36 mmol/L High (11/05/23 01:38:00) Anion Gap: 9 mmol/L (11/05/23 01:38:00) BUN SerPl QN: 31 mg/dL High (11/05/23 01:38:00) Creatinine SerPl QN: 1.04 mg/dL (11/05/23 01:38:00) Estimated GFR (CKD-EPI, no race): 52 mL/min/1.73m2 Low (11/05/23 01:38:00) Estimated CRCL (CG): 47 mL/min Low (11/05/23 01:38:00) Glucose SerPl QN: 134 mg/dL High (11/05/23 01:38:00) Calcium Total SerPl QN: 9.6 mg/dL (11/05/23 01:38:00) Alkaline Phos SerPl QN: 95 Units/L (11/05/23 01:38:00) ALT SerPl QN: 26 Units/L (11/05/23 01:38:00) AST SerPl QN: 34 Units/L (11/05/23 01:38:00) Bilirubin Total SerPl QN: 0.5 mg/dL (11/05/23 01:38:00) Total Protein SerPl QN: 7.1 GM/dL (11/05/23 01:38:00) Albumin SerPl QN: 3.6 GM/dL (11/05/23 01:38:00) Troponin-I High Sensitivity: 9 ng/L (11/05/23 02:50:00) BNP Pl QN: 29 pg/mL (11/05/23 01:38:00) Lactate Venous Pl QN: 2.1 mmol/L (11/05/23 04:50:00) pH Bld Venous QN: 7.43 (11/05/23 01:38:00) PCO2 Bld Venous QN: 61 mmHg Critical (11/05/23 01:38:00) PO2 Bld Venous QN: <34 Low (11/05/23 01:38:00) Base Excess Bld Venous: 13 mmol/L High (11/05/23 01:38:00) Bicarb Bld Venous Calc: 40 mmol/L High (11/05/23 01:38:00) O2 Sat Bld Venous Calc: 57 % (11/05/23 01:38:00) Patient Temperature: 37 DegC (11/05/23 01:38:00) Urine Studies: Color: Yellow (11/05/23 05:00:00) Clarity: Slightly Cloudy (11/05/23 05:00:00) Specific Gravity: 1.035 High (11/05/23 05:00:00) pH: 6.5 (11/05/23 05:00:00) Protein: 30 Abnormal (11/05/23 05:00:00) Glucose: Normal (11/05/23 05:00:00) Ketones: TRACE. Abnormal (11/05/23 05:00:00) Bilirubin: NEGATIVE (11/05/23 05:00:00) Hgb Ur: NEGATIVE (11/05/23 05:00:00) Nitrite: NEGATIVE (11/05/23 05:00:00) Urobilinogen: 2.0 2 Abnormal (11/05/23 05:00:00) Leukocyte Esterase Ur: Trace25 Abnormal (11/05/23 05:00:00) WBC: 0-5 (11/05/23 05:00:00) RBC: 3-5 Abnormal (11/05/23 05:00:00) Bacteria: TRACE. (11/05/23 05:00:00) Squamous Epithelial: Moderate (11/05/23 05:00:00) Amorphous Crys Ur: PRESENT. (11/05/23 05:00:00) All Other Labs: COVID 19 Specimen Source: Nasopharyngeal (11/05/23 01:38:00) Coronavirus SARS-CoV2 Rapid: Not Detected (11/05/23 01:38:00) Micro - Last 7 days Rapid Influenza Method: FIA (11/05/23 02:22:00) Rapid Influenza A: Negative (11/05/23 02:22:00) Rapid Influenza B: Negative (11/05/23 02:22:00) Diagnostics Radiology Results - Last 24 hours Across Visits 11/05/2023 03:09 - XR Chest PA or AP Portable IMPRESSION: 1. Small left pleural effusion and probable left basilaratelectasis, infiltrate and/or parenchymal scarring.Template Version: Thank you for consulting our team of subspecialty radiologists at Radiology. Please contact us with any questions. Signature Line Electronically Signed on 11/05/23 12:40 ________________________________________________________ MD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 05.06.2023
- Impfdatum
- 14.07.2022
- Beginn
- 11.10.2022
- Tage bis Beginn
- 89,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Angioedema
Hypotension
Symptomtext
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION ANGIOEDEMA, INIT
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 14.10.2022
- Impfdatum
- 13.06.2022
- Beginn
- 13.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Limb injury
Paraesthesia
Symptomtext
Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 06.09.2022
- Impfdatum
- 08.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest discomfort
Dry skin
Dyspepsia
Dyspnoea
Erythema
Peripheral swelling
Pruritus
Symptomtext
This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (Skin itching in the bottom of hand/itching in the feet), ERYTHEMA (Redness in the hands), PERIPHERAL SWELLING (Swollen hands/swollen feet), DYSPNOEA (The patient had trouble breathing) and DYSPEPSIA (Felt like heart burn) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (infection) in January 2022. Previously administered products included for Product used for unknown indication: Pfizer vaccine (First dose, Batch Number: EN6208 and route: intramuscular) on 10-Mar-2021, Pfizer vaccine (Second dose, Batch Number: ER8737) on 31-Mar-2021, Pfizer vaccine (First booster dose and Batch Number: FH8028) on 20-Nov-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine, Pfizer vaccine and Pfizer vaccine. Concurrent medical conditions included Drug allergy (Cortisone) and Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE for Thyroid disorder NOS. On 08-Aug-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2022, the patient experienced PRURITUS (Skin itching in the bottom of hand/itching in the feet), ERYTHEMA (Redness in the hands), PERIPHERAL SWELLING (Swollen hands/swollen feet), DYSPNOEA (The patient had trouble breathing), DYSPEPSIA (Felt like heart burn) and CHEST DISCOMFORT (Pressure in chest). On 12-Aug-2022, the patient experienced DRY SKIN (The patient still felt dry skin even if it was not). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and ALBUTEROL [SALBUTAMOL] (inhalation use) at an unspecified dose and frequency. On 12-Aug-2022, PRURITUS (Skin itching in the bottom of hand/itching in the feet), ERYTHEMA (Redness in the hands) and PERIPHERAL SWELLING (Swollen hands/swollen feet) had resolved. At the time of the report, DYSPNOEA (The patient had trouble breathing), DYSPEPSIA (Felt like heart burn), CHEST DISCOMFORT (Pressure in chest) and DRY SKIN (The patient still felt dry skin even if it was not) had not resolved. The patient medical history was not related to mentioned adverse events and not with both acute and chronic illnesses at the time of vaccination. The patient was not given other vaccines within one month prior to Moderna COVID-19 vaccine. The patient had not a history of myocarditis/pericarditis. It was reported that two days after the second booster, the patient experienced an extreme side effect such as skin itching in the bottom of hand, redness, swollen, and feet were also started itching and were swelled, the patient still felt skin dry even if it was not because the patient moisturized it. The itchiness was gone, pressure comes and goes. The patient was thinking about visit emergency room. The adverse events had not caused patient to seek medical care, but the patient visited to primary HCP (health care professional). For cardiac symptoms, primary HCP recommended patient to visit a cardiologist. Treatment information included the patient had Benadryl, inhaler Albuterol, nebulizer for pressure in chest, felt like a burning heart, trouble breathing and moisturizer for dry skin. No treatment was specified for rest events. The patient not had tests of cardiac lab values (electrocardiogram, cardiac test, cardiac enzymes) and not had a test of positive COVID-19 test.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Drug allergy (Cortisone); Thyroid disorder NOS
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19 (infection)
- Andere Medikamente
- LEVOTHYROXINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 11.08.2022
- Impfdatum
- 10.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest pain
Confusional state
Depressed level of consciousness
Dizziness
Hyporesponsive to stimuli
Malaise
Pain in extremity
Symptomtext
Patient presents to the clinic for 2nd booster dose of Moderna COVID-19 vaccine. After vaccination verification process and questions, patient mentioned that he has a dexcom blood glucose monitoring system and stated that his blood sugar was 152. RN asked if he had eaten lunch yet and he stated "no, I am usually a late lunch eater and eat around 2pm" it was currently 2:37pm. After administering the vaccine, the patient was discharged to the lobby and as he was walking down the hall he stated he wasn't feeling good and started to feel dizzy. With the help of 2 MAs, we assisted him into the nearest office chair in the hallway near the VS station. The patient pulled out his phone to check his blood sugar and it read 145. VS were as follows: BP 138/83, SPO2 96%, HR 45bmp and climbing, reaching the 80s. Dr. was now in hallway with RN and MAs asking him how he was feeling and A&O questions. Patient now confused, slow to respond, with a decreased level of consciousness. RN waved an ammonia capsule infront of patient's nose with no response. MA applied ice pack to back of patient's neck and cool washcloth to forehead. Dr. now in hallway with previous staff listed. Dr. asked patient if he was having any chest pain. The patient stated yes. The patient also stated that his left arm was hurting. This was the same arm he received the vaccine in and was getting a BP read from. Dr. and Dr. collaborated and stated the patient needed to go to the ER. Staff assisted patient into wheelchair. Dr. called the ER as RN and MA were wheeling the patient and his belongings to the ER. RN and MA took patient through the main ER doors where RN gave report to the ER RNs and assisted them with move of patient to the ER bed where ER staff then assumed cares.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- Admission to Emergency Department at Hospital for further workup
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- COPD, Coronary Artery Disease, Depression, Anxiety, Hyperlipidemia, Hypertension, Type 2 Diabetes, Morbid obesity, Osteoarthritis,
- Andere Medikamente
- Albuterol inhaler, Atorvastatin, Klonopin, Cyclobenzaprine, Maxepa, Advair inhaler, Lasix, Guaifenesin, Insulin Aspart, Insulin NPH, Lisinopril-Hydrochlorothiazide, Metformin, Multivitamin, Potassium Chloride, Sertraline, Tamsulosin, Triamc
- Allergien
- Simvastatin
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 11.08.2022
- Impfdatum
- 03.07.2022
- Beginn
- 03.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain
Back pain
Dyspnoea
Headache
Pain
Pyrexia
Symptomtext
Moderna 7/3/2022 right deltoid, abdominal pain, sleep at 7 pm, 3 AM 103F and pounding headache, couldn't breathe due to shortness of breath unknown if anxiety. Back pain, sore. Past history. Fever until 2 PM. Local Pharmacy. Note will be placed in MyChart. Moderna Covid-19 , mRNA, LNP-S, PF Vaccine lot number 014B22A.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Ketorolac, Penicillin's
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 01.08.2022
- Impfdatum
- 08.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 3,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Aphonia
Chest discomfort
Cough
Decreased appetite
Dysphagia
Dyspnoea
Fatigue
Headache
Hyperhidrosis
Malaise
Mucosal discolouration
Oropharyngeal pain
Pyrexia
Respiratory symptom
Retching
Rhinorrhoea
SARS-CoV-2 test negative
Streptococcus test negative
Symptomtext
On July 11, I noticed when I woke up, I had a scratchy throat and a cough and respiratory symptoms. On the 12th, that included fatigue and exhaustion. I still continued with these upper respiratory symptoms until July 19th. On the 20th, I was feeling better, but I had a lot of nasal discharge until the 22nd. Then, I noticed on the evening of the 26th, I had a hacking cough, scratchy throat, and I was starting to feel very tired. I wanted to see what it would be like the next morning. The next morning, I was ill again, and it was obvious. I had a fever of 100.5. I had a negative COVID-19 test at home. I had my pulse oximeter at 95% and I had no appetite and fatigue and had tightness in chest. I was even dry heaving. At that point, I contacted my physician's office and they decided to set up a telehealth next morning. The next morning on the 28, my temp was 99.9, and I was tachycardic walking to the kitchen. I had no appetite, and I couldn?t swallow well. A lot of fatigue. I looked at the back of my throat and there was nothing there, just a little irritated. I did my telehealth visit and she wanted me to come in for testing. I did go in and tested for strep and COVID-19 and both were negative. We talked about over-the-counter therapies and azithromycin and I refused. On the 29th, I woke up in the morning and the temp was 98.8 and went up to 99.2. My chest felt looser. My fever had broken because my bed sheets were a bit wet. I still had the sore throat, and had the nasal discharge and fatigue. The 30th, at 3AM I think I had another fever and kept coughing. I couldn't catch my breathe and it was terrible. I was finally calmed down and able to go to sleep. When I woke up, I was again drenched in sweat. I changed my medication, and my temp was 99.5 at the highest. I had no voice at all on the 30th. On the 31st, had a better night. Temp was 99.3. Tachycardia in the morning. I did walk early in the morning, but it was exhausting. My nasal discharge was yellow and gray, but I cleared that. Helped with the headache I had. I still had no voice, and every swallow was still hard, but I was able to drink a little more freely. I still had to lay down at some point. I'm basically sleeping 10+ hours a night. I had another bout in the middle of the night last night. I was coughing, gagging. This morning the temp was 98.9. still had tachycardia but pulse went down. My face was puffy, but my throat is better. Still tired. Still have no appetite, but at least my weight loss has been stable at only 3 pounds.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- At-Home COVID-19 Test 07/11/2022 - Negative; At-Home COVID-19 Test 07/12/2022 - Negative; At-Home COVID-19 Test 07/13/2022 - Negative; At-Home COVID-19 Test 07/26/2022 - Negative; At-Home COVID-19 Test 07/27/2022 - Negative; PCR COVID-19 Test 07/28/2022 - Negative; Strep Test 07/28/2022 - Negative
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- History of Skin Cancers
- Andere Medikamente
- Valtrex; Estradiol Cream; Minoxidil Lotion for Scalp; Colace; Multivitamin; Calcium; Vitamin D; Biotin; Magnesium; Glucosamine Chondroitin; Fiber
- Allergien
- Doxycycline
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 01.08.2022
- Impfdatum
- 29.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal discomfort
Asthenia
Chest discomfort
Chills
Dyspnoea
Eye disorder
Eye pain
Injection site erythema
Injection site swelling
Lethargy
Limb discomfort
Mobility decreased
Nausea
Pain in extremity
Paraesthesia oral
Pharyngeal swelling
Pyrexia
Symptomtext
Started within 3 hours and lasted ~ one day (took OTC allergy pill) - swollen throat Started within 10 minutes and lasted 8 hours on and off - pain in opposite leg shin. Started within 4 hours and lasted for 3 days - upset stomach/nauseous. Started within 4 hours and last a few minutes - tingling lips. Started within minutes and lasted 2 days - unable to lift arm, arm heaviness Started on day 2 after shot and lasted through day 4 (still current) - swollen ~1 inch outward from arm and circular redness around injection site. Started within 4 hours and lasted 3 day, worst on night 2 - fever, chills. Started within 2 hours and lasted 4 days (current) - lethargic and no energy Started within 4 hours and lasted ~5 hours - heavy chest/hard to breathe a little. Started within 2 hours and lasted 4 days (current) and has been getting worse over time - random sharp pains and throbbing in right eye where I have an existing health condition
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Right eye injury at age 12 - left with no lens on the eye, an oil bubble in the back of the eye holding the shape and pressure of the eye, calcium deposits on the eye; no vision but some light possible.
- Andere Medikamente
- Valcyclovir; Birth control
- Allergien
- Amoxycillin
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 06.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Balance disorder
Condition aggravated
Dizziness
Feeling abnormal
Headache
Impaired driving ability
Loss of personal independence in daily activities
Mobility decreased
Nausea
Pain in extremity
Vertigo
Vomiting
Symptomtext
Received 2nd booster on Wed. 7/6 arm sore. Woke up Thursday morning with dizziness, headache. Tried to go about my day but experienced nausea and vomiting 3 times. Took to bed. Friday morning called Dr who said symptoms would subside. Bed-ridden and Fri. evening experienced vertigo. Saturday Dr prescribed meclizine 25mg every 6 hours. After 3 doses, I was able to get out of bed for extended time, Sunday too. Monday morning still having a dizzy feeling but feeling somewhat better. Dr said to try to taper. I went 25 hours without dose but felt a bit worse. Now (Wed-Fri) back to dosing every 8-10 hours. 9 days post booster, head still dizzy, balance off, not feeling like I can drive or resume normal activities. Signed up for vestibular therapy. I can't believe this happened!
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- 2019 suffered sudden one-sided sensory hearing loss with vertigo needing emergency room care. Unknown etiology. Recurrence of mild vertigo, 2021 and treated Feb. 2022. Both incidents treated with vestibular therapy which returned me back to normal.
- Andere Medikamente
- metoprolol, rosuvastatin, Vitamin D, fiber pills
- Allergien
- penecillin
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 08.07.2022
- Beginn
- 09.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Ear pain
Hallucination
Lymphadenopathy
Migraine
Nausea
Oropharyngeal pain
Symptomtext
Client stated that she had migraine with nausea, hallucinations, swollen lymph nodes on left side and severe back pain. She started that the pain also affected with ear-ache/sore throat type symptoms. She stated that she still has severe back pain, which is debilitating, but has improved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- None, instructed to contact pcp. Does not intend to have to see her, but will let her know of difficulties.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- migraine headache
- Andere Medikamente
- 3 5-day courses of 20mg (10mg BID) doses of prednisone annually (unknown as to last doses) Losartan 50 mg qd Oxy-IR, as needed, for migraines Phenergan, as needed Vitamins and minerals including Vitamin D, Magnesium
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 07.07.2022
- Impfdatum
- 01.07.2022
- Beginn
- 04.07.2022
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest discomfort
Chest pain
Dizziness
Palpitations
Symptomtext
Heavy heart, chest pain, heart palpitations, light head
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 04.07.2022
- Impfdatum
- 24.06.2022
- Beginn
- 25.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Diarrhoea
Fatigue
Feeling hot
Headache
Lethargy
Malaise
Mobility decreased
Nausea
Paraesthesia
Symptomtext
14 hrs following vaccines felt lethargic, hot, nauseous. Headache, malaise , chills, pins & needles in arms and legs, nausea severe enough to keep me in bed for 2 days. Gradual letup of symptoms except prolonged nausea , diarrhea & fatigue still continuing 8 days later. Can?t get back to normal routine still.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- None, just waiting it out at home
- Aktuelle Erkrankungen
- Recovering from a head cold the week prior
- Vorgeschichte
- Menopause
- Andere Medikamente
- Ibuprofen 400mg
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 46,0
- Geschlecht
- M
- Eingang
- 01.07.2022
- Impfdatum
- 24.06.2022
- Beginn
- 25.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Pain in extremity
Palpitations
Peripheral swelling
Vertigo
Symptomtext
Achy swollen left leg tiredness vertigo and heart palpitations
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- None the most severe case was on Sunday. Called a telehealth nurse on that day. Was told to drink fluids and take tylenol and bed rest.
- Aktuelle Erkrankungen
- Went to a doctor for irregular heartbeat june 8th was given a heart monitor to wear for 14 days to monitor my heartbeat. Have glaucoma and arthritis
- Vorgeschichte
- Arthritis
- Andere Medikamente
- None
- Allergien
- Food nuts and fish
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 21.06.2022
- Impfdatum
- 15.06.2022
- Beginn
- 16.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injected limb mobility decreased
Injection site swelling
Symptomtext
Pt came into pharmacy on 6/21/22 and wanted to speak with a pharmacist. She stated when she received her 2nd covid booster (moderna) the technician that gave the shot administered it too high and hit a nerve. Patient experienced a swollen imz site and complete immobility for 2 days and saw her dr on 6/20/22. Dr gave her exercises to increase her range of motion and pt is experiencing an improvement in range of motion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- unknown
- Andere Medikamente
- Ventolin HFA, fluoxetine, Sumatriptan, baclofen, Bupropion sr, losartan
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 20.06.2023
- Impfdatum
- 16.06.2022
- Beginn
- 01.01.2023
- Tage bis Beginn
- 199,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Fatigue
Heart rate increased
Nasal congestion
No adverse event
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 in 01/2023. I contacted my provider and got a prescription for PAXLOVID. It made me sick after two days, so I stopped taking. I took over the counter medicine to help me with my symptoms. I had chest congestion and nasal congestion. I had trouble with a dry unproductive cough. I got a prescription for a steroid and an antibiotic, and the cough finally got better. In 04/2023, I got sick again with chest congestion. I got another prescription for steroids and antibiotic. As of today, I am feeling better. In a couple of weeks, I am to contact my doctor and get a referral for a pulmonologist. When I lay down, I feel my heart beating. If I get up to fast, I notice my heartbeat goes up quickly. I do get tired very easily.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- JAN2023 COVID-19 test positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Osteoarthritis
- Andere Medikamente
- N/A
- Allergien
- Bee stings
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 14.03.2023
- Impfdatum
- 02.02.2021
- Beginn
- 04.03.2021
- Tage bis Beginn
- 30,0
- Dosis
- 4
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Muscle spasms
Neuralgia
Therapeutic response unexpected
Walking aid user
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- I do not feel that the taking the Modena Vaccine was adverse. It has been quite positive. Center of Disease Control Dear: I have sent letters to the Multiple Sclerosis Society and Agency. I?ve known for years that there is no known cause nor a cure for MS. In both of those letters I outlined the amazing improvements enjoyed by me over the last two years. I?ve heard speculation that MS could be brought on by some form of a viral infection. I was originally diagnosed in 1993. I plodded along until 2000 when I was required to stop working as a lending officer. Most years saw me having at least two exacerbations of the disease. I was usually able to somewhat recover through those times with the help of a steroid drip. The following is a basic explanation of what has occurred since February 2021 as I received Moderna injections. The injection dates are: 2-2-21, 3-3-21, 9-30-21. 6-22-22, and 10-26-22. I received my first Moderna Covid-19 injection on February 2, 2021. Within days my wife and I started to see some dramatic changes in my MS symptoms. At the time I was dealing with substantial MS related nerve pain. I was taking 80 MG of Methadone to deal with that pain. It appeared that the amount of my pain level was lessening. After taking the follow-up injection of the Moderna drug the pain began to be substantially less. In March 2021, I decided to begin working myself off of the prescribed Methadone. I went from 80 mg daily to zero in October 2021 when my Pain Doctor at the Facility put me on a very low dosage of Buprenorphine. My pain level continues to be quite low. During October 2021 I also stopped taking the approved MS Drug, Copaxone, which I had been on since 1998, I continue to improve. In fact, I began an exercise routine in January 2022. Each morning, this includes 30? sit-ups, 2? minutes on an elliptical machine, 20? jumping-jacks, 30? twist of my torso, and neck stretching for several minutes. I occasionally use my cane for balance. I realize that the MS may never go away completely. I still have fatigue, low level nerve pain and some spasms. I am 76 and happy to be able to assist my wife with house and yard work on a daily basis. I have read and been in many discussions regarding MS. The medical treatments of the disease during the past two years are very exciting. The lessening or elimination of my symptom have nothing to do with the new drugs. I have never heard of people afflicted with MS improving as rapidly as I?ve experienced. Regardless, the Moderna injections have been a blessing.
- Andere Medikamente
- Copaxone, Methadone, Cabapentin, Brain Health Supplement, Multi-Vitamin, Calcium, Vitamin D3
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 14.02.2023
- Impfdatum
- 10.08.2022
- Beginn
- 12.08.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cardiac dysfunction
Chills
Pain
SARS-CoV-2 antibody test
Symptomtext
Irregular cardiac function, body aches chills
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- Antibody test for Covid
- Aktuelle Erkrankungen
- Blood pressure issue
- Vorgeschichte
- None
- Andere Medikamente
- Rosuvastatin: Clopidogrel: Metoprolol: Aspirin
- Allergien
- Seasonal Allergies like rag weed. Atorvastatin: LIPITOR
- Vorherige Impfungen
- FLU SHOT
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 06.01.2023
- Impfdatum
- 02.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bone disorder
Pain in extremity
Sensation of foreign body
Symptomtext
Feeling something in her bones; migrating in the body in the lower back like a flu shot; Sore upper arm; This spontaneous case was reported by a patient and describes the occurrence of BONE DISORDER (Feeling something in her bones), SENSATION OF FOREIGN BODY (migrating in the body in the lower back like a flu shot) and PAIN IN EXTREMITY (Sore upper arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. The patient's past medical history included Sleepy (May be after third or second dose, patient felt sleepy and always soreness in the injection site) and Injection site pain (May be after third or second dose, patient felt sleepy and always soreness in the injection site). Previously administered products included for Product used for unknown indication: Pfizer (Lot number ER2630, Dose 1) on 19-Mar-2021, Pfizer (Lot number EW0158, Dose 2) on 09-Apr-2021, Pfizer (Lot number 32030BD and Dose 3) on 21-Oct-2021. Past adverse reactions to the above products included Vaccination complication with Pfizer, Pfizer and Pfizer. On 02-Feb-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BONE DISORDER (Feeling something in her bones), SENSATION OF FOREIGN BODY (migrating in the body in the lower back like a flu shot) and PAIN IN EXTREMITY (Sore upper arm). At the time of the report, BONE DISORDER (Feeling something in her bones), SENSATION OF FOREIGN BODY (migrating in the body in the lower back like a flu shot) and PAIN IN EXTREMITY (Sore upper arm) outcome was unknown. No concomitant product reported by reporter. No treatment medication reported by reporter. This case was linked to MOD-2023-694555 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 05-Jan-2023: Non significant live follow-up added.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Injection site pain (May be after third or second dose, patient felt sleepy and always soreness in the injection site); Sleepy (May be after third or second dose, patient felt sleepy and always soreness in the injection site)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 04.01.2023
- Impfdatum
- 21.06.2022
- Beginn
- 25.09.2022
- Tage bis Beginn
- 96,0
- Dosis
- 4
- Route/Site
- SYR / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Headache
Oropharyngeal pain
SARS-CoV-2 test positive
Symptomtext
I received my 4th Moderna Booster on 06/21/2022. My COVID-19 symptoms started on 09/25/2022 around 12:00PM in the afternoon. I had a sore throat, and a headache. I did a COVID-19 home test around 05:00PM which was positive. I called the tele doc the next day he prescribed me with PAXLOVID for 5 days. I also took ibuprofen and NYQUIL as per needed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- 04JAN2022 COVID-19 test positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 29.12.2022
- Impfdatum
- 28.06.2022
- Beginn
- 21.11.2022
- Tage bis Beginn
- 146,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Headache
Malaise
Nasopharyngitis
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
I had flown out of state, returned on 11/21/22, started feeling ill 11/21/22. I had a fever, headache, cough, head congestion. I thought I was getting a cold but once I developed a fever, I decided to use my home COVID-19 test that came back positive. I called my doctor who prescribed PAXLOVID, I started taking it on 11/23/22, by the third day I started to feel better. I did isolate for the five days. I did get rebound COVID-19 but without fever and it was relieved with over-the-counter cold medication. It wasn't as bad as the first week.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- Home COVID-19 test positive
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- Potassium; LIPITOR; PERCOCET
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 22.12.2022
- Impfdatum
- 21.06.2022
- Beginn
- 21.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Feeling abnormal
Peripheral swelling
Pruritus
Skin warm
Symptomtext
After vaccination, I went to the pharmacy then my arm started itching really really bad. I was concerned because I have several allergies to medication. I went back to location where I received the injection and they told me that it sometimes itches and to ice it and if it got worse to talk to my doctor. My arm started turning really red, my entire shoulder down to my elbow was red and hot to touch and itched so bad and very swollen. When I woke up the next morning, I tried to make an appointment with my doctor but no openings available so I walked into the clinic and demanded to speak to somebody. They sent me to see a nurse upstairs, she asked a bunch of questions. She asked if I was short of breath but I have COPD so I wasn't sure if it was from that. She told me to go home and ice it and if I further symptoms like unable to breath or tongue swelling to go to the emergency room. My arm was like that for two weeks. I kept ice on it. I rubbed BENADRYL cream on it. I kept moving it so it wouldn't be stiff. Now I'm afraid to get my 5th vaccine. I believe I'm now suffering from brain fog.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- COPD; Asthma
- Andere Medikamente
- Vitamin D3; pearls probiotic; loratadine; omeprazole; CENTRUM multivitamin for over 50 year old's; lisinopril; SPIRIVA; hydroxyzine
- Allergien
- BIAXIN; CEFZIL; CELEXA; iodine; latex; penicillin PCN class; sulfa with class; TEQUIN; tetracyclines class; codeine phosphate; erythromycin; WELLBUTRIN; codeine sulfate; sertraline; venlafaxine
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 22.12.2022
- Impfdatum
- 18.06.2022
- Beginn
- 11.11.2022
- Tage bis Beginn
- 146,0
- Dosis
- 4
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Ageusia
Anosmia
Asthenia
COVID-19
Chills
Fatigue
Impaired work ability
Nightmare
Pain
Pain in extremity
Pyrexia
SARS-CoV-2 test positive
Throat irritation
Symptomtext
On 11/11/2022 started having COVID-19 symptoms;scratchy throat; body aches specifically my thighs thighs;chills;weakness;fatigue; nightmares;fever of 101.5;sense of smell and taste I was out of work for 11 days nightmare.I tested positive 11/13. On 11/15 visited Urgent Care and was prescribed a course of Paxlovid for 5 days. I am feeling better but my sense of taste has not returned fully.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- 11/13/2022 COVID-19 - Positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Heart Palpitations ;IBS
- Andere Medikamente
- Metoprolol 50mgs Citrulline 100mg;Atorvastatin 40mgs
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 21.06.2022
- Beginn
- 20.11.2022
- Tage bis Beginn
- 152,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cough
Headache
Influenza A virus test positive
Pain
Pyrexia
Rhinorrhoea
SARS-CoV-2 test negative
Symptomtext
My adverse event for Influenza A started on 11/20/2022 in the morning around 8:00AM. I had fever, runny nose, cough, body aches, and headaches. I went to the clinic on 11/21/2022 they tested me for COVID-19, RSV and Influenza A. I tested positive for Influenza A. They prescribed with TAMIFLU for 5 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- 21DEC2022 COVID-19 test negative; 21DEC2022 Influenza A test positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Lumbar Canal Cirrhosis: Disk Generation; Fibromyalgia; Hypertension; Obesity
- Andere Medikamente
- KADIAN; CELEBREX; oxybutynin; trazodone; aspirin; multivitamins
- Allergien
- Cethromycin; benzodiazepines; Z-PAK
- Vorherige Impfungen
- All the COVID-19 I get body aches. It gets worse each time I get it.
- Staat
- CA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 06.12.2022
- Impfdatum
- 28.07.2022
- Beginn
- 30.07.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Depression
Diarrhoea
Injection site pain
Suicidal ideation
Symptomtext
Burning sensation with administration Deep depression with suicidal thoughts no attempts were made - resolved severe diarrhea for 5-8 weeks
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 05.12.2022
- Impfdatum
- 14.06.2022
- Beginn
- 03.12.2022
- Tage bis Beginn
- 172,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Pyrexia
SARS-CoV-2 test positive
Symptomtext
developed a fever and tested positive for covid on binax rapid antigen test 12/3/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 02.12.2022
- Impfdatum
- 02.08.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 3,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Blood test normal
Inflammatory marker test
Myalgia
Spinal X-ray
X-ray limb normal
Symptomtext
Three days after vaccine started feeling muscular pain all over body; Two days later also started feeling joint pain from my jaw to my feet; Called Dr and was referred to a Rheumatologist; Prescribed Meloxicam and it's helped a little but pain is still there; Currently waiting to get an MRI, appointment is at the end of December.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- Blood panel taken for inflammation markers - negative; X-ray knees cervical, neck hands and feet - negative findings.
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- Pre-diabetic;
- Andere Medikamente
- Ritalin; Spironolactone; Minoxidil; Miralax; Metrafol.
- Allergien
- Amoxicillin; Bactrim; Codeine; Demerol; Morphine; Tramadol.
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 27.11.2022
- Impfdatum
- 29.10.2022
- Beginn
- 30.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site pruritus
Vaccination site pain
Vaccination site reaction
Symptomtext
Patient said that a day or so after her vaccination, she noticed a ring around her left arm. It was about 3 inches wide and was above her elbow but below the vaccination site. It was tender to the touch and itchy and lasted about 3 weeks before it resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- None known
- Andere Medikamente
- Not known
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 14.11.2022
- Impfdatum
- 01.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 10,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Chills
Cough
Discharge
Fatigue
Malaise
Pain in extremity
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Throat irritation
Symptomtext
4th full dose of Moderna on July 1, 2022. Felt fatigue and sore arm for approx. 24 hours afterwards. On July 11, 2022, came down with scratchy throat and drainage; tested positive for Covid-19 on July 13, 2022. Started a course of Paxlovid, RX from rheumatologist. Was ill at home (chills, fever, cough, drainage, fatigue) for approx. 7 days; did not find relief from fatigue for nearly a month. On September 27, 2022, came down with scratchy throat, runny nose, and fatigue; tested positive for Covid-19 on September 30. Was ill at home for approx. 5 days, but to a lesser degree than in July. No fever this time. Fatigue lasted for about two weeks. Took Paxlovid again.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- psoriatic arthritis psoriasis endometriosis
- Andere Medikamente
- Cimzia Tylenol Multi-vitamin vit. C Vit. D3 Fish Oil CoQ10 Myoinositol NAC
- Allergien
- sulfa drugs amoxicillin intolerant to gluten and dairy
- Vorherige Impfungen
- Moderna doses 2 and 3 (reported on 11/14/2022): 4/2/21 and 11/9/21 -- Dose 2: lymph node swelling, headach, joint pain, chills/f
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 08.11.2022
- Impfdatum
- 20.06.2022
- Beginn
- 30.06.2022
- Tage bis Beginn
- 10,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Fall
Fatigue
Symptomtext
Narrative: Patient recently received his 4th moderna COVID immunization. He has not had any issues/concerns/reactions to previously administered vaccines. After receiving this 4th vaccine the patient and his wife noted that he was more fatigued than usual and they report that this fatigue resulted in him falling twice. These falls both occurred within the week following the vaccine administration. Patient is an elderly man who receives help from his wife with daily cares as well as is a part of home based primary care. There are multiple additional reasons for why the patient could have been fatigued and fallen. Patient also has diabetes and takes multiple medications that put him at increased risk for hypoglycemia which can cause fatigue and falls as well. The report noted that this reaction was only being reported as an adverse event in case the patient wanted to receive another booster in the future then the providers would know to educate on how to avoid falls. Patient as not had any documented falls since this event and has now expressed interest in receiving the bivalent booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 19.10.2022
- Impfdatum
- 20.07.2022
- Beginn
- 25.09.2022
- Tage bis Beginn
- 67,0
- Dosis
- 4
- Route/Site
- SYR / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Pyrexia
SARS-CoV-2 test positive
Symptomtext
I had the vaccination on 07/20/2022 for COVID-19. On 09/25/2022 I had a fever of 100 and a cough. On 09/29/2022 I tested COVID-19 positive. I contacted my doctor and they prescribed me antibodies on 09/30/2022. I am still testing positive and have a cough on 10/19/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- COVID-19 positive 09/29/2022
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Heart Transplant 07/2019
- Andere Medikamente
- Tacrolimus; mycophenolate mofetil; BACTRIM; aspirin; LIPITOR; tums; multivitamin; vitamin D; COZAAR; SYNTHROID; prednisone; amlodipine
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 21.09.2022
- Impfdatum
- 03.08.2022
- Beginn
- 22.08.2022
- Tage bis Beginn
- 19,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blindness
Computerised tomogram
Eye pain
Laboratory test
Magnetic resonance imaging
Symptomtext
Client woke up with blindness in eyes 8/22/2022 after receiving the COVID 19 Moderna vaccine 8/3/2022. Left eye was much worse than the right eye with pain included. Went to eye center could not get seen. Went to Emergency Room, was referred back to the eye doctor. Was given some eye drops and called 8/23/2022 early morning to got to Hospital for immediate admission.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Eye pain
- Hospital-Tage
- -
- Labordaten
- MRI, CT Scan, lab work performed at hospital where she was transferred and spent two weeks admission, evaluation and treatment.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 24.08.2022
- Impfdatum
- 26.07.2022
- Beginn
- 26.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain in extremity
Tenderness
Symptomtext
Patient reports tender sore arm that has continued since vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 23.08.2022
- Impfdatum
- 18.08.2022
- Beginn
- 18.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pruritus
Urticaria
Symptomtext
Patient had hives on arms and itchiness 10 minutes after vaccine was administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKMA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 94,0
- Geschlecht
- M
- Eingang
- 22.08.2022
- Impfdatum
- 22.07.2022
- Beginn
- 23.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Colitis
Housebound
Peripheral swelling
Vomiting
Symptomtext
Narrative: Patient 93 year old home bound - received 4th dose on 7/22/22. Had very swollen arm after injection, ws admitted to hospital 3 days later with vomitting due to colitis exacerbation
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vomiting
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 16.08.2022
- Impfdatum
- 26.07.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Fatigue
Feeling abnormal
Symptomtext
Ongoing extreme fatigue and exhaustion since day after 4th dose, brain fog, joint pain. (Lupus has been fairly stable for the last few years.)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None know
- Vorgeschichte
- Lupus, Hashimotos,
- Andere Medikamente
- Plaquenil, Synthroid, Effexor ER, Amlodopine, Spirolactone
- Allergien
- None known
- Vorherige Impfungen
- All Moderna, just fever & chills but gone within 48 hours.
- Staat
- NC
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 11.08.2022
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Burning sensation
Hypoaesthesia
Pruritus
Symptomtext
Burning, itchy, and Numbness of Left Thigh in a circle Appx 6 X 6
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Clonazepam .5 mg Trazodone 150 mg Levothyroxine 100 mcg
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 08.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Body temperature increased
Chills
Dizziness
Fatigue
Headache
Injection site pain
Pain
SARS-CoV-2 test negative
Symptomtext
Temp 101, chills, headache, injection site pain, body aches,fatigue, dizziness . Took Tylenol for 2 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- Took 2 COVID tests. Both were negative.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Thyroid removed due to cancer, high cholesterol, reflux
- Andere Medikamente
- Levothyroxine, Famotidine, Ezetimibe, vitamins D3
- Allergien
- Penicillin, Protonix, chlorhexidine
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 06.08.2022
- Impfdatum
- 04.08.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Lymph node pain
Lymphadenopathy
Pain
Pyrexia
Symptomtext
Patient states that about 24 hours after receiving vaccine, she started getting swelling in lymph nodes near her collarbone and shoulder area. She said they are extremely sore to the touch. She also had fever (102.1) , body aches and fatigue. Advised patient to monitor and seek treatment if needed. She was going to use some blue emu to help with pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Patient states she has chronic fatigue syndrome, diagnoses around 1992.
- Vorgeschichte
- Patient states she has chronic fatigue syndrome, diagnoses around 1992.
- Andere Medikamente
- -
- Allergien
- nkda
- Vorherige Impfungen
- moderna-first booster-fever, body aches, fatigue
- Staat
- TX
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 04.08.2022
- Impfdatum
- 05.01.2021
- Beginn
- 25.07.2022
- Tage bis Beginn
- 566,0
- Dosis
- 4
- Route/Site
- UN / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Malaise
Oropharyngeal pain
Productive cough
SARS-CoV-2 test positive
Symptomtext
Perhaps 3 weeks after last vaccination (second booster, Moderna) I felt mild Covid symptoms of cough and sore throat with heavy phlegm in throat; never had a fever (documented 97.3 F); symptoms lasted 2 days after which I had no further apparent illness; quarantined for 5 days after first symptoms were noted and always use a mask in public
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- Positive antigen test two days after onset of symptoms (on or about 25 Jul 2022
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Parkinsons (mild presentation)
- Andere Medikamente
- Prescriptions Carbidopa - Levodopa tabs 25-100 take 1.5 table
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 03.08.2022
- Impfdatum
- 14.06.2022
- Beginn
- 17.06.2022
- Tage bis Beginn
- 3,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: unbekannt
Amnesia
Anosmia
Blood test
Crying
Dizziness
Fatigue
Feeling abnormal
Feeling of despair
Headache
Hypersomnia
Laboratory test abnormal
Pain
Pain in extremity
Pyrexia
Red blood cell count decreased
Symptomtext
High temperature (range from 102 to 104 Deg) entire body for up to 2 weeks. Used ice bath to lower temp to 97 deg (normal for me). Currently (03?Aug/22) I have headache, bodyache, handache, extreme exhaustion, frequest sleeping beyond normal 8 hrs., unable to smell, foggy/dizzy with memory loss, difficulty with taking exams (including cognitive test from neurologist who did not want to hear about my C-19 issue with regards to cognitive challenges therefore I reported the Doctor to insurance Quality Dept for not providing my legal right for medical treatment. Doctor fired me due to no explanation provided), and outbursts of crying and feeling hopeless. Recent blood results show below RBC levles and immune cells are low and out of test range (date of test 21Jul22). I never had a medical history of low cell numbers. Promary doctor communicated that it will take 3 months for cells to rejuvinate & I should feel better (Dr, appt on 01Aug2022 and documented in medical chart.Note: I have never had a reaction to any vaccine in my lifetime until the C-19 booster (other C-19 vaccines was okay)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- NMedical results for blood test in , data base . Date of final record 21Aug22.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- yearly infections, high BP., high chol., anxiety, depression, pre-diabetic, over-weight, unable smell, GURD, cognitive
- Andere Medikamente
- bupropion XL 150 mg, Lipitor 40 mg, lexapro 20 mg, losartan 50
- Allergien
- Adhesive tape
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 29.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Myalgia
Nausea
Pyrexia
Vomiting
Symptomtext
Myalgia, Fever & NauseaVomiting Narrative:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myalgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 29.07.2022
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Myalgia
Pyrexia
Symptomtext
Dizziness, Myalgia & Fever Narrative:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 22.07.2022
- Beginn
- 23.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain
Rash
Symptomtext
Patient noted pain and then rash on 7/23 0700. Patient reports rash is near right clavicle, has spread to under right breast area and onto arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- Patient has not been seen by medical provider at time of this report.
- Aktuelle Erkrankungen
- None noted
- Vorgeschichte
- Grave's Disease - reports well controlled
- Andere Medikamente
- Multivitamin, Omega-3, Vitamin D, Biotene
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 25.07.2022
- Impfdatum
- 22.07.2022
- Beginn
- 23.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dyskinesia
Fatigue
Hypersomnia
Interchange of vaccine products
Muscular weakness
Poor quality sleep
Posture abnormal
Urinary incontinence
Symptomtext
Pronounced muscle weakness in torso (unable to sit upright, bladder incontinence), pronounced dyskinesia (unable to lift food with a fork from plate to mouth), fatigue. Started approximately 6 p.m. on 7/23/2022, or 22 hours after I received my 4th dose (2nd booster) of Covid-19 vaccine. I had Pfizer for the first 3 doses; this was my first experience with Moderna. I went to bed at 8 p.m. and slept fitfully until noon the next day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Parkinson's Disease
- Andere Medikamente
- Rytary ER 23.75-95 MG, Sertraline 100 MG, Cetirizine 10 MG, Vitamin D3 50 MCG, Vitamin B-12 500 MCG
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 24.07.2022
- Impfdatum
- 23.07.2022
- Beginn
- 24.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Pruritus
Pyrexia
Urticaria
Symptomtext
Patient reports low fever, and allergic symptoms including itching, hives, and a possible rash, all begining 7/24/22 (the day after their vaccination). Patient advised on care, and recommended to begin treatment with benadryl.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 21.07.2022
- Impfdatum
- 28.06.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 14,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood test normal
COVID-19
Chest X-ray abnormal
Cough
Fatigue
Influenza like illness
SARS-CoV-2 test positive
Symptomtext
On July 12, 2022, I started having flu-like symptoms. Tested positive for COVID on July 13, 2022 and began taking Paxlovid. On July 15, 2022, I received a chest X-ray and blood work. Both were normal. By July 18, 2022, I was getting some relief from the symptoms. As of now, July 21, I still have a slight cough and minor fatigue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Chest x-ray was clear. Blood analysis was normal.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 04.07.2022
- Beginn
- 06.07.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Aphasia
Asthenia
Blood creatine phosphokinase normal
C-reactive protein increased
Chest X-ray normal
Cough
Decreased appetite
Electrocardiogram normal
Exposure to SARS-CoV-2
Fatigue
Full blood count normal
Hypoxia
Laboratory test
Malaise
Memory impairment
Metabolic function test normal
Oropharyngeal pain
Troponin increased
Symptomtext
Patient was seen in ED at Hospital with complaint of cough, decreased appetite and generalized weakness since the morning. Patient denied any chest pain, abdominal pain, nausea, vomiting, fever or any other complaint at that time. She stated that she just had no appetite. Patient has dry cough an stated weakness that she stated started 6 to 12 hours ago. The problem occurs constantly. The problem has not changed since onset. Pertinent negatives include no chest pain, no abdominal pain, no headaches, and no shortness of breath. patient reported 2 days ago she was exposed to her husband who was positive for COVID and currently in a rehabilitation facility. Web report states patient stated she has been vaccinated and boosted x2 with last booster on July 2, 2022. Report states she started experiencing symptoms 7/6/2022 which included dry cough, fatigue and Malaise; she went to her PCP, who prescribed Paxlovid. Stated she took 1 dose prior to coming to the hospital. EKG showed normal sinus rhythm with a heart rate of 70 and no acute ST or T wave changes noted. She had a chest x-ray which showed no acute cardiopulmonary findings, and she had several labs including a CBC, CMP, total CK and troponin. All came back normal except for a troponin of 52 and 20 ketones in her UA. She was also treated with a liter bolus of 0.9 normal saline. Patient was admitted to hospital service for further management. Had Low grade temp 99.1. Mild hypoxia 86-88% documented as isolated incident, other recordings >90%. No oxygen needed. CRP 1.8. Chest x-ray with no acute cardiopulmonary findings. HS troponin was minimally elevated at 52, down to 46 and 48 today. Patient has been vaccinated for COVID-19. Reports 4th dose 7/2/2022. ID was consulted for further recommendations. Patient has some word finding/memory issues, forgetful. Uncertain how this compares to baseline. Patient states it is worse than usual for her. Denies cough, headache, chest pain, shortness of breath, body/muscle aches. No fevers, chills. Mild sore throat. The plan was to discharge patient home on prescription of Paxloid and resume prior medication. Health department has no further information on this patient's discharge or outcome.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Labs EKG Chest XR
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- ? Arthritis DJD knees, hands ? CAD (coronary artery disease), native coronary artery ? Cataract monitored ? Hypertension ? Hypothyroidism ? Osteopenia
- Andere Medikamente
- unknown
- Allergien
- Ace inhibitors Codeine
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood glucose
Diabetes mellitus inadequate control
Disorientation
Dizziness
Fall
Symptomtext
concerned about her blood sugar not being controlled, even with the medication/After vaccination her sugar was in the 400's.; Fell down twice/ The evening of vaccination day, heard her hit the floor/fell down twice; she was loosing orientation; she was dizzy/felt lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of DIABETES MELLITUS INADEQUATE CONTROL (concerned about her blood sugar not being controlled, even with the medication/After vaccination her sugar was in the 400's.) in a 65-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Patient never had any COVID-19 vaccine. Concurrent medical conditions included Type 1 diabetes mellitus. Concomitant products included INSULIN LISPRO (HUMALOG) for Type 1 diabetes mellitus. On 07-Jul-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 07-Jul-2022, the patient experienced DIABETES MELLITUS INADEQUATE CONTROL (concerned about her blood sugar not being controlled, even with the medication/After vaccination her sugar was in the 400's.) (seriousness criterion medically significant), FALL (Fell down twice/ The evening of vaccination day, heard her hit the floor/fell down twice), DISORIENTATION (she was loosing orientation) and DIZZINESS (she was dizzy/felt lightheaded). The patient was treated with INSULIN LISPRO (HUMALOG) for Diabetes mellitus aggravated, at a dose of extra dose (dose increased). At the time of the report, DIABETES MELLITUS INADEQUATE CONTROL (concerned about her blood sugar not being controlled, even with the medication/After vaccination her sugar was in the 400's.) outcome was unknown and FALL (Fell down twice/ The evening of vaccination day, heard her hit the floor/fell down twice), DISORIENTATION (she was loosing orientation) and DIZZINESS (she was dizzy/felt lightheaded) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2022, Blood glucose: 400's. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. The reporter stated the evening of vaccination day, he heard patient hit the floor, rescued her and it happened a second time also. All the events lasted only 1 day. On an unknown date in Jul-2022, the patient was taking extra medication (Humalog Insulin) to keep the sugar lower, but it did not keep normal. Reporter further stated that he was concerned about patient's blood sugar not being controlled, even with the medication. Reporter stated the patient had called the doctor and the doctor stated that it was normal for the sugar to go up, it was just like getting a flu. Treating physician suggested to keep adjusting insulin level to keep the sugar around 200's or lower. Company comment-This spontaneous case concerns a female patient aged 65 years with relevant medical history of Type 1 diabetes mellitus reported, who experienced the unexpected serious (medically significant) event of Diabetes mellitus inadequate control the same day after receiving first dose of mRNA-1273 vaccine. Patient had a little splurge up, was dizzy and fell down twice along with disorientation in the evening after vaccination. It lasted for a day. She is having uncontrolled blood sugars even with extra medication Humalog Insulin. After vaccination her blood sugars was in 400's (unit not specified). Consulted a doctor, was advised to adjust insulin and to keep blood sugars below200. Outcome of the event was unknown at the time of report. Relevant medical history could be confounder to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.; Sender's Comments: This spontaneous case concerns a female patient aged 65 years with relevant medical history of Type 1 diabetes mellitus reported, who experienced the unexpected serious (medically significant) event of Diabetes mellitus inadequate control the same day after receiving first dose of mRNA-1273 vaccine. Patient had a little splurge up, was dizzy and fell down twice along with disorientation in the evening after vaccination. It lasted for a day. She is having uncontrolled blood sugars even with extra medication Humalog Insulin. After vaccination her blood sugars was in 400's (unit not specified). Consulted a doctor, was advised to adjust insulin and to keep blood sugars below200. Outcome of the event was unknown at the time of report. Relevant medical history could be confounder to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- Test Date: 202207; Test Name: blood sugar; Result Unstructured Data: 400's
- Aktuelle Erkrankungen
- Type 1 diabetes mellitus
- Vorgeschichte
- Comments: Patient never had any COVID-19 vaccine.
- Andere Medikamente
- HUMALOG
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Headache
Symptomtext
Headache CHILLS Narrative:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 14.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Symptomtext
Dizziness lightheaded Narrative: V/S checked. Observed for 30 minutes. Felt better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 13.07.2022
- Impfdatum
- 21.06.2022
- Beginn
- 06.07.2022
- Tage bis Beginn
- 15,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Disturbance in attention
Fatigue
Headache
Hot flush
Impaired work ability
Malaise
Night sweats
Pain
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test positive
Secretion discharge
Sneezing
Symptomtext
I contracted COVID-19 on 07/06/2022 with symptoms of headache, congestion, runny nose, sneezing, hot flashes, night sweats, cough, mucous, extreme fatigue, body aches, and lack of focus. My symptoms began to improve on 07/09/2022. I felt well enough to work remotely today 07/13/2022. I was not prescribed any medications for my symptoms. I still have a slight cough, but I am feeling recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- COVID-19 PCR test was positive on 07/08/2022.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 12.07.2022
- Impfdatum
- 09.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cold sweat
Fatigue
Feeling hot
Hyperhidrosis
Hypersomnia
Night sweats
Pain in extremity
Symptomtext
profuse sweating
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 12.07.2022
- Impfdatum
- 27.06.2022
- Beginn
- 04.07.2022
- Tage bis Beginn
- 7,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Pain in extremity
Pruritus
Sensitive skin
Skin warm
Urticaria
Symptomtext
I received the vaccine on 06/27/2022. Later that night arm was sore. A week later in the evening I started having intense itching. next day around my groin area , right lower arm inside wrist I noticed I had hives on chest neck and back and hair. On July 5 I went to the doctor and my skin was very warm to touch and itching. I was prescribed Prednisone tab decreasing over a period of 12 days. I was was offer Hydroxyzine for 30 days. Still have contact dermatologist still visible. skin a little more sensitive. I was diagnosed with allergic urticaria.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- frequency of urination
- Andere Medikamente
- Omeprazole; Atorvastatin; Glucosamine; Chondroitin ; One A day Centrum Silver ; Fish oil tablets; Equate Fiber Supplement.
- Allergien
- Latex; Sulfa; Erythromycin; Hydrochlorothiazide ;
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 11.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Inappropriate schedule of product administration
Injection site erythema
Injection site pain
Symptomtext
Patient denies any ill effects-VAERS submitted only because of special requirements for COVID vaccines. Pt received her 2nd booster 13 days early
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- N/A - patient denies any ill effects beyond pain and redness at injection site (expected).
- Aktuelle Erkrankungen
- Neck pain, leg pain, hypokalemia
- Vorgeschichte
- COPD Chronic pain syndrome DM2 HTN RLS Sleep apnrea depression Obesity venous stasis peripheral edema Hx of PE
- Andere Medikamente
- Advair Potassium Chloride Gabapentin Pravastatin Levothyroxine Metformin Warfarin Victoza Furosemide amlodipine famotidine lisinopril Vitamin D3 Albuterol nebs and inhaler PRN Percocet PRN Cyclobenzaprine PRN
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 11.07.2022
- Impfdatum
- 08.07.2022
- Beginn
- 08.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
COVID-19
Cough
Diarrhoea
Fatigue
Infection
Injection site pain
Nausea
Oropharyngeal pain
Paranasal sinus discomfort
Rash
SARS-CoV-2 test positive
Symptomtext
On the same day of vaccination I had sore throat later that day and pain at injection site. On Saturday was really intense all day joint pain in the afternoon, I got severe diarrhea and nausea. Then I started coughing intermittently , it wasn't bad. Saturday night I actually slept better and the joint pain died down. On Sunday the cough was worse and it felt like I had sinus pressure and infection and fatigue. I broke out in a rash on my trunk front and back. Its typical for me when I get a significant illness, its an indicator that I have getting better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- 7/8/2022- at home COVID-19 test- negative; 7/11/2022 at home COVID-19 test - positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Migraines; Connective tissue disorder; Fibromyalgia; Chronic fatigue; IBS
- Andere Medikamente
- Famotidine; Loratadine; Turmeric with black pepper; Capsulated form of blended mushrooms; Ashwagandha; Magnesium Malate; L-Methylfolate; Magnesium L-threonate; Vitamin D3; Omega solution with Omega 3,6,and 9;Probiotic
- Allergien
- Contact Dermatitis Latex Allergy; Eggs; Almonds; CYP2D6 Metabolizer; NAT2 Acetylator Flow
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 08.07.2022
- Impfdatum
- 16.06.2022
- Beginn
- 17.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Extra dose administered
Vaginal haemorrhage
Symptomtext
The patient refers that after first dose 0n 6/22/21 she had difficulty in walking. After 2nd dose on 7/20 she was leaning to the side while walking. On 6/16/22 she had 4th dose and she presented abdominal pain the same day. When she woke up in the morning of 6/17 she noticed vaginal bleeding that has continue until now but in less amount (spotting).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- No medical tests, She is trying to get evaluation by a gynecologist. At this moment she has been unsuccessful on getting the appointment.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Multivitamins
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 08.07.2022
- Impfdatum
- 03.07.2022
- Beginn
- 03.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Injection site erythema
Injection site pruritus
Symptomtext
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Additional Details: pt takes cetrizin 10mg
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 06.07.2022
- Impfdatum
- 05.07.2022
- Beginn
- 05.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Fatigue
Headache
Injection site pain
Pyrexia
Symptomtext
Sore injection site Chills Headache Fatigue Low Grade Fever 99.9F
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- temperature check
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Vitamin E
- Allergien
- Vioxx and Naproxen
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 05.07.2022
- Impfdatum
- 24.06.2022
- Beginn
- 30.06.2022
- Tage bis Beginn
- 6,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Nasal congestion
Pain
Pelvic pain
Pyrexia
SARS-CoV-2 test positive
Throat irritation
Symptomtext
Vaccine given on 6/24 - tested positive for Covid on 6/30. Woke up to stuffy nose, scratchy throat, and overall achey-ness. Took at-home covid test in AM of the 30th, it was negative. As day progressed, pelvis started to really hurt and started to run a fever of 100.5 being the highest noted. Took second at-home covid test in late afternoon, it was positive. (the test line popped positive before the serum even made it to the control line). On 7/1, visited Drug store for a Rapid test, that was also positive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- 6/30 (AM) - At-Home Test - Negative 6/30 (PM) - At-Home Test - Positive 7/1 - Drug store - Rapid Test - Positive
- Aktuelle Erkrankungen
- Memory issues beginning after date of previous vaccination (9/2021), cognitive issues beginning after date of previous vaccination (9/2021), headaches, MRI conducted on 6/20/2022 indicated increased intercranial pressure
- Vorgeschichte
- High cholesterol, psoriasis, psoriatic arthritis, depression (diagnosed as Bipolar II)
- Andere Medikamente
- Lamotrigine, Remicade, Rosuvastatin, Zyrtec, Buspar
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 02.07.2022
- Impfdatum
- 30.06.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Diarrhoea
Symptomtext
Patient CAME INTO THE PHARMACY COMPALING OF DIARREA THAT STARTED THE MORNING AFER THE VACCINE AND CONTINUES TO TODAY
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- METOPROLOL, MYRBETRIQ
- Allergien
- ASPRIN
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 29.06.2022
- Impfdatum
- 29.06.2022
- Beginn
- 29.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Urticaria
Symptomtext
Hives under left arm by arm pit, down left side, on stomach. Hives appeared 1 hour after vaccination injection and became itchy by hour 2. Benadryl was taken.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- NA
- Allergien
- Dairy, penicillin, lidocaine, blue dye
- Vorherige Impfungen
- COVID-19 first booster resulted in COVID-arm, age 34, Date of vaccine 11/03/2021, mRNA, Moderna
- Staat
- GA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 28.06.2022
- Impfdatum
- 24.06.2022
- Beginn
- 24.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Cold sweat
Discomfort
Feeling abnormal
Gastrooesophageal reflux disease
Head discomfort
Heart rate increased
Neck pain
Pyrexia
Sensory disturbance
Thirst
Tinnitus
Symptomtext
As of Friday, 6.24.22, I immediately started feeling extreme pressure in my head. Started with fever and rapid heartbeat. It continue getting worst, Friday, Saturday and Sunday. Ears ringing and felt like needle piercing through my eardrums. Then on Saturday morning, I got very thirsty, was drinking Vitamin water with B12. On Monday, you woke up and had very bad abdominal pain, the kind that put me in a fetal position with cold sweats like I have right now. It lasted 24 hours. So much pressure in my abdominal. I could drink a little water and it would hurt me even more. I had some kind of acid come up, like I was trying to get sick. It wasn't much, but then back to the fetal position all night. Drinking made it worst. I wasn't going to get the vaccination cause it caused me hurt the last time, but I needed this vaccination to travel. My head is still foggy, and I have cold sweats. I do not want to go to the hospital cause it's 5000.00 per hospital visit. To get in with my VA is like pulling teeth, so I am trying to decide if I need to go to the hospital. At this point I'm not sure what they can do, my heart has taking a beating, neck pain, feel like someone is sticking me in my left side of my chest.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Pain pill due to spinal problems - Tramadol
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 27.06.2022
- Impfdatum
- 23.06.2022
- Beginn
- 27.06.2022
- Tage bis Beginn
- 4,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Hypophagia
Malaise
Unresponsive to stimuli
Symptomtext
6/23/22 Received vaccine 6/24/22 Seen by NP with c/o not feeling well. Fatigue and not eating but drinking appropriately. 6/27/22 Found unresponsive in room.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- respiratory failure
- Andere Medikamente
- -
- Allergien
- Azithromycin, Succinylcholine
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 26.06.2022
- Impfdatum
- 25.06.2022
- Beginn
- 25.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site induration
Injection site mass
Injection site pruritus
Injection site swelling
Symptomtext
Hard, raised lump with redness, swelling and itchiness. The lump appeared several hours after injection and or the right of the injection needle mark. The lump has grown overnight and is about the diameter of a golf ball
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Viral respiratory illness two weeks prior -non COVID
- Vorgeschichte
- Diagnosed with ankylosing spondylitis (haven?t taken humira or methotrexate 3 weeks prior to vaccine) Asthma
- Andere Medikamente
- Apri Vitamin D Folic acid Vitamin c Advair Flonase Azelastine
- Allergien
- Penicillin Paxil
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 26.06.2022
- Impfdatum
- 23.06.2022
- Beginn
- 24.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site erythema
Injection site pruritus
Symptomtext
red, circular area at injection site, itchy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 25.06.2022
- Impfdatum
- 23.06.2022
- Beginn
- 24.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Contusion
Erythema
Induration
Pruritus
Swelling
Symptomtext
red, round circular area with bruising, itches, hard bump
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 24.06.2022
- Impfdatum
- 22.06.2022
- Beginn
- 23.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Nausea
Vertigo
Symptomtext
vertigo, dizziness, nausea becoming significantly less serious; mild symptoms continuing as of 22 hours after onset
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Lyrica,Norco,Amlodipine,simvastatin,synthroid,tizanidine
- Allergien
- -
- Vorherige Impfungen
- vertigo, dizziness,nausea on 01/09/2022 after Moderna 058F21A COVID-19 injection on 01/08/2022
- Staat
- MO
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 23.06.2022
- Impfdatum
- 20.06.2022
- Beginn
- 23.06.2022
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Symptomtext
Rash on left arm. treatment with Tylenol and ibuprofen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 23.06.2022
- Impfdatum
- 15.06.2022
- Beginn
- 15.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Angioedema
Diarrhoea
Fatigue
Headache
Lip swelling
Oropharyngeal pain
Periorbital swelling
Rash erythematous
Rash papular
Rash pruritic
Swelling
Urticaria
Vomiting
Symptomtext
hives Onset 6 days ago. Severity is 7. Location is generalized and more on upper extremities. The patient describes it as erythematous, itchy and papular. It occurs continuously. The problem is worse. Relieving factors include IM Benadryl.. Pertinent negatives include diarrhea, fatigue, headache, sore throat and vomiting. Comments: h/o hay fever and Had his 2nd booster shot of Moderna COVID vaccine on 6/15/21 at 2 PM(no problems with previous 3 doses). Started itching at 6 PM and full blown hives at 9 PM with periorbital/lip swelling(R>>L). Angioedema/swelling The symptoms began 6 days ago. daily. Angioedema/swelling The symptoms began 6 days ago. The symptoms are reported as being moderate. The symptoms occur daily. He states the symptoms . Had significant periorbital and lip(R>>L) swelling with hives. off & on since 6/15. 3 ER visits for the problem. Parenteral Benadryl provided temporary relief. Switched from dose pack to higher dose of PO Prednisone(40mg). History of mild hayfever since childhood, usually doesn't take meds. Patient Plan 1) Allegra 180 mg 2-4 QAM. 2) Zyrtec 10mg 2-4 QPM. 3) Pepcid 20mg 1-2 B.I.D. 4) Singulair 10mg QD (monitor for stimulant/behavioural side effects as explained). 5) Continue PO Prednisone as before.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, Coronary arteriosclerosis in native artery, Mixed hyperlipidemia, Joint pain and Nocturia
- Andere Medikamente
- -
- Allergien
- ATORVASTATIN CALCIUM, CLARITHROMYCIN, PCN, SULFA, COVID
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 22.06.2022
- Impfdatum
- 19.06.2022
- Beginn
- 21.06.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Injection site erythema
Injection site pain
Injection site pruritus
Injection site swelling
Symptomtext
The patient had redness, swelling, itching, and soreness around injection site. He noticed it starting about 2 days after getting vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 22.06.2022
- Impfdatum
- 21.06.2022
- Beginn
- 22.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Feeling cold
Injection site pain
Injection site warmth
Pyrexia
Symptomtext
The day after the injections, patient is feeling warmth and pain at injection site along with cold chills. Counseled patient to continue taking acetaminophen for the fever, chills and pain. Can use warm or cold compresses as needed. Counseled that if allergic reaction occurs to contact 911 (difficulty breathing) and md if itchy rash develops.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- M
- Eingang
- 22.06.2022
- Impfdatum
- 19.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain in extremity
Symptomtext
arms are sore; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (arms are sore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2022, the patient experienced PAIN IN EXTREMITY (arms are sore). At the time of the report, PAIN IN EXTREMITY (arms are sore) outcome was unknown. Patient took second booster dose of Moderna COVID-19 Vaccine. No concomitant information were reported by the reporter. No treatment information were reported by the reporter. This case was linked to MOD-2022-592045 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 21.06.2022
- Impfdatum
- 16.06.2022
- Beginn
- 20.06.2022
- Tage bis Beginn
- 4,0
- Dosis
- 4
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain
Rash
Sleep disorder
Symptomtext
PT HAS A RASH BEGINNING UNDER HER LEFT ARM AND TRAVELING DOWN HER SIDE BEGINNING AT 1AM ON 6/20/22. THE PAIN WOKE HER UP AND ANYTHING TOUCHING THE RASH HURTS. SHE WILL GO TO THE DR ON 6/22/22 AT 9:20AM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- NO TESTING AT THIS TIME
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NO MEDICATIONS
- Allergien
- NO ALLERGIES
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 46,0
- Geschlecht
- U
- Eingang
- 21.06.2022
- Impfdatum
- 14.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature
Feeling cold
Glossodynia
Myalgia
Pyrexia
Vaccination site erythema
Vaccination site pain
Vaccination site pruritus
Vaccination site swelling
Vaccination site warmth
Symptomtext
woke up freezing cold but not shivering/felt like I could not get warm; white sore on the left side of my tongue (same side I got the shot on) that started being sore the second day; ran a fever (ear thermometer) of between 102.5-104.0/ran 101.5 fever; hotness at the injection site/injection site is still hot; injection site is still itchy; soreness at the injection site/injection site is still sore; swelling at the injection site/injection site is still swollen; redness at the injection site/injection site is still red; body aches; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE WARMTH (hotness at the injection site/injection site is still hot), FEELING COLD (woke up freezing cold but not shivering/felt like I could not get warm), GLOSSODYNIA (white sore on the left side of my tongue (same side I got the shot on) that started being sore the second day), VACCINATION SITE PRURITUS (injection site is still itchy) and VACCINATION SITE PAIN (soreness at the injection site/injection site is still sore) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE (initial dose) on 15-Mar-2021 and JANSSEN COVID-19 VACCINE (booster dose; Lot number: 213D21A) on 13-Nov-2021. Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE and JANSSEN COVID-19 VACCINE. Concurrent medical conditions included Overweight. On 14-Jun-2022 at 3:30 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jun-2022, the patient experienced GLOSSODYNIA (white sore on the left side of my tongue (same side I got the shot on) that started being sore the second day) and PYREXIA (ran a fever (ear thermometer) of between 102.5-104.0/ran 101.5 fever). In June 2022, the patient experienced VACCINATION SITE WARMTH (hotness at the injection site/injection site is still hot), VACCINATION SITE PRURITUS (injection site is still itchy), VACCINATION SITE PAIN (soreness at the injection site/injection site is still sore), VACCINATION SITE SWELLING (swelling at the injection site/injection site is still swollen), VACCINATION SITE ERYTHEMA (redness at the injection site/injection site is still red) and MYALGIA (body aches). On 15-Jun-2022 at 3:17 AM, the patient experienced FEELING COLD (woke up freezing cold but not shivering/felt like I could not get warm). The patient was treated with PARACETAMOL (TYLENOL) 15-Jun-2022 for Fever, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) 15-Jun-2022 for Fever, at an unspecified dose and frequency. On 18-Jun-2022, PYREXIA (ran a fever (ear thermometer) of between 102.5-104.0/ran 101.5 fever) had resolved. At the time of the report, VACCINATION SITE WARMTH (hotness at the injection site/injection site is still hot), VACCINATION SITE PRURITUS (injection site is still itchy), VACCINATION SITE PAIN (soreness at the injection site/injection site is still sore), VACCINATION SITE SWELLING (swelling at the injection site/injection site is still swollen) and VACCINATION SITE ERYTHEMA (redness at the injection site/injection site is still red) had not resolved and FEELING COLD (woke up freezing cold but not shivering/felt like I could not get warm), GLOSSODYNIA (white sore on the left side of my tongue (same side I got the shot on) that started being sore the second day) and MYALGIA (body aches) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jun-2022, Body temperature: 102.5-104.0 102.5-104.0 (unit not reported). On 16-Jun-2022, Body temperature: 101.5 101.5 (unit not reported). The patient was not taking any medicine concomitantly. The patient reported that the injection site intensified in direct sunlight. The patient reported that, husband and elderly mom also got the shot at the same time and had no effects. For fever, the patient continued treatment with alternating Tylenol and Advil till 09:00 pm of 15-Jun-2022. Treatment information for rest of the events were not provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myalgia
- Hospital-Tage
- -
- Labordaten
- Test Date: 20220615; Test Name: Body temperature; Result Unstructured Data: 102.5-104.0 (unit not reported); Test Date: 20220616; Test Name: Body temperature; Result Unstructured Data: 101.5 (unit not reported)
- Aktuelle Erkrankungen
- Overweight
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 20.06.2022
- Impfdatum
- 17.06.2022
- Beginn
- 19.06.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pruritus
Injection site swelling
Injection site warmth
Symptomtext
Redness, swelling, pruritus, and warmth below the injection site
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypertension, Hyperlipidemia
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 20.06.2022
- Impfdatum
- 17.06.2022
- Beginn
- 18.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Fall
Fatigue
Hemiparesis
Loss of personal independence in daily activities
Movement disorder
Urinary incontinence
Symptomtext
On 6/18/22 Client had increased fatigue, increased urinary incontinence, increased weakness (had 3 falls in 24 hour period first starting at 9:00am.) Client had new right sided weakness and wasn't able to use right arm or right leg. Staff have to completely assist client with eating.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- none.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Atrial fibrillation, Hypertension, Hyperlipidemia, Chronic anticoagulation, Mild episode of recurrent major depressive disorder, Cerebral infarction, Left hemiparesis, Poor memory, History of stroke with residual deficit, Multi-infarct dementia without behavioral disturbance,
- Andere Medikamente
- Acetaminophen, Citracal Petities/Vitamin D, Fluoxetine, Jantoven, Lisinopril, Metoprolol Tartrate, Mirtazapine, Omeprazole, Rosuvastain, Tab-A-Vite, Tamsulosin, Muscle Rub Cream, Lorazepam, Morphine
- Allergien
- Allergic to Atorvastatin
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 20.06.2022
- Impfdatum
- 16.06.2022
- Beginn
- 16.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site extravasation
Symptomtext
Error: Leaking from Injection Site-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site extravasation
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 19.06.2022
- Impfdatum
- 13.06.2022
- Beginn
- 13.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Decreased appetite
Diarrhoea
Fatigue
Headache
Vomiting
Symptomtext
started day as shot and has lasted last 6 days. vomiting, diarrhea, complete loss of appetite, extreme fatigue, violent headaches at the back of head
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- no known illness a month before vaccine
- Vorgeschichte
- no known health condition. Patient had covid before getting her first shot which was before 3/23/2021. She got covid again after her second shot which would have been after april 27, 2021.
- Andere Medikamente
- unknown what medications patient takes. She did take extra strength tylenol to treat headache and took an unknown nausea medication for the vomiting and diarrhea
- Allergien
- codeine allergy, no other known drug allergies
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 16.06.2022
- Impfdatum
- 10.06.2022
- Beginn
- 11.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dysuria
Headache
Nausea
Pain
Pyrexia
Symptomtext
Fever nausea burning of urine body aches headaches
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Hypothyrodism, diabetes
- Andere Medikamente
- No
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 15.06.2022
- Impfdatum
- 14.06.2022
- Beginn
- 15.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Injection site erythema
Injection site mass
Injection site pain
Injection site warmth
Symptomtext
The following day, about 2 inches below the injection site, her arm had a lump slightly larger than a Quarter, and was a little sore to the touch, and was slightly red and slightly warm to the touch. I instructed her to put ice on it, take tylenol or ibuprofen, and if it got worse as the night went on or in the morning, she was going to go have it checked out at her Dr office.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- -
- Geschlecht
- F
- Eingang
- 15.06.2022
- Impfdatum
- 09.06.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Feeling abnormal
Gait disturbance
Loss of personal independence in daily activities
Vomiting
Symptomtext
patient feels like she was dying; can hardly walk across the house without having to sit down; barely able to keep anything down; very, very tired; vomiting all morning; This spontaneous case was reported by a pharmacist and describes the occurrence of FEELING ABNORMAL (patient feels like she was dying), GAIT DISTURBANCE (can hardly walk across the house without having to sit down), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (barely able to keep anything down), FATIGUE (very, very tired) and VOMITING (vomiting all morning) in an elderly female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On 09-Jun-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On an unknown date, the patient experienced FEELING ABNORMAL (patient feels like she was dying), GAIT DISTURBANCE (can hardly walk across the house without having to sit down), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (barely able to keep anything down), FATIGUE (very, very tired) and VOMITING (vomiting all morning). At the time of the report, FEELING ABNORMAL (patient feels like she was dying), GAIT DISTURBANCE (can hardly walk across the house without having to sit down), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (barely able to keep anything down), FATIGUE (very, very tired) and VOMITING (vomiting all morning) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant medication information was not provided by the reporter. No treatment was given to the patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 13.06.2022
- Impfdatum
- 09.06.2022
- Beginn
- 09.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site induration
Injection site inflammation
Injection site pain
Injection site rash
Rash
Symptomtext
Patient presents in the area of injection "rash", rash, and itching. In addition to common adverse effects such as redness, pain, hardening and inflammation. Patient showed up at the pharmacy on Saturday, June 11, 2022 to notify. He was guided on common adverse effects and instructed to remain symptomatic by Monday to visit his preferred doctor. Report Monday 13 June 3:25pm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 13.06.2022
- Impfdatum
- 11.06.2022
- Beginn
- 12.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Feeling hot
Insomnia
Muscle tightness
Pain in extremity
Swelling
Symptomtext
He got his vaccine, he woke up the next morning, felt warm and took some Tylenol. He was very tried, and ate some breakfast but noticed soreness under his arm. He woke up again and it was severe, and put heating pad on it. He went back to sleep, woke up and put the sleeping pad back on it, and took some more Tylenol. He was up half the night with the pain. It's right underneath the armpit, on the side of his heart at the bottom part. It feels swollen, like a muscle is tightening in it. He is going to his doctor today. He is getting raised marks on his foot again, and has an appointment with his dermatologist today as well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- High blood pressure, high cholesterol, thyroid disease, Crohn's disease, history of mild heart attack.
- Andere Medikamente
- Losartan, Metoprolol, Levothyroxine, Atorvastatin, Vitamin D3, Sr's over 50 multivitamin, iron, Vitamin E,
- Allergien
- IVP dye, (itching).
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 09.06.2022
- Beginn
- 10.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Incorrect dose administered
Pain in extremity
Vomiting
Symptomtext
Patient received additional dose (0.5mL)vs. booster dose(0.25mL); patient experiencing weakness, vomiting, arm soreness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- psoriatic arthritis; HTN; neuropathy; diabetes mellitus
- Andere Medikamente
- insulin levemir ; amlodipine; glipizide XL; lexapro ; Metoprolol ER; atorvastatin; Vitamin D
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 11.10.2023
- Impfdatum
- 01.07.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 153,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test
Symptomtext
The patient also states she had COVID in December 2022; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (The patient also states she had COVID in December 2022) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. Concurrent medical conditions included Drug allergy (she is allergic to thimerosal). On 01-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2022, the patient experienced COVID-19 (The patient also states she had COVID in December 2022). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, COVID-19 (The patient also states she had COVID in December 2022) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2022, SARS-CoV-2 test: Positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient stated that she had Moderna all the way through. She wants to know if the new vaccine had thimerosal because she was allergic to thimerosal. The patient also states she had COVID in December 2022. She ended up taking Paxlovid at the time. She wants to make sure that it was ok to take Spikevax. The patient was unsure whether her Moderna dose on 1Jul2022 was monovalent or bivalent vaccine. Patient had Moderna on 12Feb2021, Moderna on 12Mar2021, and Moderna on 21Nov2021 Moderna on 01Jul2022 (lot number 014B22A). Concomitant medications were not reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Date: 202212; Test Name: COVID-19 Virus test; Test Result: Positive
- Aktuelle Erkrankungen
- Drug allergy (she is allergic to thimerosal)
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 25.07.2023
- Impfdatum
- 30.06.2022
- Beginn
- 02.10.2022
- Tage bis Beginn
- 94,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 4 vaccines Moderna 1/2/21 lot# 011L20A; Moderna 1/30/21 lot# 012L20A; Pifzer 11/9/21 lot# FG3527; MOderna 6/30/22 Lot# 014B22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 100,0
- Geschlecht
- M
- Eingang
- 05.07.2023
- Impfdatum
- 15.06.2022
- Beginn
- 29.10.2022
- Tage bis Beginn
- 136,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 4 vaccines Moderna 2/23/21 lot# 031M20A; Moderna 3/23/21 lot# 044A21A; Moderna 12/7/21 lot# 077C21B; Moderna 6/15/22 lot# 014B22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 20.06.2023
- Impfdatum
- 17.06.2022
- Beginn
- 17.04.2023
- Tage bis Beginn
- 304,0
- Dosis
- 4
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Biopsy breast abnormal
Breast cancer female
Breast operation
Ultrasound breast abnormal
Symptomtext
I was due for my annual mammogram in 2022. I had an ultrasound and diagnostic and a biopsy and it came back positive for breast cancer in my left breast. I had surgery in May 17, 2023 and I am on a treatment with Tamoxifen for 5 years.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Biopsy breast abnormal
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Osteo Bioflex; Vitamin C
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.06.2023
- Impfdatum
- 08.04.2021
- Beginn
- 14.07.2022
- Tage bis Beginn
- 462,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
COVID-19 immunisation
SARS-CoV-2 test
Vaccination failure
Symptomtext
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a patient of unspecified age, sex, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1805031 expiry: UNKNOWN) dose was not reported, 1 total administered at left arm on 08-APR-2021 for covid-19 prophylaxis. The patient received non-company suspect vaccine Moderna (elasomeran) (Dose number in series 2) (form of admin, route of admin were not reported, batch number: 005C21A expiry: UNKNOWN) dose was not reported, administered on 22-NOV-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with non-company suspect vaccine Moderna (elasomeran) (Dose number in series 2). The patient received non-company suspect vaccine Moderna (elasomeran) (Dose number in series 3) (form of admin, route of admin were not reported, batch number: 014B22A expiry: UNKNOWN) dose was not reported, administered on 14-JUL-2022 for covid-19 prophylaxis which was revaccination with different covid-19 vaccine (Dose number in series 3). No concomitant medications were reported. On an unspecified date in 2023, the patient experienced covid-19 infection (confirmed covid-19 infection) (Dose number in series 3) which led to confirmed clinical vaccination failure (Dose number in series 1) and received non-company treatment drug Paxlovid (nirmatrelvir/ritonavir) from 26-MAY-2023 to 31-MAY-2023 for covid-19 treatment. Original positive test on 26-MAY-2023 with negative testing (2023) following completion of Paxlovid. Patient experienced worsening of symptoms (had improved but never fully resolved) with new positive covid test on 09-JUN-2023. The action taken with covid-19 vaccine ad26.cov2.s, elasomeran, and elasomeran was not applicable. The patient was recovering from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure and revaccination with different covid-19 vaccine was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20230629512-confirmed clinical vaccination failure. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Date: 2023; Test Name: COVID-19 VIRUS TEST; Test Result: Negative ; Test Date: 20230526; Test Name: COVID-19 VIRUS TEST; Test Result: Positive ; Test Date: 20230609; Test Name: COVID-19 VIRUS TEST; Test Result: Positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 02.05.2023
- Impfdatum
- 10.06.2022
- Beginn
- 12.10.2022
- Tage bis Beginn
- 124,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 4 vaccines Moderna 1/4/21 Lot# 025J20A; Moderna 2/1/21 Lot# 012L20A; Moderna 11/17/21 Lot# 067F21A; Moderna 6/10/22 Lot# 014B22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 25.04.2023
- Impfdatum
- 21.02.2021
- Beginn
- 01.03.2022
- Tage bis Beginn
- 373,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Tinnitus
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tinnitus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- TINNITUS, high blood pressure, celiac disease
- Andere Medikamente
- Amlodipine, Metropol, Pantoprazole, vitamin d, vitamin c, omega 3,
- Allergien
- celiac disease
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 19.04.2023
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 19.04.2023
- Impfdatum
- 30.08.2022
- Beginn
- 12.04.2023
- Tage bis Beginn
- 225,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 3 vaccines Moderna 11/22/21 Lot# 034F21A; Moderna 12/20/21 Lot# 067H21A; Moderna 8/30/22 Lot# 014B22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 19.04.2023
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 19.04.2023
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 19.04.2023
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 18.04.2023
- Impfdatum
- 14.06.2022
- Beginn
- 18.04.2023
- Tage bis Beginn
- 308,0
- Dosis
- 5
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cough
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cough
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 17.04.2023
- Impfdatum
- 18.07.2022
- Beginn
- 18.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 17.04.2023
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 17.04.2023
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 18.07.2022
- Beginn
- 18.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 17.04.2023
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- U
- Eingang
- 17.04.2023
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 17.04.2023
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 17.04.2023
- Impfdatum
- 18.07.2022
- Beginn
- 18.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 17.04.2023
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- U
- Eingang
- 17.04.2023
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below. This patient returned on 3/6/23 to be revaccinated; Moderna Lot#066H22A Exp:03/18/23
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 14.04.2023
- Impfdatum
- 07.07.2022
- Beginn
- 17.07.2022
- Tage bis Beginn
- 10,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 4 vaccines Pfizer 1/20/21 Lot# El3249; Pfizer 2/11/21 lot# EM9810; Pfizer 10/29/21 Lot# 320308D; Moderna 7/7/22 Lot# 014B22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 12.04.2023
- Impfdatum
- 29.11.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
No adverse event
Symptomtext
No adverse event. Staff member said hat because the third shot inn the series was not Bivalent it had to be reported to VAERS. It was given because there was an issue with our shipment of bivalent vaccine. The patient is being notified that he got a monovaent and being offered a bivalent.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 04.04.2023
- Impfdatum
- 18.07.2022
- Beginn
- 18.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below. Letter was returned to sender on 3/1/23.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 03.04.2023
- Impfdatum
- 24.07.2022
- Beginn
- 29.03.2023
- Tage bis Beginn
- 248,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 3 vaccines MOderna 4/24/21 Lot# 043B21A; Moderna 5/22/21 Lot# 041C21A; Moderna 7/24/22 Lot# 014B22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 27.03.2023
- Impfdatum
- 05.08.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
PT WAS ADMINISTERED INCORRECT DOSE FOR PRIMARY DOSING SERIES. GIVEN 0.5mL INSTEAD OF RECOMMENDED 0.25 mL FOR THIS MODERNA VACCINE LOT NUMBER. NO TREATMENT NECESSARY, NO OBSERVED OUTCOMES OR SYMPTOMS.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.03.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Circumstance or information capable of leading to medication error
No adverse event
Symptomtext
Possible administration of expired vaccine; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible administration of expired vaccine) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible administration of expired vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible administration of expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible administration of expired vaccine). No concomitant medications was reported. It was reported that may be possible administration of expired vaccine but want to check an expiration date for Moderna Monovalent vaccine. When asked if expired vaccine was administered HCP initially stated no, then answered that's what they were trying to find out. No treatment drug details was reported. Reporter did not allow further contact
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Circumstance or information capable of leading to medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 02.03.2023
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Form would change his DOB. Patient's DOB. Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration. Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below. Patient called on 2/22/23 at 11:29 am and left a message stating" I received a letter in the mail about an error in recording the expiration date. I just want to know if I need to receive another vaccine."; I, called the patient back at 12:18 pm on his cell phone as requested and left a voicemail for a return call. The patient called back at 12:49 pm; he was informed of the manufacturer's response; he verbalized understanding and gratitude; he also declines revaccination at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.02.2023
- Impfdatum
- 01.07.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Vaccine administered past the 30 day beyond use date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered past the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. In July 2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. In July 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered past the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered past the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered past the 30 day beyond use date). No concomitant medication was reported. It was reported that Vaccine administered past the 30 day beyond use date and conduct a lot assessment for the following Lots with Dates moved to refrigeration: Moderna, 014B22A, 13-JUN-2022 Moderna, 011B22A, 21-JUL-2022 Moderna, 063B22A, 12-SEP-2022 Moderna, 074B22A, 04-NOV-2022 Moderna, 015B22A, 04-DEC-2022 Moderna, 020H22A, 07-NOV-2022 Moderna, 011H22A, 04-DEC-2022 Moderna, AS1414B, 21-JUN-2022 Moderna, AR9236B, 28-AUG-2022 Moderna, AR4504B, 18-JUL-2022 Moderna, AR5186C, 09-SEP-2022 Source email was from MI-00010791. It was reported that the office was aware of 3 patients that had received mention vaccine vials. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-705204, US-MODERNATX, INC.-MOD-2023-706506 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 27-Jan-2023: Significant follow-up appended _Dosage information updated. On 31-Jan-2023: Significant Live follow up appended : Dosage information updated On 31-Jan-2023: Significant live FU received: Narrative updated. On 01-Feb-2023: Non Significant follow up appended; Sender's Comments: US-MODERNATX, INC.-MOD-2023-705204:Master case (Patient 1 of 3) US-MODERNATX, INC.-MOD-2023-706506:Patient 3 of 3
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.02.2023
- Impfdatum
- 01.07.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; office discovered that vaccines in inventory were used past there expiration date/vaccines were administered July 13-21 of 2022/vaccines used by date was July 14 2022; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (office discovered that vaccines in inventory were used past there expiration date/vaccines were administered July 13-21 of 2022/vaccines used by date was July 14 2022) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. In July 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In July 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (office discovered that vaccines in inventory were used past there expiration date/vaccines were administered July 13-21 of 2022/vaccines used by date was July 14 2022). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (office discovered that vaccines in inventory were used past there expiration date/vaccines were administered July 13-21 of 2022/vaccines used by date was July 14 2022) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (office discovered that vaccines in inventory were used past there expiration date/vaccines were administered July 13-21 of 2022/vaccines used by date was July 14 2022). No concomitant medications were provided. No treatment medications were provided. It was reported that the office was aware of 3 patients that had received mention vaccine vials. This case was linked to US-MODERNATX, INC.-MOD-2023-705204 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-705204:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.02.2023
- Impfdatum
- 01.07.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; office discovered that vaccines in inventory were used past there expiration date,vaccines were administered July 13 to 21 of 2022/vaccines used by date was July 14 2022; This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (office discovered that vaccines in inventory were used past there expiration date,vaccines were administered July 13 to 21 of 2022/vaccines used by date was July 14 2022) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. In July 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In July 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (office discovered that vaccines in inventory were used past there expiration date,vaccines were administered July 13 to 21 of 2022/vaccines used by date was July 14 2022). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (office discovered that vaccines in inventory were used past there expiration date,vaccines were administered July 13 to 21 of 2022/vaccines used by date was July 14 2022) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (office discovered that vaccines in inventory were used past there expiration date,vaccines were administered July 13 to 21 of 2022/vaccines used by date was July 14 2022). No concomitant medications were provided. No treatment medications were provided. It was reported that the office was aware of 3 patients that had received mention vaccine vials.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 17.06.2022
- Beginn
- 30.01.2023
- Tage bis Beginn
- 227,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
COVID vaccine breakthrough case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Positive COVID test on 1/30/23
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 25.01.2023
- Impfdatum
- 20.06.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 73,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test
Computerised tomogram
Hepatic cancer stage IV
Ultrasound scan
Symptomtext
Stage 4 Liver Cancer; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC CANCER STAGE IV (Stage 4 Liver Cancer) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (First dose, Lot number-013A21A and Expiry Date was unknown) on 04-Mar-2021, Moderna COVID-19 Vaccine (Second dose, Lot number-020A21A and Expiry Date was unknown) on 01-Apr-2021, Moderna COVID-19 Vaccine (Third dose and Lot number-058F21A and Expiry Date was unknown) on 02-Apr-2022. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine. Concurrent medical conditions included Diabetes (For several years) and Blood pressure high (For several years). Concomitant products included LISINOPRIL for Blood pressure high, METFORMIN for Diabetes, ACETYLSALICYLIC ACID (ASPIRIN DC) and MEN for an unknown indication. On 20-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In September 2022, the patient experienced HEPATIC CANCER STAGE IV (Stage 4 Liver Cancer) (seriousness criteria death and medically significant). The patient was treated with INSULIN at an unspecified dose and frequency. The patient died on 08-Nov-2022. The reported cause of death was stage 4 liver cancer. It is unknown if an autopsy was performed. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, Blood test: blood work showed Liver problems. In 2022, Computerised tomogram: Liver Cancer. In 2022, Ultrasound scan: Liver Cancer. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was reported that reporter and her husband received fourth dose of Moderna COVID-19 vaccine. He was not taking the Lisinopril all the time, so his blood pressure was not controlled. He visited the doctor every 4 months for routine checkup. In Sep-2022 he visited his doctor for usual checkup. The doctor started him on Insulin, then the Doctor followed with ultrasound and CT scan which showed Liver Cancer. He was diagnosed with stage 4 Liver Cancer in Sep-2022. He had 4 Chemo treatments which did not help. He died on 08-Nov-2022. She stated that her husband also took a baby Aspirin and daily Centrum vitamins for men. Concomitant and Treatment medication was not provided. Company comment: This fatal spontaneous case concerns a 69-year-old male patient with medical history of Diabetes, Blood pressure high, concomitant products included LISINOPRIL and METFORMIN, Previously administered Moderna COVID-19 Vaccine (3 doses without adverse events) who experienced the unexpected seriousness criteria death and medically significant event of Hepatic cancer stage IV approximately 3 months after a dose of mRNA-1273 bivalent vaccine. He was treated by chemotherapy (4 sessions). Death occurred on November, 8, 2022. The cause of death was not reported. It is unknown if an autopsy was performed The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Reported Cause(s) of Death: Stage 4 Liver Cancer
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood test
- Hospital-Tage
- -
- Labordaten
- Test Date: 2022; Test Name: blood work; Result Unstructured Data: blood work showed Liver problems; Test Date: 2022; Test Name: CT scan; Result Unstructured Data: Liver Cancer; Test Date: 2022; Test Name: ultrasound scan; Result Unstructured Data: Liver Cancer
- Aktuelle Erkrankungen
- Blood pressure high (For several years); Diabetes (For several years)
- Vorgeschichte
- -
- Andere Medikamente
- METFORMIN; LISINOPRIL; ASPIRIN DC; CENTRUM MEN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 19.01.2023
- Impfdatum
- 12.07.2022
- Beginn
- 10.12.2022
- Tage bis Beginn
- 151,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Computerised tomogram
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Computerised tomogram
- Hospital-Tage
- -
- Labordaten
- Cat
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- NONE
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 10.01.2023
- Beginn
- 10.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 7+
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
Error: Wrong Vaccine/Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 10.01.2023
- Beginn
- 10.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 7+
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
Symptomtext
Error: Wrong Vaccine/Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 10.01.2023
- Beginn
- 10.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
Error: Wrong Vaccine/Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 09.01.2023
- Beginn
- 09.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
Error: Wrong Vaccine/Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 14.01.2023
- Impfdatum
- 06.01.2023
- Beginn
- 06.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
No adverse event; The patient received monovalent Moderna Covid-19 vaccine instead of Moderna Bivalent Vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (The patient received monovalent Moderna Covid-19 vaccine instead of Moderna Bivalent Vaccine) and NO ADVERSE EVENT (No adverse event) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (The patient received monovalent Moderna Covid-19 vaccine instead of Moderna Bivalent Vaccine). Patient received monovalent Moderna COVID-19 vaccine instead of Moderna Bivalent vaccine. Bivalent vaccine Lot 057A22A expiration date February 6, 2023. No concomitant medication reported. No treatment medication reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 14.01.2023
- Impfdatum
- -
- Beginn
- 06.01.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
No adverse event; patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2023, the patient experienced WRONG PRODUCT ADMINISTERED (patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine). No concomitant medications were reported. The patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine. Lot 057A22A expiration date February 6, 2023, No treatment drugs were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 14.01.2023
- Impfdatum
- 06.01.2023
- Beginn
- 06.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
No adverse event; the patient received monovalent Moderna Covid-19 vaccine instead of the Moderna Bivalent vaccine for the booster dose; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (the patient received monovalent Moderna Covid-19 vaccine instead of the Moderna Bivalent vaccine for the booster dose) and NO ADVERSE EVENT (No adverse event) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 06-Jan-2023, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2023, the patient experienced WRONG PRODUCT ADMINISTERED (the patient received monovalent Moderna Covid-19 vaccine instead of the Moderna Bivalent vaccine for the booster dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (the patient received monovalent Moderna Covid-19 vaccine instead of the Moderna Bivalent vaccine for the booster dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (the patient received monovalent Moderna Covid-19 vaccine instead of the Moderna Bivalent vaccine for the booster dose). No concomitant medication information provided. It was reported that the patient had received monovalent Moderna Covid-19 vaccine instead of the Moderna Bivalent vaccine for the booster dose. Bivalent Lot 057A22A expiration date 06-Feb-2023. No treatment information provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 09.01.2023
- Impfdatum
- 10.02.2021
- Beginn
- 22.11.2022
- Tage bis Beginn
- 650,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Mental status changes
SARS-CoV-2 test positive
Symptomtext
11/22/22 presents to ED for "altered mental status". PMHx of "CVA, CKD, left bundle branch block, hypertension"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 11/23/22 SARS-CoV-2 (COVID-19)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 19.12.2022
- Impfdatum
- 19.11.2022
- Beginn
- 19.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Product storage error
Symptomtext
Expired vaccine was placed back into refrigerator and was given to this patient when arrived. No reported adverse reaction experienced.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Hypertension, PTSD
- Andere Medikamente
- Celexa 40mg QHS, Norvasc 10mg daily
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 19.12.2022
- Impfdatum
- 19.11.2022
- Beginn
- 19.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Product storage error
Symptomtext
Expired vaccine was placed back into refrigerator and was given to this patient when arrived. No reported adverse reaction experienced.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- No significant medical history
- Andere Medikamente
- Mobic 15mg daily
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 19.12.2022
- Impfdatum
- 19.11.2022
- Beginn
- 19.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Product storage error
Symptomtext
Expired vaccine was placed back into refrigerator and was given to this patient when arrived. No reported adverse reaction experienced.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Hypertension, Hyperlipidemia, DM, AFib
- Andere Medikamente
- Coumadin 5.5mg q HS, Lidocaine 5% patch,
- Allergien
- NSAIDS
- Vorherige Impfungen
- -
- Staat
- DC
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 09.12.2022
- Impfdatum
- 30.06.2022
- Beginn
- 01.08.2022
- Tage bis Beginn
- 32,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Alopecia
Antinuclear antibody negative
Blood testosterone normal
Full blood count normal
Metabolic function test normal
Thyroid function test normal
Symptomtext
Pt. began to have bolding hair around the nape. We visited a specialist for diagnosis and treatment. A topical ointment was prescribed which did not help. The balding areas began to spread. The medication was changed, and the balding areas continues to spread.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Alopecia
- Hospital-Tage
- -
- Labordaten
- CBC, CMP, ANA, Thyroid, Testosterone- all which im told are normal.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- seasonal allergies
- Andere Medikamente
- Vitamin D
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 27.10.2022
- Impfdatum
- 22.10.2021
- Beginn
- 12.04.2022
- Tage bis Beginn
- 172,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ageusia
Anosmia
Asthenia
Blood test abnormal
COVID-19
Decreased appetite
Epstein-Barr virus infection reactivation
Hypersomnia
SARS-CoV-2 test positive
Symptomtext
I tested positive for Covid19 5 1/2 months after my first booster on 10/12/2021. I continued to test positive until 10/28/2022. My oxygen levels remains good, 96 - 98% throughout. My energy level was extremely low. I slept approx. 20 hours a day, with very little appitite and no taste or smell. Even after testing negative my energy level was extremely low, sleeping 12 hours at night and often through the day. Energy levels increased VERY slowly. I am still not back to normal. On 09/14/2022 blood work confirmed that the Epstein Barr virus was reactivated. I was prescribed Valacyclovir and Nal Trexone HCL IR for 60 days. It was also suggested I take a homeopathic remedy for 2 months. after several weeks of taking these remedies and medications my energy level seems to be improving more quickly but is by no means my usual. I still take the occasional nap. I am an athletic, energetic person that did not tire easily until I contracted Covid19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ageusia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Just diagnosed with a re-occurrence of Epstein Barr
- Andere Medikamente
- Symbicort, Estradiol, Progesterone,
- Allergien
- milk, yeast, gluten
- Vorherige Impfungen
- slight flushing of the face for 30 minutes after the first vaccine
- Staat
- MI
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 24.10.2022
- Impfdatum
- 13.07.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 94,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 4 vaccines Moderna 1/21/21 Lot# 032H20A; Unknown type or lot# 2/18/21; Moderna 11/3/21 Lot# 053E21A; Moderna 7/13/22 Lot# 014B22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 10.10.2022
- Impfdatum
- 03.07.2022
- Beginn
- 26.09.2022
- Tage bis Beginn
- 85,0
- Dosis
- 4
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
Hypoaesthesia
Symptomtext
weakness, numbness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenia
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 09.10.2022
- Impfdatum
- 14.06.2022
- Beginn
- 09.10.2022
- Tage bis Beginn
- 117,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test positive
Symptomtext
tested positive for covid on 10/9/22- has completed primary series plus 2 boosters- all Moderna- most recent dose listed above, due for bivalent booster
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ESRD w/ hemodialysis, DM2, HTN, CHF, ASHD, RA, OSA, hypothroidism
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 29.09.2022
- Impfdatum
- 28.09.2022
- Beginn
- 28.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Incorrect product formulation administered
Symptomtext
Patient requested Moderna Bivalent Covid Vaccine, recommended dosage should be 0.5 ml for this vaccine. Patient was given Moderna Covid vaccine. The recommended booster dosage for the vaccine is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 29.09.2022
- Impfdatum
- 28.09.2022
- Beginn
- 28.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Incorrect product formulation administered
Symptomtext
Patient requested Moderna Bivalent Covid Vaccine, recommended dosage should be 0.5 ml for this vaccine. Patient was given Moderna Covid vaccine. The recommended booster dosage for the vaccine is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 29.09.2022
- Impfdatum
- 28.09.2022
- Beginn
- 28.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Incorrect product formulation administered
Symptomtext
Patient requested Moderna Bivalent Covid Vaccine, recommended dosage should be 0.5 ml for this vaccine. Patient was given Moderna Covid vaccine. The recommended booster dosage for the vaccine is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- diabetes, all others unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 29,0
- Geschlecht
- U
- Eingang
- 26.09.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Product temperature excursion issue
Symptomtext
Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months; Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months; No adverse event; Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months. This vaccine was administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months. This vaccine was administered to patient), PRODUCT STORAGE ERROR (Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months) and NO ADVERSE EVENT (No adverse event) in a 29-year-old patient of an unknown gender who received mRNA-1273 (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Sep-2022, the patient received second dose of mRNA-1273 (unknown route) 1 dosage form. On 21-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months. This vaccine was administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccines (Monovalent) was removed from the refrigerator and stored at room temperature for 2 months) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months. This vaccine was administered to patient), PRODUCT STORAGE ERROR (Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccines (Monovalent) was removed from the refrigerator and stored at room temperature for 2 months) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months. This vaccine was administered to patient), PRODUCT STORAGE ERROR (Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months) and PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator and stored at room temperature for 2 months). No concomitant medications were reported. On 01-Aug-2022, the facility lost power and Moderna COVID-19 vaccines (Monovalent) were removed from the refrigerator & stored at room temperature for 2 months, while repairs were being made, related to power. Total number of vials was 2 and the size of the vial was 5.5 mL. The date the vial was initially stored in the refrigerator was unknown. The vial did undergo temperature excursions. The total amount of time the vial was exposed to room temperature was for 2 months. At some unknown point, the vaccines were returned to the refrigerator. The vials were thawed, and no changes were noted in visual inspection. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 32,0
- Geschlecht
- U
- Eingang
- 24.09.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Product temperature excursion issue
Symptomtext
Temperature excursion; No adverse event; Today (21Sep2022), 2 doses of this Moderna Covid-19 vaccine (Monovalent) were administered to patients/removed from the refrigerator & stored at room temperature for 2 months; removed from the refrigerator & stored at room temperature for 2 months; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Today (21Sep2022), 2 doses of this Moderna Covid-19 vaccine (Monovalent) were administered to patients/removed from the refrigerator & stored at room temperature for 2 months), PRODUCT STORAGE ERROR (removed from the refrigerator & stored at room temperature for 2 months), PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion) and NO ADVERSE EVENT (No adverse event) in a 32-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 21-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Today (21Sep2022), 2 doses of this Moderna Covid-19 vaccine (Monovalent) were administered to patients/removed from the refrigerator & stored at room temperature for 2 months) and PRODUCT STORAGE ERROR (removed from the refrigerator & stored at room temperature for 2 months). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Today (21Sep2022), 2 doses of this Moderna Covid-19 vaccine (Monovalent) were administered to patients/removed from the refrigerator & stored at room temperature for 2 months), PRODUCT STORAGE ERROR (removed from the refrigerator & stored at room temperature for 2 months), PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Today (21Sep2022), 2 doses of this Moderna Covid-19 vaccine (Monovalent) were administered to patients/removed from the refrigerator & stored at room temperature for 2 months), PRODUCT STORAGE ERROR (removed from the refrigerator & stored at room temperature for 2 months) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion). No concomitant medications were reported. On 01-Aug-2022, the facility lost power & Moderna Covid-19 vaccines (Monovalent) were removed from the refrigerator & stored at room temperature for 2 months, while repairs were being made, related to power. Total 2 vials were administered. The size of the vial was 5.5 mL. The date the vial was initially stored in the refrigerator was unknown. The vial did undergo temperature excursions. The total amount of time the vial was exposed to room temperature was for 2 months. The vial is stored back to the refrigerator. The vials were thawed and no changes were noted in visual inspection. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 22.09.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
No adverse reaction occurred. Vaccine was out of the temperature range for approximately 2 months and then was administered yesterday not knowing was one of the out of temperature range vaccines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- None
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- -
- Geschlecht
- M
- Eingang
- 22.09.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
The Person served did not have a reaction to vaccine given. It was noticed that the vaccine administered was one of the ones considered not usable due to the fact that the temperature was out of range and was stored for 2 months.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- see Mar
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 8,0
- Geschlecht
- M
- Eingang
- 21.09.2022
- Impfdatum
- 13.07.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Wrong formulation of Vaccine was used for child in this age group. No adverse side effect noted in Child.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 20.09.2022
- Impfdatum
- 24.08.2022
- Beginn
- 24.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Underdose
Symptomtext
doses administered after excursion on 22-Aug-2022 to 04-Sep-2022; No adverse event; Administered dose that experienced the excursion; Patient received 0.25 ml as a first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered dose that experienced the excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion on 22-Aug-2022 to 04-Sep-2022), UNDERDOSE (Patient received 0.25 ml as a first dose) and NO ADVERSE EVENT (No adverse event) in a 71-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 24-Aug-2022 at 11:45 AM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .25 milliliter. On 24-Aug-2022 at 11:45 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered dose that experienced the excursion) and UNDERDOSE (Patient received 0.25 ml as a first dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion on 22-Aug-2022 to 04-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered dose that experienced the excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion on 22-Aug-2022 to 04-Sep-2022), UNDERDOSE (Patient received 0.25 ml as a first dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Administered dose that experienced the excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion on 22-Aug-2022 to 04-Sep-2022) and UNDERDOSE (Patient received 0.25 ml as a first dose). No concomitant medications were reported. Vaccine was stored in fridge at the time of excursion. The maximum temperature reached was 52.8 Fahrenheit and the excursion duration was 8 days, 16 hours, and 30 minutes. on 22-Aug-2022 the vial was moved from freezer to refrigerator and vaccine was stored in fridge as of now. Total 3 doses were impacted from the vial. A total of 3 doses were administered with no previous excursions. On 05-Sep-2022 fridge died, ever since the fridge went out of range that past weekend and no doses was administered. The temperature went up to 70 degree and the vaccine in that fridge were moved to another fridge. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2022: Follow up received no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 20.09.2022
- Impfdatum
- 24.08.2022
- Beginn
- 24.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Underdose
Symptomtext
Vaccine was out of range/Vaccine administered after the temperature excursion occured from 22-Aug-2022 to 04-Sep-2022; No adverse event; Administered 3 doses that experienced the excursions; Patient received 0.25 ml as a first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine was out of range/Vaccine administered after the temperature excursion occured from 22-Aug-2022 to 04-Sep-2022), POOR QUALITY PRODUCT ADMINISTERED (Administered 3 doses that experienced the excursions), UNDERDOSE (Patient received 0.25 ml as a first dose) and NO ADVERSE EVENT (No adverse event) in a 28-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 24-Aug-2022 at 7:30 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .25 milliliter. On 24-Aug-2022 at 7:30 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered 3 doses that experienced the excursions) and UNDERDOSE (Patient received 0.25 ml as a first dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine was out of range/Vaccine administered after the temperature excursion occured from 22-Aug-2022 to 04-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine was out of range/Vaccine administered after the temperature excursion occured from 22-Aug-2022 to 04-Sep-2022), POOR QUALITY PRODUCT ADMINISTERED (Administered 3 doses that experienced the excursions), UNDERDOSE (Patient received 0.25 ml as a first dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine was out of range/Vaccine administered after the temperature excursion occured from 22-Aug-2022 to 04-Sep-2022), POOR QUALITY PRODUCT ADMINISTERED (Administered 3 doses that experienced the excursions) and UNDERDOSE (Patient received 0.25 ml as a first dose). No concomitant medications were reported. Vaccine was stored in fridge at the time of excursion. The maximum temperature reached was 52.8 Fahrenheit and the excursion duration was 8 days, 16 hours and 30 minutes. on 22-Aug-2022 the vial was moved from freezer to refrigerator and vaccine was stored in fridge as of now. Total 3 doses was impacted from the vial. A total of 3 doses were administered with no previous excursions. On 05-Sep-2022 fridge was died and ever since the fridge went out of range that past weekend and no doses was administered. The temperature went up to 70 degree and the vaccine in that fridge were moved to another fridge. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2022: Follow up information received contains no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 20.09.2022
- Impfdatum
- 22.08.2022
- Beginn
- 22.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Underdose
Symptomtext
doses administered after excursion , Temperature excursion on 22-Aug-2022 to 04-Sep-2022; No Adverse event; Administered 3 doses that experienced the excursions; Patient received 0.25 ml as a first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered 3 doses that experienced the excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion , Temperature excursion on 22-Aug-2022 to 04-Sep-2022), UNDERDOSE (Patient received 0.25 ml as a first dose) and NO ADVERSE EVENT (No Adverse event) in a 70-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Aug-2022 at 10:00 AM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .25 milliliter. On 22-Aug-2022 at 10:00 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered 3 doses that experienced the excursions) and UNDERDOSE (Patient received 0.25 ml as a first dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion , Temperature excursion on 22-Aug-2022 to 04-Sep-2022) and NO ADVERSE EVENT (No Adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered 3 doses that experienced the excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion , Temperature excursion on 22-Aug-2022 to 04-Sep-2022), UNDERDOSE (Patient received 0.25 ml as a first dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Administered 3 doses that experienced the excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion , Temperature excursion on 22-Aug-2022 to 04-Sep-2022) and UNDERDOSE (Patient received 0.25 ml as a first dose). No concomitant medications were reported. Vaccine was stored in fridge at the time of excursion. The maximum temperature reached was 52.8 Fahrenheit and the excursion duration was 8 days, 16 hours, and 30 minutes. on 22-Aug-2022 the vial was moved from freezer to refrigerator and vaccine was stored in fridge as of now. Total 3 doses were impacted from the vial. A total of 3 doses were administered with no previous excursions. On 05-Sep-2022 fridge died, ever since the fridge went out of range that past weekend and no doses was administered. The temperature went up to 70 degree and the vaccine in that fridge were moved to another fridge. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2022: Follow Up received included- Case became valid. Patient information, Dosage information updated. On 15-Sep-2022: Non Significant follow up appended
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 09.09.2022
- Impfdatum
- 14.06.2022
- Beginn
- 09.09.2022
- Tage bis Beginn
- 87,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asymptomatic COVID-19
Exposure to SARS-CoV-2
SARS-CoV-2 test positive
Symptomtext
tested as part of f/u surveillance from known exposure- asymptomatic- tested positive on binax rapid antigen 9/9/2022 Patient has had primary series plus 2 boosters, all Moderna- due for bivalent booster
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asymptomatic COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- RA, HTN, CHF, anemia
- Andere Medikamente
- -
- Allergien
- codeine, morphine
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 08.09.2022
- Impfdatum
- 14.06.2022
- Beginn
- 07.09.2022
- Tage bis Beginn
- 85,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cough
Respiratory tract congestion
Symptomtext
COUGH, CONGESTION
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cough
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 06.09.2022
- Impfdatum
- 13.08.2022
- Beginn
- 13.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Patient given an unapproved 3rd booster dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 02.09.2022
- Impfdatum
- 04.06.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 89,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
COVID vaccine breakthrough case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID positive test 9/1/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 29.08.2022
- Impfdatum
- 25.08.2022
- Beginn
- 25.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
MODERNA COVID-19 BOOSTER GIVEN TO 13 YO
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- NONE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 27.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 27.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 04.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 24.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 04.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 24.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 22.08.2022
- Impfdatum
- 21.07.2022
- Beginn
- 15.08.2022
- Tage bis Beginn
- 25,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 18.08.2022
- Impfdatum
- 12.03.2021
- Beginn
- 11.08.2022
- Tage bis Beginn
- 517,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered greater then 12 hours post puncture), PRODUCT STORAGE ERROR (The vial was stored at room temperature post puncture/vial exposed to room temperature for about 24 hours) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Pfizer booster) on 06-Nov-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Aug-2022 at 9:30 AM, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Aug-2022 at 9:30 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered greater then 12 hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored at room temperature post puncture/vial exposed to room temperature for about 24 hours) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered greater then 12 hours post puncture), PRODUCT STORAGE ERROR (The vial was stored at room temperature post puncture/vial exposed to room temperature for about 24 hours) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered greater then 12 hours post puncture) and PRODUCT STORAGE ERROR (The vial was stored at room temperature post puncture/vial exposed to room temperature for about 24 hours). No relevant concomitant medications were reported. Date the vial was initially stored in the refrigerator was 04-Aug-2022. Date and time vial was first punctured was 10-Aug-2022 at 9:06 AM. The vial was stored at room temperature post puncture. The vial did not undergo any temperature excursions. The vial was exposed to room temperature range (8? to 25?C equals to 46? to 77?F) for about 24 hours. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.; Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) in a 53-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.). Patient weight was unknown. No concomitant medications were reported. The pharmacist reported that, the vaccine underwent multiple temperature excursion and the storage condition at the time of temperature excursion was frozen. The maximum or minimum temperatures reached (specify temperature was in C or F) were as follows; first excursion at 5.05 Degrees Fahrenheit for 28 minutes, second excursion at 5.22 Degrees F for 28 minutes, third excursion at 5.05 Degrees Fahrenheit for 20 minutes, forth excursion at 5.02 Degrees Fahrenheit for 21 minutes, fifth excursion at 5.07 Degrees Fahrenheit for 15 minutes, sixth excursion at 5.11 Degrees Fahrenheit 29 minutes, seventh excursion at 5.05 degrees Fahrenheit for 13 minutes, eighty excursion at 5.05 degrees Fahrenheit for 34 minutes and ninth excursion at 5.11 Degrees Fahrenheit for unspecified time. On 09-Aug-2022, the vials were initially moved from freezer to refrigerator and vials were in the refrigerator under quarantine currently. Upon visual inspection vaccines appeared normal after the excursion and they were currently in the refrigerator. It was stated that, up to 9 vials from the carton of Moderna COVID-19 vaccine have been administered to patients and it was not known which dose in the series that the patient received vaccine that had undergone multiple temperature excursions. No other adverse reactions were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Follow-up document received includes no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.; Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) in a 55-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.). Patient weight was unknown. No concomitant medications were reported. The pharmacist reported that, the vaccine underwent multiple temperature excursion and the storage condition at the time of temperature excursion was frozen. The maximum or minimum temperatures reached (specify temperature was in C or F) were as follows; first excursion at 5.05 Degrees Fahrenheit for 28 minutes, second excursion at 5.22 Degrees F for 28 minutes, third excursion at 5.05 Degrees Fahrenheit for 20 minutes, forth excursion at 5.02 Degrees Fahrenheit for 21 minutes, fifth excursion at 5.07 Degrees Fahrenheit for 15 minutes, sixth excursion at 5.11 Degrees Fahrenheit 29 minutes, seventh excursion at 5.05 degrees Fahrenheit for 13 minutes, eighty excursion at 5.05 degrees Fahrenheit for 34 minutes and ninth excursion at 5.11 Degrees Fahrenheit for unspecified time. On 09-Aug-2022, the vials were initially moved from freezer to refrigerator and vials were in the refrigerator under quarantine currently. Upon visual inspection vaccines appeared normal after the excursion and they were currently in the refrigerator. It was stated that, up to 9 vials from the carton of Moderna COVID-19 vaccine have been administered to patients and it was not known which dose in the series that the patient received vaccine that had undergone multiple temperature excursions. No other adverse reactions were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Follow-up document received includes no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions; Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions). No concomitant medications were reported. The patient weight was unknown. It was not known which dose in the series had the patient received, that had undergone multiple temperature excursions. The storage condition at the time of the excursion was frozen storage. The vaccine went through several temperature excursions. The maximum or minimum temperatures reached, as applicable were as follows, 5.05 Degrees Fahrenheit (Excursion 1), 5.22 Degrees Fahrenheit (Excursion 2), 5.05 Degrees Fahrenheit (Excursion 3), 5.02 Degrees Fahrenheit (Excursion 4), 5.07 Degrees Fahrenheit (Excursion 5), 5.11 Degrees Fahrenheit (Excursion number 6), 5.05 degrees Fahrenheit (excursion number 7), 5.05 degrees Fahrenheit (Excursion 8), 5.11 Degrees Fahrenheit (Excursion 9). The excursion duration was as follows, 28 minutes (Excursion 1), 28 minutes (Excursion 2), 20 minutes (Excursion 3), 21 minutes (Excursion 4), 15 minutes (Excursion 5), 29 minutes (Excursion number 6), 13 minutes (excursion number 7), 34 minutes (Excursion 8). The Moderna COVID-19 vaccine was moved from the freezer to the refrigerator on 09-Aug-2022. On visual inspection vaccines appeared normal after the excursion and were currently in the refrigerator. 9 vials were punctured after at least one temperature excursion. There were several temperature excursions with these vials. 1 Vial was in the refrigerator under quarantine and up to 9 vials from the carton of Moderna COVID-19 vaccine had been administered to patients. No other adverse reactions were reported. No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Live follow up received contains no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.; Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) in a 63-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.). Patient weight was unknown. No concomitant medications were reported. The pharmacist reported that, the vaccine underwent multiple temperature excursion and the storage condition at the time of temperature excursion was frozen. The maximum or minimum temperatures reached were first excursion at 5.05 Degrees F (Fahrenheit) for 28 minutes, second excursion at 5.22 Degrees F for 28 minutes, third excursion at 5.05 Degrees F for 20 minutes, forth excursion at 5.02 Degrees F for 21 minutes, fifth excursion at 5.07 Degrees F for 15 minutes, sixth excursion at 5.11 Degrees F for 29 minutes, seventh excursion at 5.05 degrees F for 13 minutes, eighth excursion at 5.05 degrees F for 34 minutes and ninth excursion at 5.11 Degrees F for unspecified time. On 09-Aug-2022, the vials were initially moved from freezer to refrigerator and vials were in the refrigerator under quarantine currently. Upon visual inspection vaccines appeared normal after the excursion. It was reported that up to 9 vials from the carton of Moderna COVID-19 vaccine had been administered to patients and it was not known which dose in the series that the patient received vaccine had undergone multiple temperature excursions. No other adverse reactions were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Follow-up document received includes no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions; Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event) in an 84-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions). No concomitant medications were reported. Patient weight was unknown. The pharmacist reported that, the vaccine underwent multiple temperature excursion and the storage condition at the time of temperature excursion was frozen. The maximum or minimum temperatures reached (specify temperature was in C or F) were as follows; first excursion at 5.05 Degrees Fahrenheit for 28 minutes, second excursion at 5.22 Degrees F for 28 minutes, third excursion at 5.05 Degrees Fahrenheit for 20 minutes, forth excursion at 5.02 Degrees Fahrenheit for 21 minutes, fifth excursion at 5.07 Degrees Fahrenheit for 15 minutes, sixth excursion at 5.11 Degrees Fahrenheit 29 minutes, seventh excursion at 5.05 degrees Fahrenheit for 13 minutes, eighty excursion at 5.05 degrees Fahrenheit for 34 minutes and ninth excursion at 5.11 Degrees Fahrenheit for unspecified time. On 09-Aug-2022, the vials were initially moved from freezer to refrigerator and vials were in the refrigerator under quarantine currently. Upon visual inspection vaccines appeared normal after the excursion and they were currently in the refrigerator. It was stated that, up to 9 vials from the carton of Moderna COVID-19 vaccine have been administered to patients and it was not known which dose in the series that the patient received vaccine that had undergone multiple temperature excursions. No other adverse reactions were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Follow up received no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.; Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) in a 67-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.) and POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.). Patients weight was unknown. It was not known which dose in the series had the patient received, that had undergone multiple temperature excursions. Concomitant medication list was not provided. 13 patients received Moderna COVID-19 vaccine that had undergone multiple temperature excursions. Storage condition at the time of the excursion was frozen storage. Maximum or minimum temperatures reached, as applicable were as follows, 5.05 Degrees Farenheit (Excursion 1), 5.22 Degrees F (Excursion 2), 5.05 Degrees Farenheit (Excursion 3), 5.02 Degrees Farenheit (Excursion 4), 5.07 Degrees Farenheit (Excursion 5), 5.11 Degrees Farenheit (Excursion number 6), 5.05 degrees Farenheit (excursion number 7), 5.05 degrees Farenheit (Excursion 8), 5.11 Degrees Farenheit (Excursion 9) Excursion duration were as follows, 28 minutes (Excursion 1), 28 minutes (Excursion 2), 20 minutes (Excursion 3), 21 minutes (Excursion 4), 15 minutes (Excursion 5), 29 minutes (Excursion number 6), 13 minutes (excursion number 7), 34 minutes (Excursion 8). The Moderna COVID-19 vaccine was moved from the freezer to the refrigerator on 09-Aug-2022. On visual inspection vaccines appeared normal after the excursion and were currently in the refrigerator. 9 vials were punctured after at least one temperature excursion. There were several temperature excursions with these vials. 1 Vial was in the refrigerator under quarantine and up to 9 vials from the carton of Moderna COVID-19 vaccine had been administered to patients. No other adverse reactions were reported. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Live follow up received contains no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patients received Moderna Covid-19 vaccine that had undergone multiple temperature excursions; Patients received Moderna Covid-19 vaccine that had undergone multiple temperature excursions; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received Moderna Covid-19 vaccine that had undergone multiple temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Patients received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event) in a 61-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received Moderna Covid-19 vaccine that had undergone multiple temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Patients received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received Moderna Covid-19 vaccine that had undergone multiple temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Patients received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (Patients received Moderna Covid-19 vaccine that had undergone multiple temperature excursions). Patient weight was unknown. Concomitant medication list was not provided. It was not known which dose in the series had the patient received, that had undergone multiple temperature excursions. 13 patients received Moderna COVID-19 vaccine that had undergone multiple temperature excursions. Storage condition at the time of the excursion was frozen storage. Maximum or minimum temperatures reached, as applicable were as follows, 5.05 Degrees Fahrenheit (Excursion 1), 5.22 Degrees F (Excursion 2), 5.05 Degrees Fahrenheit (Excursion 3), 5.02 Degrees Fahrenheit (Excursion 4), 5.07 Degrees Fahrenheit (Excursion 5), 5.11 Degrees Fahrenheit (Excursion number 6), 5.05 degrees Fahrenheit (excursion number 7), 5.05 degrees Fahrenheit (Excursion 8), 5.11 Degrees Fahrenheit (Excursion 9). Excursion duration were as follows, 28 minutes (Excursion 1), 28 minutes (Excursion 2), 20 minutes (Excursion 3), 21 minutes (Excursion 4), 15 minutes (Excursion 5), 29 minutes (Excursion number 6), 13 minutes (excursion number 7), 34 minutes (Excursion 8). The Moderna COVID-19 vaccine was moved from the freezer to the refrigerator on 09-Aug-2022. On visual inspection vaccines appeared normal after the excursion and were currently in the refrigerator. 9 vials were punctured after at least one temperature excursion. There were several temperature excursions with these vials. Now 1 Vial is in the refrigerator under quarantine and up to 9 vials from the carton of Moderna COVID-19 vaccine had been administered to patients. No other adverse reactions were reported. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Live Follow up received contains no new significant information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions; Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event) in a 67-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions). Patient weight was unknown. No concomitant medications were reported. Storage condition at the time of the excursion was reported as frozen storage. Maximum or minimum temperatures reached was reported as 5.05 Degrees Fahrenheit (Excursion 1) 5.22 Degrees Fahrenheit (Excursion 2) 5.05 Degrees Fahrenheit (Excursion 3) 5.02 Degrees Fahrenheit (Excursion 4) 5.07 Degrees Fahrenheit (Excursion 5), 5.11 Degrees Fahrenheit (Excursion number 6) 5.05 degrees Fahrenheit (excursion number 7), 5.05 degrees Fahrenheit (Excursion 8) and 5.11 Degrees Fahrenheit (Excursion 9). Excursion duration was reported as 28 minutes (Excursion 1) 28 minutes (Excursion 2) 20 minutes (Excursion 3) 21 minutes (Excursion 4) 15 minutes (Excursion 5) 29 minutes (Excursion number 6), 13 minutes (Excursion number 7) and 34 minutes (Excursion 8). The Moderna Covid-19 vaccine was moved from the freezer to the refrigerator on 09-Aug-2022. It was stated that 1 vial was in the refrigerator under quarantine and up to 9 vials from the carton of Moderna Covid-19 vaccine had been administered to patients. Vaccines appeared normal after the excursion and were currently in the refrigerator. It was reported that there were several temperature excursions with these vial. It was not known which dose in the series that the patient received vaccine that had undergone multiple temperature excursions. No other adverse reactions were reported. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Follow up received contains no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.; Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.; No adverse reaction; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse reaction) in a 28-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse reaction). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that had undergone multiple temperature excursions.). No concomitant medications were reported. The pharmacist reported that, the vaccine underwent multiple temperature excursion and the storage condition at the time of temperature excursion was frozen. The maximum or minimum temperatures reached (specify temperature was in C or F) were as follows; first excursion at 5.05 Degrees Fahrenheit for 28 minutes, second excursion at 5.22 Degrees F for 28 minutes, third excursion at 5.05 Degrees Fahrenheit for 20 minutes, forth excursion at 5.02 Degrees Fahrenheit for 21 minutes, fifth excursion at 5.07 Degrees Fahrenheit for 15 minutes, sixth excursion at 5.11 Degrees Fahrenheit 29 minutes, seventh excursion at 5.05 degrees Fahrenheit for 13 minutes, eighty excursion at 5.05 degrees Fahrenheit for 34 minutes and ninth excursion at 5.11 Degrees Fahrenheit for unspecified time. On 09-Aug-2022, the vials were initially moved from freezer to refrigerator and vials were in the refrigerator under quarantine currently. Upon visual inspection vaccines appeared normal after the excursion and they were currently in the refrigerator. It was stated that, up to 9 vials from the carton of Moderna COVID-19 vaccine have been administered to patients and it was not known which dose in the series that the patient received vaccine that had undergone multiple temperature excursions. No other adverse reactions were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Follow up received included no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions; Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event) in a 53-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions). Patient weight was unknown. No concomitant medications were reported. The pharmacist reported that, the vaccine underwent multiple temperature excursion and the storage condition at the time of temperature excursion was frozen. The maximum or minimum temperatures reached (specify temperature was in C or F) were as follows; first excursion at 5.05 Degrees Fahrenheit for 28 minutes, second excursion at 5.22 Degrees F for 28 minutes, third excursion at 5.05 Degrees Fahrenheit for 20 minutes, forth excursion at 5.02 Degrees Fahrenheit for 21 minutes, fifth excursion at 5.07 Degrees Fahrenheit for 15 minutes, sixth excursion at 5.11 Degrees Fahrenheit 29 minutes, seventh excursion at 5.05 degrees Fahrenheit for 13 minutes, eighty excursion at 5.05 degrees Fahrenheit for 34 minutes and ninth excursion at 5.11 Degrees Fahrenheit for unspecified time. On 09-Aug-2022, the vials were initially moved from freezer to refrigerator and vials were in the refrigerator under quarantine currently. Upon visual inspection vaccines appeared normal after the excursion and they were currently in the refrigerator. It was stated that, up to 9 vials from the carton of Moderna COVID-19 vaccine have been administered to patients and it was not known which dose in the series that the patient received vaccine that had undergone multiple temperature excursions. No other adverse reactions were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Follow up received contains no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions; Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) in a 53-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.). No concomitant medications were reported. Patient weight was unknown. The pharmacist reported that, the vaccine underwent multiple temperature excursion and the storage condition at the time of temperature excursion was frozen. The maximum or minimum temperatures reached (specify temperature was in C or F) were as follows; first excursion at 5.05 Degrees Fahrenheit for 28 minutes, second excursion at 5.22 Degrees F for 28 minutes, third excursion at 5.05 Degrees Fahrenheit for 20 minutes, forth excursion at 5.02 Degrees Fahrenheit for 21 minutes, fifth excursion at 5.07 Degrees Fahrenheit for 15 minutes, sixth excursion at 5.11 Degrees Fahrenheit 29 minutes, seventh excursion at 5.05 degrees Fahrenheit for 13 minutes, eighty excursion at 5.05 degrees Fahrenheit for 34 minutes and ninth excursion at 5.11 Degrees Fahrenheit for unspecified time. On 09-Aug-2022, the vials were initially moved from freezer to refrigerator and vials were in the refrigerator under quarantine currently. Upon visual inspection vaccines appeared normal after the excursion and they were currently in the refrigerator. It was stated that, up to 9 vials from the carton of Moderna COVID-19 vaccine have been administered to patients and it was not known which dose in the series that the patient received vaccine that had undergone multiple temperature excursions. No other adverse reactions were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Follow-up document received includes no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.; Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) in an 18-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.), PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna COVID-19 vaccine that had undergone multiple temperature excursions.). Patient weight was unknown. No concomitant medications were reported. The pharmacist reported that, the vaccine underwent multiple temperature excursion and the storage condition at the time of temperature excursion was frozen. The maximum or minimum temperatures reached (specify temperature was in C or F) were as follows; first excursion at 5.05 Degrees Fahrenheit for 28 minutes, second excursion at 5.22 Degrees F for 28 minutes, third excursion at 5.05 Degrees Fahrenheit for 20 minutes, forth excursion at 5.02 Degrees Fahrenheit for 21 minutes, fifth excursion at 5.07 Degrees Fahrenheit for 15 minutes, sixth excursion at 5.11 Degrees Fahrenheit 29 minutes, seventh excursion at 5.05 degrees Fahrenheit for 13 minutes, eighty excursion at 5.05 degrees Fahrenheit for 34 minutes and ninth excursion at 5.11 Degrees Fahrenheit for unspecified time. On 09-Aug-2022, the vials were initially moved from freezer to refrigerator and vials were in the refrigerator under quarantine currently. Upon visual inspection vaccines appeared normal after the excursion and they were currently in the refrigerator. It was stated that, up to 9 vials from the carton of Moderna COVID-19 vaccine have been administered to patients and it was not known which dose in the series that the patient received vaccine that had undergone multiple temperature excursions. No other adverse reactions were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2022: Follow-up document received contains no new information to add
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 11.08.2022
- Impfdatum
- 12.07.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Vaccination site bruising
Vaccination site discolouration
Vaccination site warmth
Symptomtext
injection site is really hot; injection site is bruised; injection site is dark; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE WARMTH (injection site is really hot), VACCINATION SITE BRUISING (injection site is bruised) and VACCINATION SITE DISCOLOURATION (injection site is dark) in a 39-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. It was reported that patient had no allergies. Patient never had COVID positive test or diagnosis. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. No medical history reported by the patient. On 12-Jul-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced VACCINATION SITE WARMTH (injection site is really hot), VACCINATION SITE BRUISING (injection site is bruised) and VACCINATION SITE DISCOLOURATION (injection site is dark). At the time of the report, VACCINATION SITE WARMTH (injection site is really hot), VACCINATION SITE BRUISING (injection site is bruised) and VACCINATION SITE DISCOLOURATION (injection site is dark) had not resolved. The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown. No concomitant medications information was reported. The patient never experienced similar event in the past. AE did not cause patient to seek medical care. There was no change in the symptoms. No treatment medications were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was reported that patient had no allergies. Patient never had COVID positive test or diagnosis. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. No medical history reported by the patient.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 10.08.2022
- Impfdatum
- 02.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Inappropriate dose for age given. No immediate or after affects reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 10.08.2022
- Impfdatum
- 28.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product temperature excursion issue
Symptomtext
Temperature excursions duration 7 days/ the vial undergo temperature excursions; No adverse event; Dose administered after exposure to room temperature >24 hours; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after exposure to room temperature >24 hours), PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions duration 7 days/ the vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after exposure to room temperature >24 hours). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions duration 7 days/ the vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after exposure to room temperature >24 hours), PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions duration 7 days/ the vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after exposure to room temperature >24 hours) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions duration 7 days/ the vial undergo temperature excursions). It was unknown that other vaccines were received by the patient within 1 month prior to Moderna COVID-19 vaccine. It was unknown that patient received any concomitant and treatment medication. It was unknown that patient received a full dose for primary series or a booster dose. Number of doses/vials were 1 dose from 1 vial. It was unknown when the vial was initially stored in the refrigerator. It was reported that vial undergone temperature excursion for 7 days. Storage condition at the time of the excursion was room temperature.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 05.08.2022
- Impfdatum
- 28.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
The client was vaccinated on 7/28/2022 with an expired Moderna vaccine. The vaccine was thawed and accidentally used 1 day following the marked B.U.D. date of 7/27/2022. Pt tolerated vaccination well on 7/27/2022. The vaccine administration error was not realized until after vaccination clinic ended and RN returned thawed/non-punctured Moderna vaccine to Pharmacy. Safety event completed in Pharmacy, team leadership aware. Additional safety checks and protocols put into place to mitigate future risk of administration errors in both the Pharmacy as well as on our City Mobile vaccination team.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 05.08.2022
- Impfdatum
- 28.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
The client was vaccinated on 7/28/2022 with an expired Moderna vaccine. The vaccine was thawed and accidentally used 1 day following the marked B.U.D. date of 7/27/2022. Pt tolerated vaccination well on 7/27/2022. The vaccine administration error was not realized until after vaccination clinic ended and RN returned thawed/non-punctured Moderna vaccine to Pharmacy at the HCF. Safety event completed in the Pharmacy, team leadership aware. Additional safety checks and protocols put into place to mitigate future risk of administration errors in both the Pharmacy as well as on our City Mobile vaccination team.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 05.08.2022
- Impfdatum
- 28.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
The client was vaccinated on 7/28/2022 with an expired Moderna vaccine. The vaccine was thawed and accidentally used 1 day following the marked B.U.D. date of 7/27/2022. Pt tolerated vaccination well on 7/27/2022. The vaccine administration error was not realized until after vaccination clinic ended and RN returned thawed/non-punctured Moderna vaccine to Pharmacy. Safety event completed in Pharmacy, team leadership aware. Additional safety checks and protocols put into place to mitigate future risk of administration errors in both the Pharmacy as well as on our Mobile vaccination team.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Pt is allergic to Penicillin
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 05.08.2022
- Impfdatum
- 28.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
The client was vaccinated on 7/28/2022 with an expired Moderna vaccine. The vaccine was thawed and accidentally used 1 day following the marked B.U.D. date of 7/27/2022. Pt tolerated vaccination well on 7/27/2022. The vaccine administration error was not realized until after vaccination clinic ended and RN returned thawed/non-punctured Moderna vaccine to Pharmacy. Safety event completed in Pharmacy, team leadership aware. Additional safety checks and protocols put into place to mitigate future risk of administration errors in both the Pharmacy as well as on our Mobile vaccination team.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 05.08.2022
- Impfdatum
- 28.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
The client was vaccinated on 7/28/2022 with an expired Moderna vaccine. The vaccine was thawed and accidentally used 1 day following the marked B.U.D. date of 7/27/2022. Pt tolerated vaccination well on 7/27/2022. The vaccine administration error was not realized until after vaccination clinic ended and RN returned thawed/non-punctured Moderna vaccine to Pharmacy. Safety event completed in Pharmacy, team leadership aware. Additional safety checks and protocols put into place to mitigate future risk of administration errors in both the Pharmacy as well as on our Mobile vaccination team.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 05.08.2022
- Impfdatum
- 28.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
The client was vaccinated on 7/28/2022 with an expired Moderna vaccine. The vaccine was thawed and accidentally used 1 day following the marked B.U.D. date of 7/27/2022. Pt tolerated vaccination well. The vaccine administration error was not realized until after vaccination clinic ended and RN returned unused vaccine to Pharmacy. Safety event completed in Pharmacy, team leadership aware. Additional safety checks and protocols put into place to mitigate future risk of administration errors in both the Pharmacy as well as on our Mobile vaccination team.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 04.08.2022
- Impfdatum
- 25.07.2022
- Beginn
- 25.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
No known side effects occurred. The patient was given a dose of 0.5ml for their booster shot and should have received a 0.25ml dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 28.07.2022
- Impfdatum
- 01.07.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna Covid-19 vaccine that underwent a temperature excursion; Patient received Moderna Covid-19 vaccine that underwent a temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Janssen (Batch number-1855835 and Dose 1.) on 18-Jan-2022. Past adverse reactions to the above products included No adverse event with Janssen. On 01-Jul-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications information was reported. The Nurse had discovered 2 temperature excursions of the Moderna Covid-19 vaccine for two different lot numbers of the Moderna Covid-19 vaccine. The temperature in the refrigerator that the Moderna Covid-19 vaccine reached 13.1 degrees Celsius on 28-Jun-2022 and on 19-Jul-2022, the vaccine reached a temperature of 9 degrees Celsius. None of the vaccine in the refrigerator underwent two different temperature excursions. The temperature excursion was not known of at the time of administration of the vaccine. The temperature excursion was found out about after a review of the temperature datalogger on the refrigerator that the Moderna Covid-19 vaccine was stored in. The Nurse had used the online Temperature excursion tool and was comfortable that her patients doses were valid and that the affected vaccine was viable for future doses. Side effects after any dose was reported as unknown. No treatment medications were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Poor quality product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- 06.07.2022
- Beginn
- 06.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Poor quality product administered
Product temperature excursion issue
Symptomtext
Patient received Moderna Covid-19 vaccine that underwent a temperature excursion; Patient received Moderna Covid-19 vaccine that underwent a temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: Janssen Vaccine (Batch number- 1808980) on 05-May-2021. Past adverse reactions to the above products included No adverse event with Janssen Vaccine. On 06-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Patient's weight was unknown. It was reported that the patient received Moderna Covid-19 vaccine that underwent a temperature excursion. The temperature excursion was not known of at the time of administration of the vaccine. The temperature excursion was found out about after a review of the temperature datalogger on the refrigerator that the Moderna Covid-19 vaccine was stored in. The Nurse has used the online Temperature excursion tool and was comfortable that her patient dose was valid and that the affected vaccine was viable for future doses. Side effects after any doses was unknown. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Poor quality product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 28.07.2022
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator was on 15-Jun-2022 and the vaccine was administered on 21-Jul-2022; The patient received COVID-19 vaccine past its Use by date of 16-Jul-2022 in her left arm on 21-Jul-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received COVID-19 vaccine past its Use by date of 16-Jul-2022 in her left arm on 21-Jul-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator was on 15-Jun-2022 and the vaccine was administered on 21-Jul-2022) in a 75-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 21-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received COVID-19 vaccine past its Use by date of 16-Jul-2022 in her left arm on 21-Jul-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator was on 15-Jun-2022 and the vaccine was administered on 21-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received COVID-19 vaccine past its Use by date of 16-Jul-2022 in her left arm on 21-Jul-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator was on 15-Jun-2022 and the vaccine was administered on 21-Jul-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. The vial did not undergo any temperature excursions. The reporter reported that the patient was administered with Moderna COVID-19 vaccine past the 30 day use by date. No treatment information was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 27.07.2022
- Impfdatum
- 20.07.2022
- Beginn
- 20.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Wrong technique in product usage process
Symptomtext
Doctor gave vaccine in June and again in July from same opened vial. Did not realize use-by was 12 hour after puncturing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 26.07.2022
- Impfdatum
- 25.07.2022
- Beginn
- 25.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
A half dose (0.25) was given for the second primary injection, rather than administering a full dose (0.5).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 25.07.2022
- Impfdatum
- 20.06.2022
- Beginn
- 20.07.2022
- Tage bis Beginn
- 30,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Inappropriate schedule of product administration
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after three vaccines ; Moderna 11/22/21 Lot# 034F21A; Moderna 12/22/21 Lot# 067H21A; Moderna 6/20/22 Lot# 014B22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 25.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 17.07.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Lymphadenopathy
Symptomtext
Systemic: Lymph Node Swelling-Medium, Additional Details: Pt developed lymph node swelling under shoulder on same side as vaccine (left). pt has discussed with dr and dr is monitoring
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Lymphadenopathy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 24.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 18.07.2022
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Dose administered after exposure to room temperature greater than 24 hours/dose was administered outside the standard time frame; Dose administered after exposure to room temperature greater than 24 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after exposure to room temperature greater than 24 hours/dose was administered outside the standard time frame) and PRODUCT STORAGE ERROR (Dose administered after exposure to room temperature greater than 24 hours) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-Jul-2022 at 1:00 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 18-Jul-2022 at 10:30 AM, the patient experienced PRODUCT STORAGE ERROR (Dose administered after exposure to room temperature greater than 24 hours). On 19-Jul-2022 at 1:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after exposure to room temperature greater than 24 hours/dose was administered outside the standard time frame). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after exposure to room temperature greater than 24 hours/dose was administered outside the standard time frame) and PRODUCT STORAGE ERROR (Dose administered after exposure to room temperature greater than 24 hours) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant drug was reported. It was reported that vial was taken out of the fridge on 18-Jul-2022 at 10:30 AM. It was also reported that vial did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8 degree celcius to 25 degree celcius is equal to 46 degree to 77 degree F) was reported as 27 hours approximately. No treatment medications were reported
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vial was placed in the refrigerator on 16-Jun-2022 with a use by date of 17-Jul-2022 and was administered on 19-Jul-2022; Moderna dose administered to patient after use by date of 17-Jul-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna dose administered to patient after use by date of 17-Jul-2022) and PRODUCT STORAGE ERROR (Vial was placed in the refrigerator on 16-Jun-2022 with a use by date of 17-Jul-2022 and was administered on 19-Jul-2022) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna dose administered to patient after use by date of 17-Jul-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was placed in the refrigerator on 16-Jun-2022 with a use by date of 17-Jul-2022 and was administered on 19-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna dose administered to patient after use by date of 17-Jul-2022) and PRODUCT STORAGE ERROR (Vial was placed in the refrigerator on 16-Jun-2022 with a use by date of 17-Jul-2022 and was administered on 19-Jul-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information provided. The vial did not undergo any temperature excursions. No treatment medication information provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
A dose of Moderna Covid-19 vaccine was given today from a vial greater than 12 hrs after 1st puncture, but not more than 24 hrs.; Vial was first punctured and then stored in room temperature for greater than 12 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A dose of Moderna Covid-19 vaccine was given today from a vial greater than 12 hrs after 1st puncture, but not more than 24 hrs.) and PRODUCT STORAGE ERROR (Vial was first punctured and then stored in room temperature for greater than 12 hours) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Jul-2022 at 10:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jul-2022, the patient experienced PRODUCT STORAGE ERROR (Vial was first punctured and then stored in room temperature for greater than 12 hours). On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (A dose of Moderna Covid-19 vaccine was given today from a vial greater than 12 hrs after 1st puncture, but not more than 24 hrs.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A dose of Moderna Covid-19 vaccine was given today from a vial greater than 12 hrs after 1st puncture, but not more than 24 hrs.) and PRODUCT STORAGE ERROR (Vial was first punctured and then stored in room temperature for greater than 12 hours) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment details were reported. It was reported that the dose was given past 12 hours post punctured. Number of doses/vials was 1 dose. Vial was initially stored in the refrigerator on 06-Jul-2022 Vial was first punctured on 14-Jul-2022 Vial was stored in the Room temperature post punctured. Vial did not undergo any temperature excursions. Vial was not exposed to room temperature more than 24 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 23.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Patients received first dose 0.25ml from Red Cap adult vial; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (Patients received first dose 0.25ml from Red Cap adult vial) in a 4-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Jul-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jul-2022, the patient experienced INCORRECT DOSE ADMINISTERED (Patients received first dose 0.25ml from Red Cap adult vial). At the time of the report, INCORRECT DOSE ADMINISTERED (Patients received first dose 0.25ml from Red Cap adult vial) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant drug was reported. The patient received Moderna COVID-19 vaccine from a vial with red cap and a label with light blue border. No Treatment medications were reported. This case was linked to MODERNATX, INC.-MOD-2022-609133 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2022-609133:CMOD22-03372- crosslink (2 year 11 months old patient), Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Patient received Moderna Covid-19 vaccine that was first placed in the Pharmacies refrigerator more than 30 days ago. 35 days to be exact; Beyond use date of the vaccine was 8JUL2022, and the date that the vaccine was administered was 13Jul2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Beyond use date of the vaccine was 8JUL2022, and the date that the vaccine was administered was 13Jul2022) and PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine that was first placed in the Pharmacies refrigerator more than 30 days ago. 35 days to be exact) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 13-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 13-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Beyond use date of the vaccine was 8JUL2022, and the date that the vaccine was administered was 13Jul2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine that was first placed in the Pharmacies refrigerator more than 30 days ago. 35 days to be exact). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Beyond use date of the vaccine was 8JUL2022, and the date that the vaccine was administered was 13Jul2022) and PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine that was first placed in the Pharmacies refrigerator more than 30 days ago. 35 days to be exact) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant products were reported. Manufacturer expiration date of the vaccine was reported as 11-Nov-2022. The vial didn't undergo any temperature excursions. No treatment drugs were reported Reporter did not allow further contact
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 23.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
(Moderna) Vaccine was given beyond the refrigeration use; (Moderna) Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 13-Jul-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use). At the time of the report, EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications details were not reported by the reporter. On 02-Jun-2022 vial was initially stored in the refrigerator and vaccine was administered on 07-Jul-2022. It was reported that patient received first booster dose. The vial does not undergo any temperature excursions. Treatment details were not reported by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 23.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 02-Jun-2022 and was administered on 12-Jul-2022; (Moderna) Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 02-Jun-2022 and was administered on 12-Jul-2022) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 02-Jun-2022 and was administered on 12-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 02-Jun-2022 and was administered on 12-Jul-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant product use was provided. The vial was initially stored in the refrigerator on 02-Jun-2022. The vial did not undergo any temperature excursion. No treatment medication was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 23.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
This spontaneous case was reported by a medical assistant and describes the occurrence of INCORRECT DOSE ADMINISTERED (Pediatric patient of age 2 year 11 months old received first dose 0.25ml from Red Cap adult vial) in a 2-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Jul-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jul-2022, the patient experienced INCORRECT DOSE ADMINISTERED (Pediatric patient of age 2 year 11 months old received first dose 0.25ml from Red Cap adult vial). At the time of the report, INCORRECT DOSE ADMINISTERED (Pediatric patient of age 2 year 11 months old received first dose 0.25ml from Red Cap adult vial) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient's age reported as 2 year 11 months old. No concomitant medications were reported. No treatment details were reported. It was reported that the patient received Moderna COVID-19 Vaccine dose of 0.25 ml from a vial with red cap and a label with light blue border with order number NDC: 80777-273-10. Reporter already notified the health department.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 22.07.2022
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient was administered vaccine on 7/21/22 with use before date of 7/16/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 22.07.2022
- Impfdatum
- 22.06.2022
- Beginn
- 30.06.2022
- Tage bis Beginn
- 8,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Blood pressure decreased
Cardiac pacemaker insertion
Electrocardiogram
Pericardial effusion
Symptomtext
Ended up with fluid around my heart and had to get a pace maker because my bottom number of my heart dropped.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood pressure decreased
- Hospital-Tage
- 4,0
- Labordaten
- 6/30/22 through 7/3/2022 Ekgs,
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- fibromyalgia and type 2 diabetes
- Andere Medikamente
- Multi vitamins, vitamin D, vitamin B12 metformin, lisinopryl, escilatopram, and trulicity
- Allergien
- cymbalta
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 21.07.2022
- Impfdatum
- 18.07.2022
- Beginn
- 18.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Medication pulled from freezer, dated with 70 day expiration date instead of 30 day. Patient received medication that was expired by two days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
There was Moderna vaccine on the counter at room temperature and this was used to give patient her second booster of moderna vaccine, 0.25mL. It was discovered after the fact that this was taken out the day prior on 7/18/2022 at 10:30AM and had not been discarded at the end of the day. The vial had not been labeled with the date and time it was removed from the fridge. Patient did not have a reaction to the vaccine given and displayed no signs or symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- COVID-19 (6/23/2022)
- Vorgeschichte
- Diabetic, hypercholesterolemia, hypothyroidism
- Andere Medikamente
- Alogliptin, aspirin, atrovastatin, levothyroxine, cyclobezapri
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 19.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Error: Administered expired product.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 19.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 19.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 19.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
(Moderna) Vaccine was given beyond the refrigeration use; (Moderna) Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use). At the time of the report, EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. The vial was initially stored in the refrigerator on 02-Jun-2022. The vial does not undergo any temperature excursions. No treatment medications was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 19.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Moderna Vaccine was given beyond the refrigeration use; Moderna Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (Moderna Vaccine was given beyond the refrigeration use) in a 34-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-Jul-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Vaccine was given beyond the refrigeration use). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (Moderna Vaccine was given beyond the refrigeration use) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided. The vial was initially stored in the refrigerator on 02-Jun-2022 The vial did not undergo any temperature excursion. Treatment information was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 19.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
initially stored in the refrigerator JUNE 02 2022 and the vaccine was given on 11 July 2022; Moderna Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (initially stored in the refrigerator JUNE 02 2022 and the vaccine was given on 11 July 2022) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 11-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (initially stored in the refrigerator JUNE 02 2022 and the vaccine was given on 11 July 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (initially stored in the refrigerator JUNE 02 2022 and the vaccine was given on 11 July 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant medications were provided. The vial was initially stored in the refrigerator on 02 Jun 2022. The vial did not undergo any temperature excursions. No treatment medications were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
(Moderna) Vaccine was given beyond the refrigeration use; (Moderna) Vaccine was given beyond the refrigeration use; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 11-Jul-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use). At the time of the report, EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. No treatment medications was reported. The vial was initially stored in the refrigerator on 02-Jun-2022. The vial does not undergo any temperature excursions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 19.07.2022
- Impfdatum
- 08.07.2022
- Beginn
- 08.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
(Moderna) Vaccine was given beyond the refrigeration use; (Moderna) Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use). At the time of the report, EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. The vial was initially stored in the refrigerator on 02-Jun-2022. The vial does not undergo any temperature excursions. No treatment medications was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 08.07.2022
- Beginn
- 08.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 08-Jul-2022.; Moderna vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 08-Jul-2022.) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 08-Jul-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 08-Jul-2022.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. The vial was initially stored in the refrigerator on 02 Jun 2022. The vial did not undergo any temperature excursions. No treatment medications were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.; Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 07-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications details were not reported by the reporter. 5 vials were involved and 9 doses were administered to patients. on 02-Jun-2022 vial was initially stored in the refrigerator and vaccine was administered on 07-Jul-2022. It was reported that patient received second booster dose. The vial does not undergo any temperature excursions. Treatment details were not reported by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 09.07.2022
- Beginn
- 09.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
they received the Moderna on 08Jun2022 refrigerated with 30 day use by date of 08Jul2022.; adult patient received Moderna COVID-19 vaccine after 30 day BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (adult patient received Moderna COVID-19 vaccine after 30 day BUD) and PRODUCT STORAGE ERROR (they received the Moderna on 08Jun2022 refrigerated with 30 day use by date of 08Jul2022.) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. The patient had no known drug allergy (KNDA). It was unknown whether the patient was never diagnosed/tested positive for COVID-19. It was unknown whether the patient had any acute illness at the time of vaccination and up to one month before it. Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE on 15-May-2021. Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE. Concurrent medical conditions included Hypertension, Hypercholesterolaemia and Diabetes. Concomitant products included LEVOTHYROXINE, WARFARIN, SIMVASTATIN and METOPROLOL for an unknown indication. On 09-Jul-2022 at 9:56 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milligram. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (adult patient received Moderna COVID-19 vaccine after 30 day BUD). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (they received the Moderna on 08Jun2022 refrigerated with 30 day use by date of 08Jul2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (adult patient received Moderna COVID-19 vaccine after 30 day BUD) and PRODUCT STORAGE ERROR (they received the Moderna on 08Jun2022 refrigerated with 30 day use by date of 08Jul2022.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (adult patient received Moderna COVID-19 vaccine after 30 day BUD) and PRODUCT STORAGE ERROR (they received the Moderna on 08Jun2022 refrigerated with 30 day use by date of 08Jul2022.) to be not related. The vial was initially stored in the refrigerator on 08-Jun-2022. The best use by date was 08-Jul-2022. The patient had inadvertently given one day past the 30-day refrigeration date. The patient had no adverse reaction. The patient did not seek medical care in response to the event. The patient did not experience similar event in the past. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2022: Follow up received include significant information removed classification of invalid, reporter details, patient initials, age, ethnic, race, added historical vaccine and suspect vaccine details, added concomitant medications, updated reporter causality from not provided to not related and narrative updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Diabetes; Hypercholesterolaemia; Hypertension
- Vorgeschichte
- Comments: The patient had no known drug allergy (KNDA). It was unknown whether the patient was never diagnosed/tested positive for COVID-19. It was unknown whether the patient had any acute illness at the time of vaccination and up to one month before it.
- Andere Medikamente
- LEVOTHYROXINE; WARFARIN; SIMVASTATIN; METOPROLOL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 15.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient given a 2nd booster when not approved under 50 years of age.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 15.07.2022
- Impfdatum
- 16.06.2022
- Beginn
- 16.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
had a vial of Moderna in their refrigerator and it eclipsed the 30 days by one day; the pharmacy had a vial of Moderna in their refrigerator and it eclipsed the 30 days by one day and they inadvertently gave a dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (the pharmacy had a vial of Moderna in their refrigerator and it eclipsed the 30 days by one day and they inadvertently gave a dose) and PRODUCT STORAGE ERROR (had a vial of Moderna in their refrigerator and it eclipsed the 30 days by one day) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 11-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (the pharmacy had a vial of Moderna in their refrigerator and it eclipsed the 30 days by one day and they inadvertently gave a dose). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (had a vial of Moderna in their refrigerator and it eclipsed the 30 days by one day). At the time of the report, EXPIRED PRODUCT ADMINISTERED (the pharmacy had a vial of Moderna in their refrigerator and it eclipsed the 30 days by one day and they inadvertently gave a dose) and PRODUCT STORAGE ERROR (had a vial of Moderna in their refrigerator and it eclipsed the 30 days by one day) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. On 10-Jun-2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. There was no adverse event and product complain associated with this case. No treatment medication was reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2022: Live follow up received and Batch Number was added.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Patient received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator on 10JUN2022; The patient received vaccine past the 30 day use by date as his second booster dose of the Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received vaccine past the 30 day use by date as his second booster dose of the Moderna Covid-19 vaccine) and PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator on 10JUN2022) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 11-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received vaccine past the 30 day use by date as his second booster dose of the Moderna Covid-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator on 10JUN2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received vaccine past the 30 day use by date as his second booster dose of the Moderna Covid-19 vaccine) and PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator on 10JUN2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Dosage text was reported as second booster dose. Number of doses or vials were 4 doses. Date the vial was initially stored in the refrigerator was on 10-Jun-2022 at 10:38 PM. The vial did not underwent any temperature excursions. The patient received the vaccine in his left arm shoulder deltoid muscle and reported no other adverse reactions or side effects. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2022-606358, US-MODERNATX, INC.-MOD-2022-606349, US-MODERNATX, INC.-MOD-2022-606336 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-606358:Same reporter US-MODERNATX, INC.-MOD-2022-606349:Same reporter US-MODERNATX, INC.-MOD-2022-606336:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 15.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 10-Jun-2022 at 10:38 pm and the vaccine was administered on 11-Jul-2022; patient received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jun-2022 at 10:38 pm and the vaccine was administered on 11-Jul-2022) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On 11-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jun-2022 at 10:38 pm and the vaccine was administered on 11-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jun-2022 at 10:38 pm and the vaccine was administered on 11-Jul-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. On 11-Jul-2022, the patient received second booster dose. Date the vial was initially stored in the refrigerator on 10-JUN-2022 at 10:38PM.The vial did not undergo any temperature excursions. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2022-606336, US-MODERNATX, INC.-MOD-2022-606349, US-MODERNATX, INC.-MOD-2022-606361 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-606336:Same reporter US-MODERNATX, INC.-MOD-2022-606349:Same reporter US-MODERNATX, INC.-MOD-2022-606361:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
the vial was initially stored in the refrigerator on 10-JUN-2022 at 10:38PM, administration of vaccine on 11-JUL-2022; 4 patients received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 patients received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 10-JUN-2022 at 10:38PM, administration of vaccine on 11-JUL-2022) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis. No Medical History information was reported. On 11-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 patients received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 10-JUN-2022 at 10:38PM, administration of vaccine on 11-JUL-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 patients received Moderna Covid-19 vaccine 31 days after the vaccine was placed in the refrigerator) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 10-JUN-2022 at 10:38PM, administration of vaccine on 11-JUL-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant drug was reported. The patient received vaccine past the 30 day use by date as her second booster dose. It was reported that the vial did not undergo any temperature excursions. The patient received the vaccine in left arm shoulder deltoid muscle and reports no other adverse reactions or side effects. No treatment drug was reported. This case was linked to US-MODERNATX, INC.-MOD-2022-606358, US-MODERNATX, INC.-MOD-2022-606361 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-606358:Same reporter US-MODERNATX, INC.-MOD-2022-606361:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 10-Jun-2022 at 10:38 pm and the vaccine was administered on 11-Jul-2022; patient received Moderna COVID-19 vaccine 31 days after the vaccine was placed in the refrigerator; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jun-2022 at 10:38 pm and the vaccine was administered on 11-Jul-2022) and EXPIRED PRODUCT ADMINISTERED (patient received Moderna COVID-19 vaccine 31 days after the vaccine was placed in the refrigerator) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer (primary series (first dose)), Pfizer (primary series (first booster dose)) and Pfizer (primary series (second dose)). Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. On 11-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received Moderna COVID-19 vaccine 31 days after the vaccine was placed in the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jun-2022 at 10:38 pm and the vaccine was administered on 11-Jul-2022). At the time of the report, PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jun-2022 at 10:38 pm and the vaccine was administered on 11-Jul-2022) and EXPIRED PRODUCT ADMINISTERED (patient received Moderna COVID-19 vaccine 31 days after the vaccine was placed in the refrigerator) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. The vial did not undergo any temperature excursions. The patient did not report any other adverse reactions or side effects. No treatment information was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Inappropriate schedule of product administration
Symptomtext
Patient was administered their 3rd dose (1st booster) on 3/24/2022 and their 4th dose (2nd booster) on 7/14/2022. The second booster was 10 days early. No clinical problems were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Type 2 Diabetes
- Andere Medikamente
- None Reported
- Allergien
- None Reported
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
patient was given vaccine on 7/13/22 which had a refrigeration expiration date of 7/2/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 14.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
patient was given vaccine on 7/12/22 which had a refrigeration expiration date of 7/2/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
patient was given vaccine on 7/12/22 which had a refrigeration expiration date of 7/2/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 14.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
patient was given vaccine on 7/8/22 which had a refrigeration expiration date of 7/2/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 14.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient was given vaccine on 7/8/22 which had a refrigeration expiration date of 7/2/2022. This was second booster dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
patient was given vaccine on 7/8/22 which had a refrigeration expiration date of 7/2/2022. This was second booster dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 14.07.2022
- Impfdatum
- 08.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 6,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
patient was given vaccine on 7/8/22 which had a refrigeration expiration date of 7/2/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 08.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 6,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
patient was given vaccine on 7/8/22 which had a refrigeration expiration date of 7/2/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 7,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient was administered vaccine on 7/7 which had an refrigerator expiration date of 7/2.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 23,0
- Geschlecht
- M
- Eingang
- 12.07.2022
- Impfdatum
- 05.07.2022
- Beginn
- 05.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 12.07.2022
- Impfdatum
- 24.06.2022
- Beginn
- 24.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Discomfort
Nasopharyngitis
SARS-CoV-2 test positive
Sneezing
Symptomtext
I had discomfort the first few days with the booster. Then on July 7th, 2022 I started feeling like I had a bad cold. I took a home test for COVID and it came back positive. I went to the pharmacy and did a test there through the drive through, and it came back the next day positive. I was sneezing, coughing, headache, and it felt like a huge head cold. I did not have trouble with my lungs or coughing. When I started to feel better, then around 2 days after that I started having stomach problems, heavy fatigue, and coughing began. Today, July 12, I feel much better. So in total the symptoms lasted around 10 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID test with positive result
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes; high blood pressure; breast cancer 2011; stroke in 2016
- Andere Medikamente
- Vitamin D3; aspirin; Metformin; Glimepiride; Atorvastatin; Carvedilol
- Allergien
- None
- Vorherige Impfungen
- Pneumonia shot 2021, due to no one telling me that I didn't need more then one. I had 9. The 9th one is the one I reacted badly
- Staat
- WI
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 11.07.2022
- Impfdatum
- 09.07.2022
- Beginn
- 09.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
none- vaccine was administered 1 day past best by date
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 11.07.2022
- Impfdatum
- 09.07.2022
- Beginn
- 09.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
none, patient was given IMZ 1 day past best by date
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- diabetes, high blood pressure
- Andere Medikamente
- Levothyroxine, warfarin, simvastatin, Lantus, metoprolol er
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 11.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
Error: Wrong Vaccine/Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 9,0
- Geschlecht
- F
- Eingang
- 09.07.2022
- Impfdatum
- 09.07.2022
- Beginn
- 09.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
NO ADVERSE EFFECTS. PARENTS OF PATIENT REQUESTED THE MODERNA BOOSTER FOR THEIR DAUGHTER. AT THE VACCINATIONTABLE IT WAS AGAIN REQUESTED. THE VACCINE WAS ORDERED BY THE VACCINATOR AND BROUGHT TO THE STATTION. THE VACCINATOR ADMINISTERED THE VACCINE. AFTER THE ADMINISTATION, SHE REALIZED HER ERROR. AND REPORTED IT TO THE SITE LEAD.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- ukn
- Vorgeschichte
- none
- Andere Medikamente
- ukn
- Allergien
- ukn
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 09.07.2022
- Impfdatum
- 09.07.2022
- Beginn
- 09.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
NO ADVERSE EFFECTS. PARENTS OF PATIENT REQUESTED THE MODERNA BOOSTER FOR THEIR DAUGHTER. AT THE VACCINATIONTABLE IT WAS AGAIN REQUESTED. THE VACCINE WAS ORDERED BY THE VACCINATOR AND BROUGHT TO THE STATTION. THE VACCINATOR ADMINISTERED THE VACCINE. AFTER THE ADMINISTATION, SHE REALIZED HER ERROR. AND REPORTED IT TO THE SITE LEAD.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- ukn
- Vorgeschichte
- none
- Andere Medikamente
- ukn
- Allergien
- ukn
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 09.07.2022
- Impfdatum
- 02.07.2022
- Beginn
- 04.07.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Tinnitus
Symptomtext
Started hearing loud humming/tinny sound in my head (not really in my ears). Would intensify in the morning and late afternoon. It is a persistent high pitched noise.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tinnitus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DC
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 08.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Inappropriate schedule of product administration
Symptomtext
Patient had his first Booster Moderna COVID 19 vaccine on April 7th, 2022 and he presented to clinic to get the 2nd Booster yesterday on June 7th 2022, 3 months after first booster, the health care staff who administered the vaccine thought it was 4Months since the first booster and gave it to patient then reported to the supervisor when realized that it was only 3 months
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- No tests order, No Adverse event noted .. This is to report the error made regarding the interval.. vaccine given one Month earlier.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Type II Diabetes Hypertension
- Andere Medikamente
- Vaccine error- Moderna 2nd booster dose given 1 month earlier--No Adverse event identified
- Allergien
- Tylenol ASA Simvastatin
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 07.07.2022
- Impfdatum
- 27.06.2022
- Beginn
- 27.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
On 6/27/22, patient received Moderna COVID vaccine (lot # 014B22A) that has been left on in room temperature since 6/24/22. Moderna was contacted and they performed an analysis of the vials associated with the storage excursion for this event. They found that the vaccine administered on 6/27/22 from lot # 014B22A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Patient was informed of the incident and to watch for any signs of infection (which did not occur).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- calcium, vitamin d3, folic acid, mvi
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 55,0
- Geschlecht
- M
- Eingang
- 07.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Interchange of vaccine products
Symptomtext
Patient originally told us that he had not had any previous COVID vaccine doses and that this would be his first dose entirely. He also confirmed this in the immunization room prior to vaccination and which time we discussed when he would return for his second dose. Patient chose to get Moderna after an explanation on both Pfizer and Moderna that we had in stock. After the vaccination was complete, the patient's wife came to the pharmacy stating we gave him a new card which he doesn't need because he already has one. We discussed that he indicated he had no previous doses so I asked her to have him return to the pharmacy with his card so we could take a look at it. When he returned we discovered he had received one previous dose of the Pfizer vaccine on 2/11/22 from a different facility. Per protocol, patient does not need to re-dose and both he and his wife were advised that he will need to return when he is eligible for his first booster dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Patient had a previous stroke from covid infection
- Vorgeschichte
- Patient had a previous stroke from covid infection
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 07.07.2022
- Impfdatum
- 05.07.2022
- Beginn
- 05.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Confusional state
Fall
Symptomtext
Fall Confusion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Confusional state
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High cholesterol Pre-diabetes Dementia Hypertension
- Andere Medikamente
- Metoprolol Amlopidine Allergy Rosuvastatin
- Allergien
- Tetanus
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 05.07.2022
- Impfdatum
- 30.06.2022
- Beginn
- 30.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 05.07.2022
- Impfdatum
- 01.07.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Error: Dose in Series Given Too Early-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 04.07.2022
- Impfdatum
- 30.06.2022
- Beginn
- 30.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was first punctured on 29-Jun-2022 around 1 PM and administered to patient on 30-Jun-2022 around 3 PM; Vaccine was administered past the 12 hour puncture period; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administered past the 12 hour puncture period) and PRODUCT STORAGE ERROR (The vial was first punctured on 29-Jun-2022 around 1 PM and administered to patient on 30-Jun-2022 around 3 PM) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On 30-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administered past the 12 hour puncture period). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was first punctured on 29-Jun-2022 around 1 PM and administered to patient on 30-Jun-2022 around 3 PM). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administered past the 12 hour puncture period) and PRODUCT STORAGE ERROR (The vial was first punctured on 29-Jun-2022 around 1 PM and administered to patient on 30-Jun-2022 around 3 PM) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Dose for suspect product was reported as second booster dose. It was reported that patient was on a few maintenance medications. It was reported that the vial (1 dose from 1 vial) was initially stored in refrigerator on 28-Jun-2022 and was punctured first on 29-Jun-2022 around 1PM. The vial was stored at room temperature post puncture for around 26 hours and was administered to patient on 30-Jun-2022 around 3 PM. The vial did not undergo any temperature excursion. It was also reported that patient was not experiencing any symptoms and no treatment was given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 04.07.2022
- Impfdatum
- 30.06.2022
- Beginn
- 30.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
received expired 2nd booster of Moderna COVID-19 vaccine 28 hours after first punctured; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired 2nd booster of Moderna COVID-19 vaccine 28 hours after first punctured) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On 30-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired 2nd booster of Moderna COVID-19 vaccine 28 hours after first punctured). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received expired 2nd booster of Moderna COVID-19 vaccine 28 hours after first punctured) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. The vial was initially stored in the refrigerator was on 22-Jun-2022, the vial was first punctured on 29-Jun-2022 around 11 am, the vaccine was administered on 30-Jun-2022 at approximately 3 pm, the vial was stored at room temperature post puncture, the vial did not undergo any temperature excursions and the total amount of time the vial was exposed to room temperature range (8 degree to 25 degree Celsius= 46 degree to 77 degree Fahrenheit) was 28 hours. The reporter reported that the patient had not reported any adverse event. No treatment information was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 03.07.2022
- Impfdatum
- 27.06.2022
- Beginn
- 24.06.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Dose administered >12 hours post puncture & after exposure to room temperature >24 hours; Total amount of time after post puncture the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F) almost 70 hours; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered >12 hours post puncture & after exposure to room temperature >24 hours) and PRODUCT STORAGE ERROR (Total amount of time after post puncture the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F) almost 70 hours) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 vaccination. No Medical History information was reported. On 27-Jun-2022 at 9:52 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jun-2022, the patient experienced PRODUCT STORAGE ERROR (Total amount of time after post puncture the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F) almost 70 hours). On 27-Jun-2022 at 9:52 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered >12 hours post puncture & after exposure to room temperature >24 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered >12 hours post puncture & after exposure to room temperature >24 hours) and PRODUCT STORAGE ERROR (Total amount of time after post puncture the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F) almost 70 hours) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported The vial had been first punctured on Friday & left out at room temperature over the weekend. It was reported that date the vial was initially stored in the refrigerator was 24Jun2022 and on the same day at 12:10pm vial was first punctured. The vial did not undergo any temperature excursions. No treatment medication was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 30.06.2022
- Impfdatum
- 28.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Symptomtext
No adverse effects. Contacted patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Allergic rhinitis.
- Vorgeschichte
- Gastroesophageal reflux; Depressive disorder.
- Andere Medikamente
- Famotidine; Bupropion; Cetirizine; Hydroxyzine; Fluticasone; Probiotics.
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 30.06.2022
- Impfdatum
- 30.06.2022
- Beginn
- 30.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
No adverse event
Symptomtext
There was no adverse reaction to the vaccine. The patient received her 2nd dose of Moderna vaccine too soon. She had gotten her 1st dose on 6/9/2022 so she wasn't due for another week since the dosing interval between the 1st and 2nd doses is 4 weeks. The patient left the vaccine clinic after waiting the 15 minutes with no reactions to the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 30.06.2022
- Impfdatum
- 28.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
Incorrect dose was administered. 0.5 ml was administered Correct dose is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 30.06.2022
- Impfdatum
- 28.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Incorrect dose was administered. 0.5 ml was administered Correct dose is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 30.06.2022
- Impfdatum
- 28.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
Incorrect dose was administered. 0.5 ml was administered. Correct dose is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 30.06.2022
- Impfdatum
- 28.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
Incorrect dose was administered. 0.5 ml was administered Correct dose is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 30.06.2022
- Impfdatum
- 28.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
Incorrect dose was administered. 0.5 ml was administered Correct dose is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 30.06.2022
- Impfdatum
- 28.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
Incorrect dose was administered. 0.5 ml was administered Correct dose is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 30.06.2022
- Impfdatum
- 28.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
Incorrect dose was administered. 0.5 ml was administered. Correct dose is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 30.06.2022
- Impfdatum
- 28.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
Incorrect dose was administered. 0.5 ml was administered. Correct dose is 0.25 ml.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 28.06.2022
- Impfdatum
- 23.06.2022
- Beginn
- 28.06.2022
- Tage bis Beginn
- 5,0
- Dosis
- 4
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Vaccination error
Symptomtext
Client given a 2nd booster but does not meet current requirements for second booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination error
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 20.06.2022
- Impfdatum
- 15.06.2022
- Beginn
- 15.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
No adverse event
Symptomtext
Patient received a full 0.5ml dose instead of the 0.25ml booster dose. This was his 4th Moderna dose (2nd booster). Patient was contacted on Thursday, June 16th and made aware of the error. No adverse effects noted from the patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 17.06.2022
- Impfdatum
- 14.06.2022
- Beginn
- 14.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
Baby received 2nd dose of COVID-19 vaccine with 0.25 ml Moderna COVID-19 vaccine instead of Pfizer COVID-19 vaccine; Baby received 2nd dose of COVID-19 vaccine with 0.25 ml Moderna COVID-19 vaccine instead of Pfizer COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Baby received 2nd dose of COVID-19 vaccine with 0.25 ml Moderna COVID-19 vaccine instead of Pfizer COVID-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Baby received 2nd dose of COVID-19 vaccine with 0.25 ml Moderna COVID-19 vaccine instead of Pfizer COVID-19 vaccine) in a 5-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Pfizer in May 2022. Past adverse reactions to the above products included No adverse event with Pfizer. On 14-Jun-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .25 milliliter. On 14-Jun-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Baby received 2nd dose of COVID-19 vaccine with 0.25 ml Moderna COVID-19 vaccine instead of Pfizer COVID-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Baby received 2nd dose of COVID-19 vaccine with 0.25 ml Moderna COVID-19 vaccine instead of Pfizer COVID-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Baby received 2nd dose of COVID-19 vaccine with 0.25 ml Moderna COVID-19 vaccine instead of Pfizer COVID-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Baby received 2nd dose of COVID-19 vaccine with 0.25 ml Moderna COVID-19 vaccine instead of Pfizer COVID-19 vaccine) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No Concomitant medication was reported Second dose of moderna was supposed to be the 2nd primary Pfizer dose for this patient. No Treatment medication was reported
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 16.06.2022
- Impfdatum
- 13.06.2022
- Beginn
- 13.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Peripheral swelling
Symptomtext
moderna arm red swelling
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- pain
- Andere Medikamente
- none
- Allergien
- codeine, duloxetine, antihistamines
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 10.06.2022
- Beginn
- 10.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
Patient is 40 years and and got second moderna booster 0.25 ml dose. AT the time of emergency use authorization, patient is supposed to be 50 and older or have certain medical conditon for second moderna booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -